BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sartor RB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2006;3:390-407. [PMID: 16819502 DOI: 10.1038/ncpgasthep0528] [Cited by in Crossref: 1075] [Cited by in F6Publishing: 1022] [Article Influence: 67.2] [Reference Citation Analysis]
Number Citing Articles
1 Carbonnel F, Jantchou P, Monnet E, Cosnes J. Environmental risk factors in Crohn's disease and ulcerative colitis: an update. Gastroentérologie Clinique et Biologique 2009;33:S145-57. [DOI: 10.1016/s0399-8320(09)73150-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 12] [Article Influence: 3.1] [Reference Citation Analysis]
2 Okada T, Kanda T, Ueda N, Ikebuchi Y, Hashiguchi K, Nakao K, Isomoto H. IL-8 and LYPD8 expression levels are associated with the inflammatory response in the colon of patients with ulcerative colitis. Biomed Rep 2020;12:193-8. [PMID: 32190307 DOI: 10.3892/br.2020.1280] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Li X, Gao Y, Yang M, Zhao Q, Wang G, Yang YM, Yang Y, Liu H, Zhang Y. Identification of gene expression changes from colitis to CRC in the mouse CAC model. PLoS One. 2014;9:e95347. [PMID: 24743346 DOI: 10.1371/journal.pone.0095347] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
4 Ryma T, Samer A, Soufli I, Rafa H, Touil-boukoffa C. Role of Probiotics and Their Metabolites in Inflammatory Bowel Diseases (IBDs). Gastroenterology Insights 2021;12:56-66. [DOI: 10.3390/gastroent12010006] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Kobayashi Y, Rupa P, Kovacs-nolan J, Turner PV, Matsui T, Mine Y. Oral Administration of Hen Egg White Ovotransferrin Attenuates the Development of Colitis Induced by Dextran Sodium Sulfate in Mice. J Agric Food Chem 2015;63:1532-9. [DOI: 10.1021/jf505248n] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
6 Stanke-Labesque F, Pofelski J, Moreau-Gaudry A, Bessard G, Bonaz B. Urinary leukotriene E4 excretion: a biomarker of inflammatory bowel disease activity. Inflamm Bowel Dis. 2008;14:769-774. [PMID: 18286646 DOI: 10.1002/ibd.20403] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
7 Mohammadi A, Kelly OB, Smith MI, Kabakchiev B, Silverberg MS. Differential miRNA Expression in Ileal and Colonic Tissues Reveals an Altered Immunoregulatory Molecular Profile in Individuals With Crohn's Disease versus Healthy Subjects. J Crohns Colitis 2019;13:1459-69. [PMID: 31001642 DOI: 10.1093/ecco-jcc/jjz076] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
8 Magnusson MK, Wick MJ. Intestinal dendritic cell and macrophage subsets: Tipping the balance to Crohn's disease? Eur J Microbiol Immunol (Bp) 2011;1:19-24. [PMID: 24466433 DOI: 10.1556/EuJMI.1.2011.1.5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
9 Luo L, Qing L, Yao C, Liu D, Li Y, Li T, Feng P. Efficacy and safety of hyperbaric oxygen therapy for moderate-to-severe ulcerative colitis: a protocol for a systematic review and meta-analysis. BMJ Open 2021;11:e047543. [PMID: 34183344 DOI: 10.1136/bmjopen-2020-047543] [Reference Citation Analysis]
10 Burge K, Gunasekaran A, Eckert J, Chaaban H. Curcumin and Intestinal Inflammatory Diseases: Molecular Mechanisms of Protection. Int J Mol Sci 2019;20:E1912. [PMID: 31003422 DOI: 10.3390/ijms20081912] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 12.3] [Reference Citation Analysis]
11 Lust M, Vulcano M, Danese S. The protein C pathway in inflammatory bowel disease: the missing link between inflammation and coagulation. Trends Mol Med 2008;14:237-44. [PMID: 18457995 DOI: 10.1016/j.molmed.2008.03.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
12 Büning J, von Smolinski D, Tafazzoli K, Zimmer KP, Strobel S, Apostolaki M, Kollias G, Heath JK, Ludwig D, Gebert A. Multivesicular bodies in intestinal epithelial cells: responsible for MHC class II-restricted antigen processing and origin of exosomes. Immunology 2008;125:510-21. [PMID: 18710406 DOI: 10.1111/j.1365-2567.2008.02864.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
13 Moeinian M, Ghasemi-Niri SF, Mozaffari S, Abdolghaffari AH, Baeeri M, Navaea-Nigjeh M, Abdollahi M. Beneficial effect of butyrate, Lactobacillus casei and L-carnitine combination in preference to each in experimental colitis. World J Gastroenterol 2014; 20(31): 10876-10885 [PMID: 25152589 DOI: 10.3748/wjg.v20.i31.10876] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
14 Chang J, Leong RW, Wasinger VC, Ip M, Yang M, Phan TG. Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing. Gastroenterology 2017; 153: 723-731. e1. [PMID: 28601482 DOI: 10.1053/j.gastro.2017.05.056] [Cited by in Crossref: 92] [Cited by in F6Publishing: 91] [Article Influence: 18.4] [Reference Citation Analysis]
15 Yamamoto-Furusho JK, Sarmiento-Aguilar A, Parra-Holguín NN, Bozada-Gutiérrez KE. Evaluation of a vaccination regimen and care in relation to follow-up and treatment of patients with inflammatory bowel disease. Rev Gastroenterol Mex (Engl Ed) 2019;84:11-7. [PMID: 29605092 DOI: 10.1016/j.rgmx.2018.02.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Jin Y, Yang J, Lin L, Lin Y, Zheng C. The Attenuation of Scutellariae radix Extract on Oxidative Stress for Colon Injury in Lipopolysaccharide-induced RAW264.7 Cell and 2,4,6-trinitrobenzene Sulfonic Acid-induced Ulcerative Colitis Rats. Pharmacogn Mag 2016;12:153-9. [PMID: 27076753 DOI: 10.4103/0973-1296.177913] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
17 Uronis JM, Mühlbauer M, Herfarth HH, Rubinas TC, Jones GS, Jobin C. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS One. 2009;4:e6026. [PMID: 19551144 DOI: 10.1371/journal.pone.0006026] [Cited by in Crossref: 291] [Cited by in F6Publishing: 273] [Article Influence: 22.4] [Reference Citation Analysis]
18 Takayama T, Kamada N, Chinen H, Okamoto S, Kitazume MT, Chang J, Matuzaki Y, Suzuki S, Sugita A, Koganei K. Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn’s disease. Gastroenterology. 2010;139:882-892, 892.e1-3. [PMID: 20638936 DOI: 10.1053/j.gastro.2010.05.040] [Cited by in Crossref: 150] [Cited by in F6Publishing: 154] [Article Influence: 12.5] [Reference Citation Analysis]
19 Yamasaki H, Mitsuyama K, Masuda J, Tomiyasu N, Takedatsu H, Akashi H, Matsumoto S, Takedatsu H, Kuwaki K, Tsuruta O, Sata M. Mechanisms underlying the effects of leukocyte apheresis with a fiber filter in a rat model of dextran sulfate sodium-induced colitis. Dig Dis Sci 2010;55:596-606. [PMID: 19259814 DOI: 10.1007/s10620-009-0768-6] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
20 Ge X, Chen Z, Xu Z, Lv F, Zhang K, Yang Y. The effects of dihydroartemisinin on inflammatory bowel disease-related bone loss in a rat model. Exp Biol Med (Maywood) 2018;243:715-24. [PMID: 29763384 DOI: 10.1177/1535370218769420] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
21 Lorenzi L, Bisoffi Z, Bortesi L, Zamboni G, Liut F, Villanacci V. Schaumann bodies in Crohn's disease: a case report and review of the literature. J Crohns Colitis 2012;6:800-3. [PMID: 22503169 DOI: 10.1016/j.crohns.2012.03.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
22 Nazir Y, Hussain SA, Abdul Hamid A, Song Y. Probiotics and Their Potential Preventive and Therapeutic Role for Cancer, High Serum Cholesterol, and Allergic and HIV Diseases. Biomed Res Int 2018;2018:3428437. [PMID: 30246019 DOI: 10.1155/2018/3428437] [Cited by in Crossref: 39] [Cited by in F6Publishing: 26] [Article Influence: 9.8] [Reference Citation Analysis]
23 Chen JF, Luo DD, Lin YS, Liu YH, Wu JZ, Yi XQ, Wu Y, Zhang Q, Gao CJ, Cai J, Su ZR. Aqueous extract of Bruguiera gymnorrhiza leaves protects against dextran sulfate sodium induced ulcerative colitis in mice via suppressing NF-κB activation and modulating intestinal microbiota. J Ethnopharmacol 2020;251:112554. [PMID: 31923541 DOI: 10.1016/j.jep.2020.112554] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Coburn LA, Gong X, Singh K, Asim M, Scull BP, Allaman MM, Williams CS, Rosen MJ, Washington MK, Barry DP, Piazuelo MB, Casero RA Jr, Chaturvedi R, Zhao Z, Wilson KT. L-arginine supplementation improves responses to injury and inflammation in dextran sulfate sodium colitis. PLoS One. 2012;7:e33546. [PMID: 22428068 DOI: 10.1371/journal.pone.0033546] [Cited by in Crossref: 97] [Cited by in F6Publishing: 94] [Article Influence: 9.7] [Reference Citation Analysis]
25 Omonijo FA, Liu S, Hui Q, Zhang H, Lahaye L, Bodin J, Gong J, Nyachoti M, Yang C. Thymol Improves Barrier Function and Attenuates Inflammatory Responses in Porcine Intestinal Epithelial Cells during Lipopolysaccharide (LPS)-Induced Inflammation. J Agric Food Chem 2019;67:615-24. [DOI: 10.1021/acs.jafc.8b05480] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 9.8] [Reference Citation Analysis]
26 Zhao Y, Sun Y, Ding Y, Wang X, Zhou Y, Li W, Huang S, Li Z, Kong L, Guo Q, Lu N. GL-V9, a new synthetic flavonoid derivative, ameliorates DSS-induced colitis against oxidative stress by up-regulating Trx-1 expression via activation of AMPK/FOXO3a pathway. Oncotarget. 2015;6:26291-26307. [PMID: 26327408 DOI: 10.18632/oncotarget.4657] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
27 Hemminki K, Li X, Sundquist K, Sundquist J. Familial association of inflammatory bowel diseases with other autoimmune and related diseases. Am J Gastroenterol. 2010;105:139-147. [PMID: 19707191 DOI: 10.1038/ajg.2009.496] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
28 Vitor CE, Figueiredo CP, Hara DB, Bento AF, Mazzuco TL, Calixto JB. Therapeutic action and underlying mechanisms of a combination of two pentacyclic triterpenes, alpha- and beta-amyrin, in a mouse model of colitis. Br J Pharmacol 2009;157:1034-44. [PMID: 19508397 DOI: 10.1111/j.1476-5381.2009.00271.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 4.5] [Reference Citation Analysis]
29 Mitchell CJ, Howarth GS, Chartier LC, Trinder D, Lawrance IC, Huang LS, Mashtoub S. Orally administered emu oil attenuates disease in a mouse model of Crohn's-like colitis. Exp Biol Med (Maywood) 2020;245:1697-707. [PMID: 32903038 DOI: 10.1177/1535370220951105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Singh K, Chaturvedi R, Asim M, Barry DP, Lewis ND, Vitek MP, Wilson KT. The apolipoprotein E-mimetic peptide COG112 inhibits the inflammatory response to Citrobacter rodentium in colonic epithelial cells by preventing NF-kappaB activation. J Biol Chem. 2008;283:16752-16761. [PMID: 18417477 DOI: 10.1074/jbc.m710530200] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
31 Zhou L, Foster JA. Psychobiotics and the gut-brain axis: in the pursuit of happiness. Neuropsychiatr Dis Treat. 2015;11:715-723. [PMID: 25834446 DOI: 10.2147/ndt.s61997] [Cited by in Crossref: 23] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
32 Hart AL, Ng SC. Crohn’s disease. Medicine 2011;39:229-36. [DOI: 10.1016/j.mpmed.2011.01.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
33 Vila J, Sáez-López E, Johnson JR, Römling U, Dobrindt U, Cantón R, Giske CG, Naas T, Carattoli A, Martínez-Medina M, Bosch J, Retamar P, Rodríguez-Baño J, Baquero F, Soto SM. Escherichia coli: an old friend with new tidings. FEMS Microbiol Rev 2016;40:437-63. [PMID: 28201713 DOI: 10.1093/femsre/fuw005] [Cited by in Crossref: 108] [Cited by in F6Publishing: 82] [Article Influence: 27.0] [Reference Citation Analysis]
34 Khajah MA, Ananthalakshmi KV, Edafiogho I. Anti-Inflammatory Properties of the Enaminone E121 in the Dextran Sulfate Sodium (DSS) Colitis Model. PLoS One 2016;11:e0168567. [PMID: 27997590 DOI: 10.1371/journal.pone.0168567] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
35 Takahashi K, Imaeda H, Fujimoto T, Ban H, Bamba S, Tsujikawa T, Sasaki M, Fujiyama Y, Andoh A. Regulation of eotaxin-3/CC chemokine ligand 26 expression by T helper type 2 cytokines in human colonic myofibroblasts. Clin Exp Immunol. 2013;173:323-331. [PMID: 23607908 DOI: 10.1111/cei.12117] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
36 Slovak J, Wang C, Sun Y, Otoni C, Morrison J, Deitz K, Levine D, Jergens A. Development and validation of an endoscopic activity score for canine inflammatory bowel disease. The Veterinary Journal 2015;203:290-5. [DOI: 10.1016/j.tvjl.2014.12.030] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
37 Feasel-aklilu S, Roberts K, Ziegler J. Parenteral Nutrition–Dependent Patient With a History of Crohn's Disease Complicated by Central Line–Associated Bloodstream Infections. Topics in Clinical Nutrition 2018;33:144-55. [DOI: 10.1097/tin.0000000000000137] [Reference Citation Analysis]
38 Slingerland AE, Schwabkey Z, Wiesnoski DH, Jenq RR. Clinical Evidence for the Microbiome in Inflammatory Diseases. Front Immunol 2017;8:400. [PMID: 28446909 DOI: 10.3389/fimmu.2017.00400] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
39 Han Y, Ma TM, Lu ML, Ren L, Ma XD, Bai ZH. Role of moxibustion in inflammatory responses during treatment of rat ulcerative colitis. World J Gastroenterol 2014; 20(32): 11297-11304 [PMID: 25170214 DOI: 10.3748/wjg.v20.i32.11297] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
40 Fuentes S, Rossen NG, van der Spek MJ, Hartman JH, Huuskonen L, Korpela K, Salojärvi J, Aalvink S, de Vos WM, D'Haens GR, Zoetendal EG, Ponsioen CY. Microbial shifts and signatures of long-term remission in ulcerative colitis after faecal microbiota transplantation. ISME J 2017;11:1877-89. [PMID: 28398347 DOI: 10.1038/ismej.2017.44] [Cited by in Crossref: 86] [Cited by in F6Publishing: 85] [Article Influence: 17.2] [Reference Citation Analysis]
41 Fan H, Liao Y, Chen XY, Zhang LJ, Liu XX, Zhong M, Tang Q. Oxymatrine attenuates ulcerative colitis by modulating the β2AR-β-arrestin2-NF-κB signaling pathway in rats. Shijie Huaren Xiaohua Zazhi 2010; 18(22): 2308-2316 [DOI: 10.11569/wcjd.v18.i22.2308] [Reference Citation Analysis]
42 Schumann S, Alpert C, Engst W, Loh G, Blaut M. Dextran sodium sulfate-induced inflammation alters the expression of proteins by intestinal Escherichia coli strains in a gnotobiotic mouse model. Appl Environ Microbiol 2012;78:1513-22. [PMID: 22210207 DOI: 10.1128/AEM.07340-11] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
43 Breton J, Kastl A, Hoffmann N, Rogers R, Grossman AB, Mamula P, Kelsen JR, Baldassano RN, Albenberg L. Efficacy of Combination Antibiotic Therapy for Refractory Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2019;25:1586-93. [PMID: 30715364 DOI: 10.1093/ibd/izz006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
44 Blandizzi C, Gionchetti P, Armuzzi A, Caporali R, Chimenti S, Cimaz R, Cimino L, Lapadula G, Lionetti P, Marchesoni A, Marcellusi A, Mennini F, Salvarani C, Girolomoni G. The Role of Tumour Necrosis Factor in the Pathogenesis of Immune-Mediated Diseases. Int J Immunopathol Pharmacol 2014;27:1-10. [DOI: 10.1177/03946320140270s101] [Cited by in Crossref: 55] [Cited by in F6Publishing: 21] [Article Influence: 6.9] [Reference Citation Analysis]
45 Moon SY, Shin SA, Oh YS, Park HH, Lee CS. Understanding the Role of the BAI Subfamily of Adhesion G Protein-Coupled Receptors (GPCRs) in Pathological and Physiological Conditions. Genes (Basel) 2018;9:E597. [PMID: 30513696 DOI: 10.3390/genes9120597] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
46 Leal RF, Ayrizono ML, Milanski M, Coope A, Fagundes JJ, Velloso LA, Coy CS. Activation of signal transducer and activator of transcription-1 (STAT-1) and differential expression of interferon-gamma and anti-inflammatory proteins in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis. Clin Exp Immunol 2010;160:380-5. [PMID: 20345984 DOI: 10.1111/j.1365-2249.2009.04088.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
47 Shih DQ, Targan SR. Immunopathogenesis of inflammatory bowel disease. World J Gastroenterol 2008; 14(3): 390-400 [PMID: 18200661 DOI: 10.3748/wjg.14.390] [Cited by in CrossRef: 115] [Cited by in F6Publishing: 119] [Article Influence: 8.2] [Reference Citation Analysis]
48 Khelifi L, Soufli I, Labsi M, Touil-Boukoffa C. Immune-protective effect of echinococcosis on colitis experimental model is dependent of down regulation of TNF-α and NO production. Acta Trop 2017;166:7-15. [PMID: 27983971 DOI: 10.1016/j.actatropica.2016.10.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
49 Kreuter R, Wankell M, Ahlenstiel G, Hebbard L. The role of obesity in inflammatory bowel disease. Biochim Biophys Acta Mol Basis Dis 2019;1865:63-72. [PMID: 30352258 DOI: 10.1016/j.bbadis.2018.10.020] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
50 Williams HR, Cox IJ, Walker DG, North BV, Patel VM, Marshall SE, Jewell DP, Ghosh S, Thomas HJ, Teare JP, Jakobovits S, Zeki S, Welsh KI, Taylor-Robinson SD, Orchard TR. Characterization of inflammatory bowel disease with urinary metabolic profiling. Am J Gastroenterol 2009;104:1435-44. [PMID: 19491857 DOI: 10.1038/ajg.2009.175] [Cited by in Crossref: 118] [Cited by in F6Publishing: 115] [Article Influence: 9.1] [Reference Citation Analysis]
51 Silva I, Pinto R, Mateus V. Preclinical Study in Vivo for New Pharmacological Approaches in Inflammatory Bowel Disease: A Systematic Review of Chronic Model of TNBS-Induced Colitis. J Clin Med 2019;8:E1574. [PMID: 31581545 DOI: 10.3390/jcm8101574] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
52 Jeengar MK, Thummuri D, Magnusson M, Naidu VGM, Uppugunduri S. Uridine Ameliorates Dextran Sulfate Sodium (DSS)-Induced Colitis in Mice. Sci Rep 2017;7:3924. [PMID: 28634361 DOI: 10.1038/s41598-017-04041-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
53 Cao L, Xu H, Wang G, Liu M, Tian D, Yuan Z. Extracellular vesicles derived from bone marrow mesenchymal stem cells attenuate dextran sodium sulfate-induced ulcerative colitis by promoting M2 macrophage polarization. Int Immunopharmacol. 2019;72:264-274. [PMID: 31005036 DOI: 10.1016/j.intimp.2019.04.020] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 9.7] [Reference Citation Analysis]
54 Beyazit Y, Koklu S, Tas A, Purnak T, Sayilir A, Kurt M, Turhan T, Celik T, Suvak B, Torun S. Serum adenosine deaminase activity as a predictor of disease severity in ulcerative colitis. J Crohns Colitis. 2012;6:102-107. [PMID: 22261534 DOI: 10.1016/j.crohns.2011.07.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
55 Gao Y, Huang Y, Zhao Y, Hu Y, Li Z, Guo Q, Zhao K, Lu N. LL202 protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting MAPK/AP-1 signaling. Oncotarget 2016;7:63981-94. [PMID: 27590510 DOI: 10.18632/oncotarget.11742] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
56 Nemeth ZH, Bogdanovski DA, Barratt-Stopper P, Paglinco SR, Antonioli L, Rolandelli RH. Crohn's Disease and Ulcerative Colitis Show Unique Cytokine Profiles. Cureus. 2017;9:e1177. [PMID: 28533995 DOI: 10.7759/cureus.1177] [Cited by in Crossref: 28] [Cited by in F6Publishing: 38] [Article Influence: 5.6] [Reference Citation Analysis]
57 Bartczak A, Zhang J, Adeyi O, Amir A, Grant D, Gorczynski R, Selzner N, Chruscinski A, Levy GA. Overexpression of fibrinogen-like protein 2 protects against T cell-induced colitis. World J Gastroenterol 2017; 23(15): 2673-2684 [PMID: 28487604 DOI: 10.3748/wjg.v23.i15.2673] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
58 Cho JM, Yun SM, Choi YH, Heo J, Kim NJ, Kim SH, Kim EH. Xanthohumol prevents dextran sulfate sodium-induced colitis via inhibition of IKKβ/NF-κB signaling in mice. Oncotarget 2018;9:866-80. [PMID: 29416662 DOI: 10.18632/oncotarget.23183] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
59 Amin N, Boccardi V, Taghizadeh M, Jafarnejad S. Probiotics and bone disorders: the role of RANKL/RANK/OPG pathway. Aging Clin Exp Res 2020;32:363-71. [PMID: 31119697 DOI: 10.1007/s40520-019-01223-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
60 Zhang L, Wei X, Zhang R, Petitte JN, Si D, Li Z, Cheng J, Du M. Design and Development of a Novel Peptide for Treating Intestinal Inflammation. Front Immunol 2019;10:1841. [PMID: 31447849 DOI: 10.3389/fimmu.2019.01841] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
61 Derikx LA, Dieleman LA, Hoentjen F. Probiotics and prebiotics in ulcerative colitis. Best Practice & Research Clinical Gastroenterology 2016;30:55-71. [DOI: 10.1016/j.bpg.2016.02.005] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 8.3] [Reference Citation Analysis]
62 Lopez-siles M, Martinez-medina M, Busquets D, Sabat-mir M, Duncan SH, Flint HJ, Aldeguer X, Garcia-gil LJ. Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes. International Journal of Medical Microbiology 2014;304:464-75. [DOI: 10.1016/j.ijmm.2014.02.009] [Cited by in Crossref: 66] [Cited by in F6Publishing: 66] [Article Influence: 8.3] [Reference Citation Analysis]
63 Levine B, Deretic V. Unveiling the roles of autophagy in innate and adaptive immunity. Nat Rev Immunol. 2007;7:767-777. [PMID: 17767194 DOI: 10.1038/nri2161] [Cited by in Crossref: 617] [Cited by in F6Publishing: 606] [Article Influence: 41.1] [Reference Citation Analysis]
64 Sharp RC, Abdulrahim M, Naser ES, Naser SA. Genetic Variations of PTPN2 and PTPN22: Role in the Pathogenesis of Type 1 Diabetes and Crohn's Disease. Front Cell Infect Microbiol 2015;5:95. [PMID: 26734582 DOI: 10.3389/fcimb.2015.00095] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 5.6] [Reference Citation Analysis]
65 Sands BE, Jacobson EW, Sylwestrowicz T, Younes Z, Dryden G, Fedorak R, Greenbloom S. Randomized, double-blind, placebo-controlled trial of the oral interleukin-12/23 inhibitor apilimod mesylate for treatment of active Crohnʼs disease: . Inflammatory Bowel Diseases 2010;16:1209-18. [DOI: 10.1002/ibd.21159] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 4.4] [Reference Citation Analysis]
66 Bafford AC, Powers S, Ha C, Kruse D, Gorfine SR, Chessin DB, Bauer JJ. Immunosuppressive Therapy Does Not Increase Operative Morbidity in Patients With Crohn’s Disease. Journal of Clinical Gastroenterology 2013;47:491-5. [DOI: 10.1097/mcg.0b013e3182677003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 6] [Article Influence: 3.4] [Reference Citation Analysis]
67 Holm TL, Tornehave D, Søndergaard H, Kvist PH, Sondergaard BC, Hansen L, Hermit MB, Holgersen K, Vergo S, Frederiksen KS, Haase C, Lundsgaard D. Evaluating IL-21 as a Potential Therapeutic Target in Crohn's Disease. Gastroenterol Res Pract 2018;2018:5962624. [PMID: 29849593 DOI: 10.1155/2018/5962624] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
68 Turnbough L, Wilson L. “Take Your Medicine”: Nonadherence Issues in Patients With Ulcerative Colitis. Gastroenterology Nursing 2007;30:212-7. [DOI: 10.1097/01.sga.0000278170.13059.e9] [Cited by in Crossref: 7] [Article Influence: 0.5] [Reference Citation Analysis]
69 Lovatt J, Gascoyne-Binzi D, Hussey T, Garside M, McGill F, Selinger CP. Screening for TB in Hospitalised Patients with Inflammatory Bowel Disease before Anti-TNF Therapy: Is QuantiFERON® Gold Testing Useful? J Clin Med 2021;10:1816. [PMID: 33919426 DOI: 10.3390/jcm10091816] [Reference Citation Analysis]
70 Kim DH, Cheon JH. Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies. Immune Netw 2017;17:25-40. [PMID: 28261018 DOI: 10.4110/in.2017.17.1.25] [Cited by in Crossref: 129] [Cited by in F6Publishing: 123] [Article Influence: 25.8] [Reference Citation Analysis]
71 Staudacher JJ, Yazici C, Carroll T, Bauer J, Pang J, Krett N, Xia Y, Wilson A, Papachristou G, Dirmeier A, Kunst C, Whitcomb DC, Fantuzzi G, Jung B. Activin in acute pancreatitis: Potential risk-stratifying marker and novel therapeutic target. Sci Rep 2017;7:12786. [PMID: 28986573 DOI: 10.1038/s41598-017-13000-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
72 Fonseca-Camarillo G, Yamamoto-Furusho JK. Immunoregulatory Pathways Involved in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2015;21:2188-2193. [PMID: 26111210 DOI: 10.1097/mib.0000000000000477] [Cited by in Crossref: 54] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
73 Kaakoush NO, Day AS, Leach ST, Lemberg DA, Nielsen S, Mitchell HM. Effect of exclusive enteral nutrition on the microbiota of children with newly diagnosed Crohn’s disease. Clin Transl Gastroenterol. 2015;6:e71. [PMID: 25588524 DOI: 10.1038/ctg.2014.21] [Cited by in Crossref: 70] [Cited by in F6Publishing: 61] [Article Influence: 10.0] [Reference Citation Analysis]
74 Rais R, Jiang W, Zhai H, Wozniak KM, Stathis M, Hollinger KR, Thomas AG, Rojas C, Vornov JJ, Marohn M, Li X, Slusher BS. FOLH1/GCPII is elevated in IBD patients, and its inhibition ameliorates murine IBD abnormalities. JCI Insight 2016;1:e88634. [PMID: 27536732 DOI: 10.1172/jci.insight.88634] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
75 Wang B, Sun S, Liu M, Chen H, Liu N, Wu Z, Wu G, Dai Z. Dietary L-Tryptophan Regulates Colonic Serotonin Homeostasis in Mice with Dextran Sodium Sulfate-Induced Colitis. J Nutr 2020;150:1966-76. [PMID: 32386234 DOI: 10.1093/jn/nxaa129] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
76 Connelly TM, Devane L, Kelly JC, Wrafter P, Messaris E. The 100 classic papers in ulcerative colitis: a bibliometric analysis. Expert Rev Gastroenterol Hepatol 2016;10:1187-95. [PMID: 27531253 DOI: 10.1080/17474124.2016.1216786] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
77 Oberc AM, Fiebig-Comyn AA, Tsai CN, Elhenawy W, Coombes BK. Antibiotics Potentiate Adherent-Invasive E. coli Infection and Expansion. Inflamm Bowel Dis 2019;25:711-21. [PMID: 30496418 DOI: 10.1093/ibd/izy361] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
78 Yu Y, Yang W, Li Y, Cong Y. Enteroendocrine Cells: Sensing Gut Microbiota and Regulating Inflammatory Bowel Diseases. Inflamm Bowel Dis 2020;26:11-20. [PMID: 31560044 DOI: 10.1093/ibd/izz217] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
79 Bonfiglio G, Neroni B, Radocchia G, Pompilio A, Mura F, Trancassini M, Di Bonaventura G, Pantanella F, Schippa S. Growth Control of Adherent-Invasive Escherichia coli (AIEC) by the Predator Bacteria Bdellovibrio bacteriovorus: A New Therapeutic Approach for Crohn's Disease Patients. Microorganisms 2019;8:E17. [PMID: 31861852 DOI: 10.3390/microorganisms8010017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
80 Bach H. What Role Does Mycobacterium avium subsp. paratuberculosis Play in Crohn's Disease? Curr Infect Dis Rep. 2015;17:463. [PMID: 25754452 DOI: 10.1007/s11908-015-0463-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
81 Tsertsvadze A, Gurung T, Court R, Clarke A, Sutcliffe P. Clinical effectiveness and cost-effectiveness of elemental nutrition for the maintenance of remission in Crohn's disease: a systematic review and meta-analysis. Health Technol Assess 2015;19:1-138. [PMID: 25831484 DOI: 10.3310/hta19260] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
82 Grundström J, Linton L, Thunberg S, Forsslund H, Janczewska I, Befrits R, van Hage M, Gafvelin G, Eberhardson M. Altered immunoregulatory profile during anti-tumour necrosis factor treatment of patients with inflammatory bowel disease. Clin Exp Immunol. 2012;169:137-147. [PMID: 22774988 DOI: 10.1111/j.1365-2249.2012.04600.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
83 Gu P, Zhu L, Liu Y, Zhang L, Liu J, Shen H. Protective effects of paeoniflorin on TNBS-induced ulcerative colitis through inhibiting NF-kappaB pathway and apoptosis in mice. Int Immunopharmacol 2017;50:152-60. [PMID: 28666238 DOI: 10.1016/j.intimp.2017.06.022] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 12.0] [Reference Citation Analysis]
84 Chen YX, Lai LN, Zhang HY, Bi YH, Meng L, Li XJ, Tian XX, Wang LM, Fan YM, Zhao ZF, Han DW, Ji C. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis. World J Gastroenterol 2016; 22(10): 2949-2959 [PMID: 26973391 DOI: 10.3748/wjg.v22.i10.2949] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
85 Zhong Y, Xiao Q, Li S, Chen L, Long J, Fang W, Yu F, Huang J, Zhao H, Liu D. Bupi Yichang Pill alleviates dextran sulfate sodium-induced ulcerative colitis in mice by regulating the homeostasis of follicular helper T cells. Phytomedicine 2022;100:154091. [PMID: 35395566 DOI: 10.1016/j.phymed.2022.154091] [Reference Citation Analysis]
86 Hong HS, Hwang DY, Park JH, Kim S, Seo EJ, Son Y. Substance-P alleviates dextran sulfate sodium-induced intestinal damage by suppressing inflammation through enrichment of M2 macrophages and regulatory T cells. Cytokine. 2017;90:21-30. [PMID: 27750083 DOI: 10.1016/j.cyto.2016.10.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
87 Cao Y, Gao J, Zhang L, Qin N, Zhu B, Xia X. Jellyfish skin polysaccharides enhance intestinal barrier function and modulate the gut microbiota in mice with DSS-induced colitis. Food Funct 2021;12:10121-35. [PMID: 34528649 DOI: 10.1039/d1fo02001c] [Reference Citation Analysis]
88 Lee S, Kim Y, Park J. Zein-alginate based oral drug delivery systems: Protection and release of therapeutic proteins. International Journal of Pharmaceutics 2016;515:300-6. [DOI: 10.1016/j.ijpharm.2016.10.023] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
89 Wang J, Chen H, Yang B, Gu Z, Zhang H, Chen W, Chen YQ. Lactobacillus plantarum ZS2058 produces CLA to ameliorate DSS-induced acute colitis in mice. RSC Adv 2016;6:14457-64. [DOI: 10.1039/c5ra24491a] [Cited by in Crossref: 22] [Cited by in F6Publishing: 1] [Article Influence: 3.7] [Reference Citation Analysis]
90 Costa Pereira C, Durães C, Coelho R, Grácio D, Silva M, Peixoto A, Lago P, Pereira M, Catarino T, Pinho S, Teixeira JP, Macedo G, Annese V, Magro F. Association between Polymorphisms in Antioxidant Genes and Inflammatory Bowel Disease. PLoS One 2017;12:e0169102. [PMID: 28052094 DOI: 10.1371/journal.pone.0169102] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
91 Lohning A, Kidachi Y, Kamiie K, Sasaki K, Ryoyama K, Yamaguchi H. 6-(methylsulfinyl)hexyl isothiocyanate (6-MITC) from Wasabia japonica alleviates inflammatory bowel disease (IBD) by potential inhibition of glycogen synthase kinase 3 beta (GSK-3β). Eur J Med Chem 2021;216:113250. [PMID: 33691258 DOI: 10.1016/j.ejmech.2021.113250] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Graff LA, Walker JR, Bernstein CN. Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm Bowel Dis 2009;15:1105-18. [PMID: 19161177 DOI: 10.1002/ibd.20873] [Cited by in Crossref: 357] [Cited by in F6Publishing: 313] [Article Influence: 27.5] [Reference Citation Analysis]
93 Junek R, Morrow R, Schoenherr J, Schubert R, Kallmeyer R, Phull S, Klöcking R. Bimodal effect of humic acids on the LPS-induced TNF-α release from differentiated U937 cells. Phytomedicine 2009;16:470-6. [DOI: 10.1016/j.phymed.2008.10.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
94 Däbritz J, Bonkowski E, Chalk C, Trapnell BC, Langhorst J, Denson LA, Foell D. Granulocyte macrophage colony-stimulating factor auto-antibodies and disease relapse in inflammatory bowel disease. Am J Gastroenterol. 2013;108:1901-1910. [PMID: 24145675 DOI: 10.1038/ajg.2013.360] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
95 Chiba M, Tsuda H, Abe T, Sugawara T, Morikawa Y. Missing environmental factor in inflammatory bowel disease: Diet-associated gut microflora. Inflammatory Bowel Diseases 2011;17:E82-3. [DOI: 10.1002/ibd.21745] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
96 Zhang X, Wu J, Ye B, Wang Q, Xie X, Shen H. Protective effect of curcumin on TNBS-induced intestinal inflammation is mediated through the JAK/STAT pathway. BMC Complement Altern Med 2016;16:299. [PMID: 27544348 DOI: 10.1186/s12906-016-1273-z] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 5.8] [Reference Citation Analysis]
97 Nagy-Szakal D, Mir SA, Ross MC, Tatevian N, Petrosino JF, Kellermayer R. Monotonous diets protect against acute colitis in mice: epidemiologic and therapeutic implications. J Pediatr Gastroenterol Nutr 2013;56:544-50. [PMID: 23085891 DOI: 10.1097/MPG.0b013e3182769748] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
98 Maerz JK, Trostel C, Lange A, Parusel R, Michaelis L, Schäfer A, Yao H, Löw HC, Frick JS. Bacterial Immunogenicity Is Critical for the Induction of Regulatory B Cells in Suppressing Inflammatory Immune Responses. Front Immunol 2019;10:3093. [PMID: 32038631 DOI: 10.3389/fimmu.2019.03093] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
99 Cartwright IM, Curtis VF, Lanis JM, Alexeev EE, Welch N, Goldberg MS, Schaefer REM, Gao RY, Chun C, Fennimore B, Onyiah JC, Gerich ME, Dempsey PJ, Colgan SP. Adaptation to inflammatory acidity through neutrophil-derived adenosine regulation of SLC26A3. Mucosal Immunol 2020;13:230-44. [PMID: 31792360 DOI: 10.1038/s41385-019-0237-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
100 Madan S, Szostak J, Komandur Elayavilli R, Tsai RT, Ali M, Qian L, Rastegar-Mojarad M, Hoeng J, Fluck J. The extraction of complex relationships and their conversion to biological expression language (BEL) overview of the BioCreative VI (2017) BEL track. Database (Oxford) 2019;2019:baz084. [PMID: 31603193 DOI: 10.1093/database/baz084] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
101 Sartor RB, Muehlbauer M. Microbial host interactions in IBD: implications for pathogenesis and therapy. Curr Gastroenterol Rep. 2007;9:497-507. [PMID: 18377803 DOI: 10.1007/s11894-007-0066-4] [Cited by in Crossref: 77] [Cited by in F6Publishing: 75] [Article Influence: 5.5] [Reference Citation Analysis]
102 Gibson DL, Ma C, Rosenberger CM, Bergstrom KS, Valdez Y, Huang JT, Khan MA, Vallance BA. Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-induced colitis. Cell Microbiol 2008;10:388-403. [PMID: 17910742 DOI: 10.1111/j.1462-5822.2007.01052.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 69] [Article Influence: 1.3] [Reference Citation Analysis]
103 Wedemeyer J, Vosskuhl K. Role of gastrointestinal eosinophils in inflammatory bowel disease and intestinal tumours. Best Pract Res Clin Gastroenterol. 2008;22:537-549. [PMID: 18492570 DOI: 10.1016/j.bpg.2007.12.001] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 3.4] [Reference Citation Analysis]
104 Murakami M, Ohta T, Ito S. Lipopolysaccharides enhance the action of bradykinin in enteric neurons via secretion of interleukin-1beta from enteric glial cells. J Neurosci Res 2009;87:2095-104. [PMID: 19235895 DOI: 10.1002/jnr.22036] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
105 Thomas C, Dimmock M, Gilletta de Saint-Joseph C, Barres B, Paul C, Cousty S, Laurencin-Dalicieux S. How Oral Specialists Can Help Diagnose and Manage Extra-Digestive Inflammatory Bowel Disease Complications. Case Rep Gastroenterol 2021;15:276-81. [PMID: 33790715 DOI: 10.1159/000513156] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Halpert G, Sredni B. The effect of the novel tellurium compound AS101 on autoimmune diseases. Autoimmun Rev 2014;13:1230-5. [PMID: 25153485 DOI: 10.1016/j.autrev.2014.08.003] [Cited by in Crossref: 41] [Cited by in F6Publishing: 28] [Article Influence: 5.1] [Reference Citation Analysis]
107 Marín-Jiménez I, Saro C, Díaz V, Acosta MB, Gómez-García M, Casbas AG. Epidemiology and hospital resources use in the treatment of ulcerative colitis at gastroenterology units in Spain (EPICURE study). Drugs Context 2018;7:212505. [PMID: 29535792 DOI: 10.7573/dic.212505] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
108 Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447:661-678. [PMID: 17554300 DOI: 10.1038/nature05911] [Cited by in Crossref: 6756] [Cited by in F6Publishing: 6076] [Article Influence: 450.4] [Reference Citation Analysis]
109 Prasad LK, O'Mary H, Cui Z. Nanomedicine delivers promising treatments for rheumatoid arthritis. Nanomedicine (Lond) 2015;10:2063-74. [PMID: 26084368 DOI: 10.2217/nnm.15.45] [Cited by in Crossref: 68] [Cited by in F6Publishing: 53] [Article Influence: 9.7] [Reference Citation Analysis]
110 Galler AI, Klavins K, Burgener IA. A Preliminary Metabolomic Study of Yorkshire Terrier Enteropathy. Metabolites 2022;12:264. [DOI: 10.3390/metabo12030264] [Reference Citation Analysis]
111 Eckmann L, Nebelsiek T, Fingerle AA, Dann SM, Mages J, Lang R, Robine S, Kagnoff MF, Schmid RM, Karin M, Arkan MC, Greten FR. Opposing functions of IKKbeta during acute and chronic intestinal inflammation. Proc Natl Acad Sci U S A 2008;105:15058-63. [PMID: 18815378 DOI: 10.1073/pnas.0808216105] [Cited by in Crossref: 113] [Cited by in F6Publishing: 113] [Article Influence: 8.1] [Reference Citation Analysis]
112 Taylor KD, Targan SR, Mei L, Ippoliti AF, McGovern D, Mengesha E, King L, Rotter JI. IL23R haplotypes provide a large population attributable risk for Crohn's disease. Inflamm Bowel Dis. 2008;14:1185-1191. [PMID: 18470928 DOI: 10.1002/ibd.20478] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
113 Angus HCK, Butt AG, Schultz M, Kemp RA. Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research. Front Med (Lausanne) 2019;6:334. [PMID: 32010704 DOI: 10.3389/fmed.2019.00334] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
114 Andoh A, Imaeda H, Aomatsu T, Inatomi O, Bamba S, Sasaki M, Saito Y, Tsujikawa T, Fujiyama Y. Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn’s disease using terminal restriction fragment length polymorphism analysis. J Gastroenterol. 2011;46:479-486. [PMID: 21253779 DOI: 10.1007/s00535-010-0368-4] [Cited by in Crossref: 127] [Cited by in F6Publishing: 118] [Article Influence: 11.5] [Reference Citation Analysis]
115 Lopez-Siles M, Enrich-Capó N, Aldeguer X, Sabat-Mir M, Duncan SH, Garcia-Gil LJ, Martinez-Medina M. Alterations in the Abundance and Co-occurrence of Akkermansia muciniphila and Faecalibacterium prausnitzii in the Colonic Mucosa of Inflammatory Bowel Disease Subjects. Front Cell Infect Microbiol 2018;8:281. [PMID: 30245977 DOI: 10.3389/fcimb.2018.00281] [Cited by in Crossref: 70] [Cited by in F6Publishing: 57] [Article Influence: 17.5] [Reference Citation Analysis]
116 Rogler G. Chronic ulcerative colitis and colorectal cancer. Cancer Lett. 2014;345:235-241. [PMID: 23941831 DOI: 10.1016/j.canlet.2013.07.032] [Cited by in Crossref: 129] [Cited by in F6Publishing: 134] [Article Influence: 14.3] [Reference Citation Analysis]
117 Xie Y, Zhuang T, Ping Y, Zhang Y, Wang X, Yu P, Duan X. Elevated systemic immune inflammation index level is associated with disease activity in ulcerative colitis patients. Clin Chim Acta 2021;517:122-6. [PMID: 33662359 DOI: 10.1016/j.cca.2021.02.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
118 Rangan P, Choi I, Wei M, Navarrete G, Guen E, Brandhorst S, Enyati N, Pasia G, Maesincee D, Ocon V, Abdulridha M, Longo VD. Fasting-Mimicking Diet Modulates Microbiota and Promotes Intestinal Regeneration to Reduce Inflammatory Bowel Disease Pathology. Cell Rep 2019;26:2704-2719.e6. [PMID: 30840892 DOI: 10.1016/j.celrep.2019.02.019] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 33.0] [Reference Citation Analysis]
119 McGillis L, Bronte-Tinkew DM, Dang F, Capurro M, Prashar A, Ricciuto A, Greenfield L, Lozano-Ruf A, Siddiqui I, Hsieh A, Church P, Walters T, Roth DE, Griffiths A, Philpott D, Jones NL. Vitamin D deficiency enhances expression of autophagy-regulating miR-142-3p in mouse and "involved" IBD patient intestinal tissues. Am J Physiol Gastrointest Liver Physiol 2021;321:G171-84. [PMID: 34159811 DOI: 10.1152/ajpgi.00398.2020] [Reference Citation Analysis]
120 Eriksson A, Flach CF, Lindgren A, Kvifors E, Lange S. Five mucosal transcripts of interest in ulcerative colitis identified by quantitative real-time PCR: a prospective study. BMC Gastroenterol 2008;8:34. [PMID: 18700007 DOI: 10.1186/1471-230X-8-34] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
121 Mi H, Liu FB, Li HW, Hou JT, Li PW. Anti-inflammatory effect of Chang-An-Shuan on TNBS-induced experimental colitis in rats. BMC Complement Altern Med 2017;17:315. [PMID: 28619075 DOI: 10.1186/s12906-017-1794-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
122 Detel D, Pugel EP, Pucar LB, Buljevic S, Varljen J. Development and resolution of colitis in mice with target deletion of dipeptidyl peptidase IV. Exp Physiol 2012;97:486-96. [PMID: 22125312 DOI: 10.1113/expphysiol.2011.061143] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
123 Carrozzino D, Porcelli P. Alexithymia in Gastroenterology and Hepatology: A Systematic Review. Front Psychol 2018;9:470. [PMID: 29681874 DOI: 10.3389/fpsyg.2018.00470] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
124 Ma Q, Ouyang Y, Meng F, Noolvi MN, Avvaru SP, More UA, Aminabhavi TM, Du M, Liu H, Zhuang Y, Pang M, Cai T, Cai Y. A review of pharmacological and clinical studies on the application of Shenling Baizhu San in treatment of Ulcerative colitis. Journal of Ethnopharmacology 2019;244:112105. [DOI: 10.1016/j.jep.2019.112105] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
125 Chen Q, Si X, Ma L, Ma P, Hou M, Bai S, Wu X, Wan Y, Xiao B, Merlin D. Oral delivery of curcumin via porous polymeric nanoparticles for effective ulcerative colitis therapy. J Mater Chem B 2017;5:5881-91. [PMID: 29081976 DOI: 10.1039/C7TB00328E] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 2.8] [Reference Citation Analysis]
126 Van Praet L, Jacques P, Van den Bosch F, Elewaut D. The transition of acute to chronic bowel inflammation in spondyloarthritis. Nat Rev Rheumatol 2012;8:288-95. [PMID: 22508429 DOI: 10.1038/nrrheum.2012.42] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
127 Jing M, Wang Y, Xu L. Andrographolide Derivative AL-1 Ameliorates Dextran Sodium Sulfate-Induced Murine Colitis by Inhibiting NF-κB and MAPK Signaling Pathways. Oxid Med Cell Longev 2019;2019:6138723. [PMID: 31687082 DOI: 10.1155/2019/6138723] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
128 Chua KH, Lian LH, Khor WC, Lee WS, Hilmi I, Goh KL, Kee BP. Association between genetic polymorphisms in interferon regulatory factor 5 (IRF5) gene and Malaysian patients with Crohn's disease. J Dig Dis 2015;16:205-16. [PMID: 25564941 DOI: 10.1111/1751-2980.12229] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
129 Dubeau MF, Iacucci M, Beck PL, Moran GW, Kaplan GG, Ghosh S, Panaccione R. Drug-induced inflammatory bowel disease and IBD-like conditions. Inflamm Bowel Dis 2013;19:445-56. [PMID: 22573536 DOI: 10.1002/ibd.22990] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
130 Sánchez A, Calpena AC, Clares B. Evaluating the Oxidative Stress in Inflammation: Role of Melatonin. Int J Mol Sci 2015;16:16981-7004. [PMID: 26225957 DOI: 10.3390/ijms160816981] [Cited by in Crossref: 81] [Cited by in F6Publishing: 75] [Article Influence: 11.6] [Reference Citation Analysis]
131 Singh UP, Singh NP, Busbee B, Guan H, Singh B, Price RL, Taub DD, Mishra MK, Nagarkatti M, Nagarkatti PS. Alternative medicines as emerging therapies for inflammatory bowel diseases. Int Rev Immunol. 2012;31:66-84. [PMID: 22251008 DOI: 10.3109/08830185.2011.642909] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
132 Dige A, Støy S, Thomsen KL, Hvas CL, Agnholt J, Dahlerup JF, Møller HJ, Grønbaek H. Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease. Scand J Immunol 2014;80:417-23. [PMID: 25346048 DOI: 10.1111/sji.12222] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
133 Li H, Fan C, Feng C, Wu Y, Lu H, He P, Yang X, Zhu F, Qi Q, Gao Y, Zuo J, Tang W. Inhibition of phosphodiesterase-4 attenuates murine ulcerative colitis through interference with mucosal immunity. Br J Pharmacol 2019;176:2209-26. [PMID: 30883697 DOI: 10.1111/bph.14667] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
134 Joo E, Yamane S, Hamasaki A, Harada N, Matsunaga T, Muraoka A, Suzuki K, Nasteska D, Fukushima T, Hayashi T, Tsuji H, Shide K, Tsuda K, Inagaki N. Enteral supplement enriched with glutamine, fiber, and oligosaccharide attenuates experimental colitis in mice. Nutrition 2013;29:549-55. [DOI: 10.1016/j.nut.2012.09.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
135 Wu S, Yoon S, Zhang YG, Lu R, Xia Y, Wan J, Petrof EO, Claud EC, Chen D, Sun J. Vitamin D receptor pathway is required for probiotic protection in colitis. Am J Physiol Gastrointest Liver Physiol 2015;309:G341-9. [PMID: 26159695 DOI: 10.1152/ajpgi.00105.2015] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 7.4] [Reference Citation Analysis]
136 Nath A, Haktanirlar G, Varga Á, Molnár MA, Albert K, Galambos I, Koris A, Vatai G. Biological Activities of Lactose-Derived Prebiotics and Symbiotic with Probiotics on Gastrointestinal System. Medicina (Kaunas) 2018;54:E18. [PMID: 30344249 DOI: 10.3390/medicina54020018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
137 Wu QJ, Zhou YM, Wu YN, Zhang LL, Wang T. The effects of natural and modified clinoptilolite on intestinal barrier function and immune response to LPS in broiler chickens. Vet Immunol Immunopathol. 2013;153:70-76. [PMID: 23453767 DOI: 10.1016/j.vetimm.2013.02.006] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 4.7] [Reference Citation Analysis]
138 Palmieri O, Mazzoccoli G, Bossa F, Maglietta R, Palumbo O, Ancona N, Corritore G, Latiano T, Martino G, Rubino R. Systematic analysis of circadian genes using genome-wide cDNA microarrays in the inflammatory bowel disease transcriptome. Chronobiol Int. 2015;32:903-916. [PMID: 26172092 DOI: 10.3109/07420528.2015.1050726] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
139 Shen N, Clemente JC. Engineering the Microbiome: a Novel Approach to Immunotherapy for Allergic and Immune Diseases. Curr Allergy Asthma Rep 2015;15:39. [PMID: 26143390 DOI: 10.1007/s11882-015-0538-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
140 Gonçalves CC, Hernandes L, Bersani-Amado CA, Franco SL, Silva JF, Natali MR. Use of propolis hydroalcoholic extract to treat colitis experimentally induced in rats by 2,4,6-trinitrobenzenesulfonic Acid. Evid Based Complement Alternat Med 2013;2013:853976. [PMID: 24101941 DOI: 10.1155/2013/853976] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
141 Bjerketorp J, Ng Tze Chiang A, Hjort K, Rosenquist M, Liu WT, Jansson JK. Rapid lab-on-a-chip profiling of human gut bacteria. J Microbiol Methods 2008;72:82-90. [PMID: 18055047 DOI: 10.1016/j.mimet.2007.10.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
142 Ahmad H, Kumar VL. Pharmacotherapy of ulcerative colitis - current status and emerging trends. J Basic Clin Physiol Pharmacol 2018;29:581-92. [PMID: 30089097 DOI: 10.1515/jbcpp-2016-0014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
143 Tomita T, Kanai T, Nemoto Y, Totsuka T, Okamoto R, Tsuchiya K, Sakamoto N, Watanabe M. Systemic, but Not Intestinal, IL-7 Is Essential for the Persistence of Chronic Colitis. J Immunol 2007;180:383-90. [DOI: 10.4049/jimmunol.180.1.383] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
144 Feng W, Chen G, Cai D, Zhao S, Cheng J, Shen H. Inflammatory Bowel Disease and Risk of Ischemic Heart Disease: An Updated Meta-Analysis of Cohort Studies. J Am Heart Assoc 2017;6:e005892. [PMID: 28768646 DOI: 10.1161/JAHA.117.005892] [Cited by in Crossref: 35] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
145 Alavala S, Sangaraju R, Nalban N, Sahu BD, Jerald MK, Kilari EK, Sistla R. Stevioside, a diterpenoid glycoside, shows anti-inflammatory property against Dextran Sulphate Sodium-induced ulcerative colitis in mice. Eur J Pharmacol 2019;855:192-201. [PMID: 31075241 DOI: 10.1016/j.ejphar.2019.05.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
146 Ktsoyan ZA, Beloborodova NV, Sedrakyan AM, Osipov GA, Khachatryan ZA, Manukyan GP, Arakelova KA, Hovhannisyan AI, Arakelyan AA, Ghazaryan KA, Zakaryan MK, Aminov RI. Management of familial Mediterranean fever by colchicine does not normalize the altered profile of microbial long chain fatty acids in the human metabolome. Front Cell Infect Microbiol 2013;3:2. [PMID: 23373011 DOI: 10.3389/fcimb.2013.00002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
147 Iljazovic A, Roy U, Gálvez EJC, Lesker TR, Zhao B, Gronow A, Amend L, Will SE, Hofmann JD, Pils MC, Schmidt-Hohagen K, Neumann-Schaal M, Strowig T. Perturbation of the gut microbiome by Prevotella spp. enhances host susceptibility to mucosal inflammation. Mucosal Immunol 2021;14:113-24. [PMID: 32433514 DOI: 10.1038/s41385-020-0296-4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 17.5] [Reference Citation Analysis]
148 Rani U, Rana A. Listeria monocytogenes Meningitis After Treatment With Infliximab in an 8-Year-Old Pediatric Patient With Crohn's Disease. ACG Case Rep J 2021;8:e00624. [PMID: 34258304 DOI: 10.14309/crj.0000000000000624] [Reference Citation Analysis]
149 Soufli I, Toumi R, Rafa H, Amri M, Labsi M, Khelifi L, Nicoletti F, Touil-Boukoffa C. Crude extract of hydatid laminated layer from Echinococcus granulosus cyst attenuates mucosal intestinal damage and inflammatory responses in Dextran Sulfate Sodium induced colitis in mice. J Inflamm (Lond). 2015;12:19. [PMID: 25844068 DOI: 10.1186/s12950-015-0063-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
150 Hoffner O’connor M, Berglind A, Kennedy Ng MM, Keith BP, Lynch ZJ, Schaner MR, Steinbach EC, Herzog J, Trad OK, Jeck WR, Arthur JC, Simon JM, Sartor RB, Furey TS, Sheikh SZ. BET Protein Inhibition Regulates Macrophage Chromatin Accessibility and Microbiota-Dependent Colitis. Front Immunol 2022;13:856966. [DOI: 10.3389/fimmu.2022.856966] [Reference Citation Analysis]
151 Chumanevich AA, Witalison EE, Chaparala A, Chumanevich A, Nagarkatti P, Nagarkatti M, Hofseth LJ. Repurposing the anti-malarial drug, quinacrine: new anti-colitis properties. Oncotarget 2016;7:52928-39. [PMID: 27447967 DOI: 10.18632/oncotarget.10608] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
152 Scaldaferri F, Gerardi V, Mangiola F, Lopetuso LR, Pizzoferrato M, Petito V, Papa A, Stojanovic J, Poscia A, Cammarota G, Gasbarrini A. Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update. World J Gastroenterol 2016; 22(24): 5505-5511 [PMID: 27350728 DOI: 10.3748/wjg.v22.i24.5505] [Cited by in CrossRef: 74] [Cited by in F6Publishing: 66] [Article Influence: 12.3] [Reference Citation Analysis]
153 Tarhini AA, Joshi I, Garner F. Sargramostim and immune checkpoint inhibitors: combinatorial therapeutic studies in metastatic melanoma. Immunotherapy 2021;13:1011-29. [PMID: 34157863 DOI: 10.2217/imt-2021-0119] [Reference Citation Analysis]
154 Andoh A, Yagi Y, Shioya M, Nishida A, Tsujikawa T, Fujiyama Y. Mucosal cytokine network in inflammatory bowel disease. World J Gastroenterol 2008; 14(33): 5154-5161 [PMID: 18777592 DOI: 10.3748/wjg.14.5154] [Cited by in CrossRef: 81] [Cited by in F6Publishing: 86] [Article Influence: 5.8] [Reference Citation Analysis]
155 Babickova J, Gardlik R. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease. World J Gastroenterol 2015; 21(40): 11321-11330 [PMID: 26525290 DOI: 10.3748/wjg.v21.i40.11321] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
156 Westbrook AM, Szakmary A, Schiestl RH. Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models. Mutat Res. 2010;705:40-59. [PMID: 20298806 DOI: 10.1016/j.mrrev.2010.03.001] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 6.3] [Reference Citation Analysis]
157 Chen X, Yang K, Xu Y, Li K. Top-100 highest-cited original articles in inflammatory bowel disease: A bibliometric analysis. Medicine (Baltimore) 2019;98:e15718. [PMID: 31096525 DOI: 10.1097/MD.0000000000015718] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
158 Tan Y, Zou KF, Qian W, Chen S, Hou XH. Expression and implication of toll-like receptors TLR2, TLR4 and TLR9 in colonic mucosa of patients with ulcerative colitis. J Huazhong Univ Sci Technolog Med Sci. 2014;34:785-790. [PMID: 25318894 DOI: 10.1007/s11596-014-1353-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
159 Nerich V, Monnet E, Weill A, Vallier N, Vanbockstael V, Auleley G, Balaire C, Dubost P, Rican S, Allemand H, Carbonnel F. Fine-scale geographic variations of inflammatory bowel disease in France: Correlation with socioeconomic and house equipment variables: . Inflammatory Bowel Diseases 2010;16:813-21. [DOI: 10.1002/ibd.21122] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
160 Aomatsu T, Imaeda H, Matsumoto K, Kimura E, Yoden A, Tamai H, Fujiyama Y, Mizoguchi E, Andoh A. Faecal chitinase 3-like-1: a novel biomarker of disease activity in paediatric inflammatory bowel disease: Faecal chitinase 3-like-1 and IBD. Alimentary Pharmacology & Therapeutics 2011;34:941-8. [DOI: 10.1111/j.1365-2036.2011.04805.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
161 Piqué N, Berlanga M, Miñana-Galbis D. Health Benefits of Heat-Killed (Tyndallized) Probiotics: An Overview. Int J Mol Sci 2019;20:E2534. [PMID: 31126033 DOI: 10.3390/ijms20102534] [Cited by in Crossref: 108] [Cited by in F6Publishing: 84] [Article Influence: 36.0] [Reference Citation Analysis]
162 Fan Y, Yi W, Huang H, Mei Z, Feng Z. Efficacy of herbal medicine (Gegen Qinlian Decoction) on ulcerative colitis: A systematic review of randomized controlled trials. Medicine (Baltimore). 2019;98:e18512. [PMID: 31876740 DOI: 10.1097/md.0000000000018512] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
163 D'Haens G, Sandborn WJ, Colombel JF, Rutgeerts P, Brown K, Barkay H, Sakov A, Haviv A, Feagan BG; Laquinimod for Crohn's Disease Investigators. A phase II study of laquinimod in Crohn's disease. Gut 2015;64:1227-35. [PMID: 25281416 DOI: 10.1136/gutjnl-2014-307118] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 6.0] [Reference Citation Analysis]
164 Zhao WC, Song LJ, Deng HZ. Protective effect of total alkaloids of Sophora alopecuroides on dextran sulfate sodium-induced chronic colitis. Chin J Integr Med. 2011;17:616-624. [PMID: 21826597 DOI: 10.1007/s11655-011-0813-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
165 Andoh A, Kuzuoka H, Tsujikawa T, Nakamura S, Hirai F, Suzuki Y, Matsui T, Fujiyama Y, Matsumoto T. Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn’s disease. J Gastroenterol. 2012;47:1298-1307. [PMID: 22576027 DOI: 10.1007/s00535-012-0605-0] [Cited by in Crossref: 105] [Cited by in F6Publishing: 104] [Article Influence: 10.5] [Reference Citation Analysis]
166 Kim DH, Hwang JS, Lee IH, Nam ST, Hong J, Zhang P, Lu LF, Lee J, Seok H, Pothoulakis C, Lamont JT, Kim H. The Insect Peptide CopA3 Increases Colonic Epithelial Cell Proliferation and Mucosal Barrier Function to Prevent Inflammatory Responses in the Gut. J Biol Chem 2016;291:3209-23. [PMID: 26655716 DOI: 10.1074/jbc.M115.682856] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
167 Li S, Takasu C, Lau H, Robles L, Vo K, Farzaneh T, Vaziri ND, Stamos MJ, Ichii H. Dimethyl Fumarate Alleviates Dextran Sulfate Sodium-Induced Colitis, through the Activation of Nrf2-Mediated Antioxidant and Anti-inflammatory Pathways. Antioxidants (Basel) 2020;9:E354. [PMID: 32344663 DOI: 10.3390/antiox9040354] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
168 Celiberto LS, Bedani R, Rossi EA, Cavallini DC. Probiotics: The scientific evidence in the context of inflammatory bowel disease. Crit Rev Food Sci Nutr 2017;57:1759-68. [PMID: 25996176 DOI: 10.1080/10408398.2014.941457] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
169 Ahn J, Son S, Oliveira SC, Barber GN. STING-Dependent Signaling Underlies IL-10 Controlled Inflammatory Colitis. Cell Rep 2017;21:3873-84. [PMID: 29281834 DOI: 10.1016/j.celrep.2017.11.101] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 15.3] [Reference Citation Analysis]
170 Glas J, Seiderer J, Czamara D, Pasciuto G, Diegelmann J, Wetzke M, Olszak T, Wolf C, Müller-Myhsok B, Balschun T, Achkar JP, Kamboh MI, Franke A, Duerr RH, Brand S. PTGER4 expression-modulating polymorphisms in the 5p13.1 region predispose to Crohn's disease and affect NF-κB and XBP1 binding sites. PLoS One 2012;7:e52873. [PMID: 23300802 DOI: 10.1371/journal.pone.0052873] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]
171 Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008;134:577-594. [PMID: 18242222 DOI: 10.1053/j.gastro.2007.11.059] [Cited by in Crossref: 1201] [Cited by in F6Publishing: 1136] [Article Influence: 85.8] [Reference Citation Analysis]
172 Ravikumar B, Sarkar S, Davies JE, Futter M, Garcia-Arencibia M, Green-Thompson ZW, Jimenez-Sanchez M, Korolchuk VI, Lichtenberg M, Luo S, Massey DC, Menzies FM, Moreau K, Narayanan U, Renna M, Siddiqi FH, Underwood BR, Winslow AR, Rubinsztein DC. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev. 2010;90:1383-1435. [PMID: 20959619 DOI: 10.1152/physrev.00030.2009] [Cited by in Crossref: 1202] [Cited by in F6Publishing: 1135] [Article Influence: 100.2] [Reference Citation Analysis]
173 Kennedy NA, Walker AW, Berry SH, Duncan SH, Farquarson FM, Louis P, Thomson JM, Satsangi J, Flint HJ, Parkhill J. The impact of different DNA extraction kits and laboratories upon the assessment of human gut microbiota composition by 16S rRNA gene sequencing. PLoS One. 2014;9:e88982. [PMID: 24586470 DOI: 10.1371/journal.pone.0088982] [Cited by in Crossref: 166] [Cited by in F6Publishing: 151] [Article Influence: 20.8] [Reference Citation Analysis]
174 Chang M, Lee AJ, Fitzpatrick L, Zhang M, Sun SC. NF-kappa B1 p105 regulates T cell homeostasis and prevents chronic inflammation. J Immunol 2009;182:3131-8. [PMID: 19234210 DOI: 10.4049/jimmunol.0803637] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
175 Lozano-Pérez AA, Rodriguez-Nogales A, Ortiz-Cullera V, Algieri F, Garrido-Mesa J, Zorrilla P, Rodriguez-Cabezas ME, Garrido-Mesa N, Utrilla MP, De Matteis L, de la Fuente JM, Cenis JL, Gálvez J. Silk fibroin nanoparticles constitute a vector for controlled release of resveratrol in an experimental model of inflammatory bowel disease in rats. Int J Nanomedicine 2014;9:4507-20. [PMID: 25285004 DOI: 10.2147/IJN.S68526] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
176 Saber S, Abd El-Fattah EE, Yahya G, Gobba NA, Maghmomeh AO, Khodir AE, Mourad AAE, Saad AS, Mohammed HG, Nouh NA, Shata A, Amin NA, Abou El-Rous M, Girgis S, El-Ahwany E, Khalaf EM, El-Kott AF, El-Baz AM. A Novel Combination Therapy Using Rosuvastatin and Lactobacillus Combats Dextran Sodium Sulfate-Induced Colitis in High-Fat Diet-Fed Rats by Targeting the TXNIP/NLRP3 Interaction and Influencing Gut Microbiome Composition. Pharmaceuticals (Basel) 2021;14:341. [PMID: 33917884 DOI: 10.3390/ph14040341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
177 Glenn AJ, Fielding KA, Chen J, Comelli EM, Ward WE. Long-term vitamin D3 supplementation does not prevent colonic inflammation or modulate bone health in IL-10 knockout mice at young adulthood. Nutrients 2014;6:3847-62. [PMID: 25247786 DOI: 10.3390/nu6093847] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
178 Fujii H, Shinzaki S, Iijima H, Wakamatsu K, Iwamoto C, Sobajima T, Kuwahara R, Hiyama S, Hayashi Y, Takamatsu S, Uozumi N, Kamada Y, Tsujii M, Taniguchi N, Takehara T, Miyoshi E. Core Fucosylation on T Cells, Required for Activation of T-Cell Receptor Signaling and Induction of Colitis in Mice, Is Increased in Patients With Inflammatory Bowel Disease. Gastroenterology 2016;150:1620-32. [DOI: 10.1053/j.gastro.2016.03.002] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 7.7] [Reference Citation Analysis]
179 Algieri F, Rodríguez-nogales A, Garrido-mesa N, Vezza T, Garrido-mesa J, Utrilla MP, Montilla A, Cardelle-cobas A, Olano A, Corzo N, Guerra-hernández E, Zarzuelo A, Rodriguez-cabezas ME, Galvez J. Intestinal Anti-inflammatory Effects of Oligosaccharides Derived from Lactulose in the Trinitrobenzenesulfonic Acid Model of Rat Colitis. J Agric Food Chem 2014;62:4285-97. [DOI: 10.1021/jf500678p] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
180 Boada-Romero E, Serramito-Gómez I, Sacristán MP, Boone DL, Xavier RJ, Pimentel-Muiños FX. The T300A Crohn's disease risk polymorphism impairs function of the WD40 domain of ATG16L1. Nat Commun 2016;7:11821. [PMID: 27273576 DOI: 10.1038/ncomms11821] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 6.8] [Reference Citation Analysis]
181 Wang X, Zhao Y, Yao Y, Xu M, Du H, Zhang M, Tu Y. Anti-inflammatory activity of di-peptides derived from ovotransferrin by simulated peptide-cut in TNF-α-induced Caco-2 cells. Journal of Functional Foods 2017;37:424-32. [DOI: 10.1016/j.jff.2017.07.064] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 3.2] [Reference Citation Analysis]
182 Jergens AE, Crandell J, Morrison JA, Deitz K, Pressel M, Ackermann M, Suchodolski JS, Steiner JM, Evans R. Comparison of oral prednisone and prednisone combined with metronidazole for induction therapy of canine inflammatory bowel disease: a randomized-controlled trial. J Vet Intern Med 2010;24:269-77. [PMID: 20051005 DOI: 10.1111/j.1939-1676.2009.0447.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 4.3] [Reference Citation Analysis]
183 Houdeau E. Sex Differences in Gastrointestinal Physiology and Diseases. Sex Differences in Physiology. Elsevier; 2016. pp. 125-43. [DOI: 10.1016/b978-0-12-802388-4.00008-2] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
184 Kleiner G, Zanin V, Monasta L, Crovella S, Caruso L, Milani D, Marcuzzi A. Pediatric patients with inflammatory bowel disease exhibit increased serum levels of proinflammatory cytokines and chemokines, but decreased circulating levels of macrophage inhibitory protein-1β, interleukin-2 and interleukin-17. Exp Ther Med. 2015;9:2047-2052. [PMID: 26136934 DOI: 10.3892/etm.2015.2370] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
185 Park SG, Mathur R, Long M, Hosh N, Hao L, Hayden MS, Ghosh S. T regulatory cells maintain intestinal homeostasis by suppressing γδ T cells. Immunity. 2010;33:791-803. [PMID: 21074460 DOI: 10.1016/j.immuni.2010.10.014] [Cited by in Crossref: 109] [Cited by in F6Publishing: 107] [Article Influence: 9.1] [Reference Citation Analysis]
186 Haas E, Rütgen BC, Gerner W, Richter B, Tichy A, Galler A, Bilek A, Thalhammer JG, Saalmüller A, Luckschander-Zeller N. Phenotypic characterization of canine intestinal intraepithelial lymphocytes in dogs with inflammatory bowel disease. J Vet Intern Med 2014;28:1708-15. [PMID: 25250556 DOI: 10.1111/jvim.12456] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
187 Ambruzs JM, Walker PD, Larsen CP. The histopathologic spectrum of kidney biopsies in patients with inflammatory bowel disease. Clin J Am Soc Nephrol. 2014;9:265-270. [PMID: 24262508 DOI: 10.2215/cjn.04660513] [Cited by in Crossref: 79] [Cited by in F6Publishing: 40] [Article Influence: 8.8] [Reference Citation Analysis]
188 Kostadinova FI, Baba T, Ishida Y, Kondo T, Popivanova BK, Mukaida N. Crucial involvement of the CX3CR1-CX3CL1 axis in dextran sulfate sodium-mediated acute colitis in mice. J Leukoc Biol. 2010;88:133-143. [PMID: 20335311 DOI: 10.1189/jlb.1109768] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 3.4] [Reference Citation Analysis]
189 Tamburini B, La Manna MP, La Barbera L, Mohammadnezhad L, Badami GD, Shekarkar Azgomi M, Dieli F, Caccamo N. Immunity and Nutrition: The Right Balance in Inflammatory Bowel Disease. Cells 2022;11:455. [DOI: 10.3390/cells11030455] [Reference Citation Analysis]
190 Makharia GK, Singh UB. In the search of a cause of Crohn’s disease. Indian J Gastroenterol 2009;28:165-8. [DOI: 10.1007/s12664-009-0067-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
191 Tomita T, Kanai T, Fujii T, Nemoto Y, Okamoto R, Tsuchiya K, Totsuka T, Sakamoto N, Akira S, Watanabe M. MyD88-dependent pathway in T cells directly modulates the expansion of colitogenic CD4+ T cells in chronic colitis. J Immunol 2008;180:5291-9. [PMID: 18390710 DOI: 10.4049/jimmunol.180.8.5291] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 3.5] [Reference Citation Analysis]
192 Zupancic T, Stojan J, Lane EB, Komel R, Bedina-Zavec A, Liovic M. Intestinal cell barrier function in vitro is severely compromised by keratin 8 and 18 mutations identified in patients with inflammatory bowel disease. PLoS One 2014;9:e99398. [PMID: 24915158 DOI: 10.1371/journal.pone.0099398] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
193 Danese S, Grisham M, Hodge J, Telliez JB. JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines. Am J Physiol Gastrointest Liver Physiol. 2016;310:G155-G162. [PMID: 26608188 DOI: 10.1152/ajpgi.00311.2015] [Cited by in Crossref: 86] [Cited by in F6Publishing: 74] [Article Influence: 12.3] [Reference Citation Analysis]
194 Ghouri YA, Richards DM, Rahimi EF, Krill JT, Jelinek KA, DuPont AW. Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease. Clin Exp Gastroenterol. 2014;7:473-487. [PMID: 25525379 DOI: 10.2147/ceg.s27530] [Cited by in Crossref: 44] [Cited by in F6Publishing: 96] [Article Influence: 5.5] [Reference Citation Analysis]
195 Bowcutt R, Malter LB, Chen LA, Wolff MJ, Robertson I, Rifkin DB, Poles M, Cho I, Loke P. Isolation and cytokine analysis of lamina propria lymphocytes from mucosal biopsies of the human colon. J Immunol Methods 2015;421:27-35. [PMID: 25769417 DOI: 10.1016/j.jim.2015.02.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
196 Stein A, Hinz M, Uncini T. Amino acid-responsive Crohn's disease: a case study. Clin Exp Gastroenterol 2010;3:171-7. [PMID: 21694863 DOI: 10.2147/CEG.S15340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 15] [Article Influence: 0.1] [Reference Citation Analysis]
197 Sun A, Ren G, Deng C, Zhang J, Luo X, Wu X, Mani S, Dou W, Wang Z. C-glycosyl flavonoid orientin improves chemically induced inflammatory bowel disease in mice. Journal of Functional Foods 2016;21:418-30. [DOI: 10.1016/j.jff.2015.12.029] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
198 Rath E, Berger E, Messlik A, Nunes T, Liu B, Kim SC, Hoogenraad N, Sans M, Sartor RB, Haller D. Induction of dsRNA-activated protein kinase links mitochondrial unfolded protein response to the pathogenesis of intestinal inflammation. Gut. 2012;61:1269-1278. [PMID: 21997551 DOI: 10.1136/gutjnl-2011-300767] [Cited by in Crossref: 84] [Cited by in F6Publishing: 85] [Article Influence: 7.6] [Reference Citation Analysis]
199 Zietek T, Rath E. Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1. Front Immunol. 2016;7:154. [PMID: 27148273 DOI: 10.3389/fimmu.2016.00154] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 9.8] [Reference Citation Analysis]
200 Hutchison J, Cohen Z, Onyeagucha BC, Funk J, Nelson MA. How microRNAs influence both hereditary and inflammatory-mediated colon cancers. Cancer Genet. 2013;206:309-316. [PMID: 24042167 DOI: 10.1016/j.cancergen.2013.06.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
201 Sun P, Su L, Zhu H, Li X, Guo Y, Du X, Zhang L, Qin C. Gut Microbiota Regulation and Their Implication in the Development of Neurodegenerative Disease. Microorganisms 2021;9:2281. [PMID: 34835406 DOI: 10.3390/microorganisms9112281] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
202 Vigsnæs LK, Holck J, Meyer AS, Licht TR. In vitro fermentation of sugar beet arabino-oligosaccharides by fecal microbiota obtained from patients with ulcerative colitis to selectively stimulate the growth of Bifidobacterium spp. and Lactobacillus spp. Appl Environ Microbiol 2011;77:8336-44. [PMID: 21984234 DOI: 10.1128/AEM.05895-11] [Cited by in Crossref: 50] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
203 Abdulla M, Al Saeed M, Fardan RH, Alalwan HF, Ali Almosawi ZS, Almahroos AF, Al Qamish J. Inflammatory bowel disease in Bahrain: single-center experience. Clin Exp Gastroenterol 2017;10:133-45. [PMID: 28765713 DOI: 10.2147/CEG.S127909] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
204 Tarabar D, Hirsch A, Rubin DT. Vedolizumab in the treatment of Crohn’s disease. Expert Review of Gastroenterology & Hepatology 2015;10:283-90. [DOI: 10.1586/17474124.2016.1135051] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
205 Huang X, Fan M, Huang W. Pleiotropic roles of FXR in liver and colorectal cancers. Mol Cell Endocrinol 2022;543:111543. [PMID: 34995680 DOI: 10.1016/j.mce.2021.111543] [Reference Citation Analysis]
206 Wu C, Sartor RB, Huang K, Tonkonogy SL. Transient activation of mucosal effector immune responses by resident intestinal bacteria in normal hosts is regulated by interleukin-10 signalling. Immunology 2016;148:304-14. [PMID: 27147411 DOI: 10.1111/imm.12612] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
207 Emami NK, Calik A, White MB, Young M, Dalloul RA. Necrotic Enteritis in Broiler Chickens: The Role of Tight Junctions and Mucosal Immune Responses in Alleviating the Effect of the Disease. Microorganisms 2019;7:E231. [PMID: 31370350 DOI: 10.3390/microorganisms7080231] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
208 Hiyama S, Iijima H, Sakakibara Y, Yamada T, Mukai A, Otake Y, Yamaguchi T, Araki M, Kawai S, Tsujii Y, Inoue T, Hayashi Y, Shinzaki S, Takehara T. Endoscopic alterations in Peyer's patches in patients with ulcerative colitis: A prospective, multicenter study. J Gastroenterol Hepatol 2020;35:1143-9. [PMID: 31734952 DOI: 10.1111/jgh.14933] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
209 Peng H, Wang C, Xu X, Yu C, Wang Q. An intestinal Trojan horse for gene delivery. Nanoscale 2015;7:4354-60. [PMID: 25619169 DOI: 10.1039/c4nr06377e] [Cited by in Crossref: 35] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
210 Lee H, Ma R, Grimm MC, Riordan SM, Lan R, Zhong L, Raftery M, Zhang L. Examination of the Anaerobic Growth of Campylobacter concisus Strains. Int J Microbiol. 2014;2014:476047. [PMID: 25214843 DOI: 10.1155/2014/476047] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
211 Dogan B, Fu J, Zhang S, Scherl EJ, Simpson KW. Rifaximin decreases virulence of Crohn's disease-associated Escherichia coli and epithelial inflammatory responses. J Antibiot (Tokyo) 2018;71:485-94. [PMID: 29410518 DOI: 10.1038/s41429-017-0022-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
212 Furey TS, Sethupathy P, Sheikh SZ. Redefining the IBDs using genome-scale molecular phenotyping. Nat Rev Gastroenterol Hepatol. 2019;16:296-311. [PMID: 30787446 DOI: 10.1038/s41575-019-0118-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
213 Hemminki K, Li X, Sundquist J, Sundquist K. Cancer risks in Crohn disease patients. Ann Oncol. 2009;20:574-580. [PMID: 18765463 DOI: 10.1093/annonc/mdn595] [Cited by in Crossref: 84] [Cited by in F6Publishing: 67] [Article Influence: 6.0] [Reference Citation Analysis]
214 Tyagi A, Kumar U, Reddy S, Santosh VS, Mohammed SB, Ehtesham NZ, Ibrahim A. Attenuation of colonic inflammation by partial replacement of dietary linoleic acid with α-linolenic acid in a rat model of inflammatory bowel disease. Br J Nutr 2012;108:1612-22. [PMID: 22243775 DOI: 10.1017/S0007114511007197] [Cited by in Crossref: 39] [Cited by in F6Publishing: 9] [Article Influence: 3.9] [Reference Citation Analysis]
215 Cseh A, Vasarhelyi B, Molnar K, Szalay B, Svec P, Treszl A, Dezsofi A, Lakatos PL, Arato A, Tulassay T, Veres G. Immune phenotype in children with therapy-naïve remitted and relapsed Crohn’s disease. World J Gastroenterol 2010; 16(47): 6001-6009 [PMID: 21157977 DOI: 10.3748/wjg.v16.i47.6001] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
216 Zhang HF, Qiu LX, Chen Y, Zhu WL, Mao C, Zhu LG, Zheng MH, Wang Y, Lei L, Shi J. ATG16L1 T300A polymorphism and Crohn’s disease susceptibility: evidence from 13,022 cases and 17,532 controls. Hum Genet. 2009;125:627-631. [PMID: 19337756 DOI: 10.1007/s00439-009-0660-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
217 Yamamoto-Furusho JK, Fonseca-Camarillo G, Furuzawa-Carballeda J, Sarmiento-Aguilar A, Barreto-Zuñiga R, Martínez-Benitez B, Lara-Velazquez MA. Caspase recruitment domain (CARD) family (CARD9, CARD10, CARD11, CARD14 and CARD15) are increased during active inflammation in patients with inflammatory bowel disease. J Inflamm (Lond) 2018;15:13. [PMID: 30008619 DOI: 10.1186/s12950-018-0189-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
218 Sun K, Buchan N, Larminie C, Pržulj N. The integrated disease network. Integr Biol (Camb) 2014;6:1069-79. [PMID: 25133803 DOI: 10.1039/c4ib00122b] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 2.9] [Reference Citation Analysis]
219 Basson A. Nutrition management in the adult patient with Crohn’s disease. South African Journal of Clinical Nutrition 2016;25:164-72. [DOI: 10.1080/16070658.2012.11734423] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
220 Tsuruta T, Katsumata E, Mizote A, Jian HJ, Muhomah TA, Nishino N. Cyclic nigerosylnigerose ameliorates DSS-induced colitis with restoration of goblet cell number and increase in IgA reactivity against gut microbiota in mice. Biosci Microbiota Food Health 2020;39:188-96. [PMID: 32775139 DOI: 10.12938/bmfh.2020-012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
221 López-Pérez AE, Nurgali K, Abalo R. Painful neurotrophins and their role in visceral pain. Behav Pharmacol 2018;29:120-39. [PMID: 29543647 DOI: 10.1097/FBP.0000000000000386] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
222 Carothers AM, Davids JS, Damas BC, Bertagnolli MM. Persistent cyclooxygenase-2 inhibition downregulates NF-{kappa}B, resulting in chronic intestinal inflammation in the min/+ mouse model of colon tumorigenesis. Cancer Res 2010;70:4433-42. [PMID: 20484034 DOI: 10.1158/0008-5472.CAN-09-4289] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
223 Lewis GJ, Massey DC, Zhang H, Bredin F, Tremelling M, Lee JC, Berzuini C, Parkes M. Genetic association between NLRP3 variants and Crohn's disease does not replicate in a large UK panel. Inflamm Bowel Dis. 2011;17:1387-1391. [PMID: 21560198 DOI: 10.1002/ibd.21499] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 3.9] [Reference Citation Analysis]
224 Salem M, Seidelin JB, Rogler G, Nielsen OH. Muramyl dipeptide responsive pathways in Crohn’s disease: from NOD2 and beyond. Cell Mol Life Sci 2013;70:3391-404. [DOI: 10.1007/s00018-012-1246-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
225 Çekiç C, Kırcı A, Vatansever S, Aslan F, Yılmaz HE, Alper E, Arabul M, Sarıtaş Yüksel E, Ünsal B. Serum Syndecan-1 Levels and Its Relationship to Disease Activity in Patients with Crohn's Disease. Gastroenterol Res Pract 2015;2015:850351. [PMID: 26294905 DOI: 10.1155/2015/850351] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
226 Zhuang Z, Wu ZG, Chen M, Wang PG. Secretion of human interferon-beta 1b by recombinant Lactococcus lactis. Biotechnol Lett 2008;30:1819-23. [PMID: 18575814 DOI: 10.1007/s10529-008-9761-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
227 Börnigen D, Morgan XC, Franzosa EA, Ren B, Xavier RJ, Garrett WS, Huttenhower C. Functional profiling of the gut microbiome in disease-associated inflammation. Genome Med 2013;5:65. [PMID: 23906180 DOI: 10.1186/gm469] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
228 Hiller F, Besselt K, Deubel S, Brigelius-flohé R, Kipp AP. GPx2 Induction Is Mediated Through STAT Transcription Factors During Acute Colitis: . Inflammatory Bowel Diseases 2015;21:2078-89. [DOI: 10.1097/mib.0000000000000464] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
229 Baudet A, Rahmi G, Bretagne AL, Gloro R, Justum AM, Reimund JM. Severe ulcerative colitis: present medical treatment strategies. Expert Opin Pharmacother. 2008;9:447-457. [PMID: 18220494 DOI: 10.1517/14656566.9.3.447] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
230 Orbán C, Szabó D, Bajnok A, Vásárhelyi B, Tulassay T, Arató A, Veres G, Toldi G. Altered calcium influx of peripheral Th2 cells in pediatric Crohn's disease: infliximab may normalize activation patterns. Oncotarget 2016;7:44966-74. [PMID: 27329601 DOI: 10.18632/oncotarget.10036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
231 Henderson AL, Brand MW, Darling RJ, Maas KJ, Detzel CJ, Hostetter J, Wannemuehler MJ, Weaver EM. Attenuation of Colitis by Serum-Derived Bovine Immunoglobulin/Protein Isolate in a Defined Microbiota Mouse Model. Dig Dis Sci 2015;60:3293-303. [PMID: 26026602 DOI: 10.1007/s10620-015-3726-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
232 Toyonaga T, Nakase H, Ueno S, Matsuura M, Yoshino T, Honzawa Y, Itou A, Namba K, Minami N, Yamada S, Koshikawa Y, Uede T, Chiba T, Okazaki K. Osteopontin Deficiency Accelerates Spontaneous Colitis in Mice with Disrupted Gut Microbiota and Macrophage Phagocytic Activity. PLoS One 2015;10:e0135552. [PMID: 26274807 DOI: 10.1371/journal.pone.0135552] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
233 Taheri M, Ghandil P, Hashemi SJ, Ghafourian M, Masjedi Zadeh AR, Ghadiri AA. Association study between two polymorphisms of tumor necrosis factor ligand superfamily member 15 (TNFSF15) gene and ulcerative colitis in south-west of Iran. J Cell Biochem 2018. [PMID: 30556168 DOI: 10.1002/jcb.28165] [Reference Citation Analysis]
234 Bourgonje AR, von Martels JZH, Gabriëls RY, Blokzijl T, Buist-Homan M, Heegsma J, Jansen BH, van Dullemen HM, Festen EAM, Ter Steege RWF, Visschedijk MC, Weersma RK, de Vos P, Faber KN, Dijkstra G. A Combined Set of Four Serum Inflammatory Biomarkers Reliably Predicts Endoscopic Disease Activity in Inflammatory Bowel Disease. Front Med (Lausanne) 2019;6:251. [PMID: 31772929 DOI: 10.3389/fmed.2019.00251] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
235 Rodiño-Janeiro BK, Alonso-Cotoner C, Pigrau M, Lobo B, Vicario M, Santos J. Role of Corticotropin-releasing Factor in Gastrointestinal Permeability. J Neurogastroenterol Motil 2015;21:33-50. [PMID: 25537677 DOI: 10.5056/jnm14084] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 7.7] [Reference Citation Analysis]
236 De Leon LM, Watson JB, Kelly CR. Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol. 2013;11:1036-1038. [PMID: 23669309 DOI: 10.1016/j.cgh.2013.04.045] [Cited by in Crossref: 136] [Cited by in F6Publishing: 122] [Article Influence: 15.1] [Reference Citation Analysis]
237 Tam JSY, Coller JK, Hughes PA, Prestidge CA, Bowen JM. Toll-like receptor 4 (TLR4) antagonists as potential therapeutics for intestinal inflammation. Indian J Gastroenterol 2021;40:5-21. [PMID: 33666891 DOI: 10.1007/s12664-020-01114-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
238 Pereira C, Grácio D, Teixeira JP, Magro F. Oxidative Stress and DNA Damage: Implications in Inflammatory Bowel Disease. Inflamm Bowel Dis 2015;21:2403-17. [PMID: 26193347 DOI: 10.1097/MIB.0000000000000506] [Cited by in Crossref: 25] [Cited by in F6Publishing: 36] [Article Influence: 4.2] [Reference Citation Analysis]
239 Sun Q, Du M, Kang Y, Zhu MJ. Prebiotic effects of goji berry in protection against inflammatory bowel disease. Crit Rev Food Sci Nutr 2022;:1-25. [PMID: 34991393 DOI: 10.1080/10408398.2021.2015680] [Reference Citation Analysis]
240 Randall CW, Vizuete JA, Martinez N, Alvarez JJ, Garapati KV, Malakouti M, Taboada CM. From historical perspectives to modern therapy: a review of current and future biological treatments for Crohn's disease. Therap Adv Gastroenterol 2015;8:143-59. [PMID: 25949527 DOI: 10.1177/1756283X15576462] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 2.9] [Reference Citation Analysis]
241 Wallace KL, Zheng LB, Kanazawa Y, Shih DQ. Immunopathology of inflammatory bowel disease. World J Gastroenterol 2014; 20(1): 6-21 [PMID: 24415853 DOI: 10.3748/wjg.v20.i1.6] [Cited by in CrossRef: 269] [Cited by in F6Publishing: 252] [Article Influence: 33.6] [Reference Citation Analysis]
242 Claes IJ, Lebeer S, Shen C, Verhoeven TL, Dilissen E, De Hertogh G, Bullens DM, Ceuppens JL, Van Assche G, Vermeire S. Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitis. Clin Exp Immunol. 2010;162:306-314. [PMID: 20731672 DOI: 10.1111/j.1365-2249.2010.04228.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 5.5] [Reference Citation Analysis]
243 Nemoto Y, Kanai T, Kameyama K, Shinohara T, Sakamoto N, Totsuka T, Okamoto R, Tsuchiya K, Nakamura T, Sudo T, Matsumoto S, Watanabe M. Long-Lived Colitogenic CD4 + Memory T Cells Residing Outside the Intestine Participate in the Perpetuation of Chronic Colitis. J Immunol 2009;183:5059-68. [DOI: 10.4049/jimmunol.0803684] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
244 Yu C, Shan T, Feng A, Li Y, Zhu W, Xie Y, Li N, Li J. Triptolide ameliorates Crohn’s colitis is associated with inhibition of TLRs/NF-κB signaling pathway. Fitoterapia. 2011;82:709-715. [PMID: 21376787 DOI: 10.1016/j.fitote.2011.02.011] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
245 Marsal J, Agace WW. Targeting T-cell migration in inflammatory bowel disease. J Intern Med 2012;272:411-29. [PMID: 22946654 DOI: 10.1111/j.1365-2796.2012.02588.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
246 Catarzi S, Marcucci T, Papucci L, Favilli F, Donnini M, Tonelli F, Vincenzini MT, Iantomasi T. Apoptosis and Bax, Bcl-2, Mcl-1 expression in neutrophils of Crohn's disease patients. Inflamm Bowel Dis 2008;14:819-25. [PMID: 18266233 DOI: 10.1002/ibd.20397] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
247 Rupp C, Mummelthei A, Sauer P, Weiss KH, Schirmacher P, Stiehl A, Stremmel W, Gotthardt DN. Non-IBD immunological diseases are a risk factor for reduced survival in PSC. Liver Int. 2013;33:86-93. [PMID: 23157607 DOI: 10.1111/liv.12028] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
248 Veny M, Esteller M, Ricart E, Piqué JM, Panés J, Salas A. Late Crohn’s disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients. Aliment Pharmacol Ther. 2010;31:561-572. [PMID: 19958311 DOI: 10.1111/j.1365-2036.2009.04209.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 4.4] [Reference Citation Analysis]
249 Fedorova IA, Danilenko VN. Immunogenic properties of a probiotic component of the human gastrointestinal tract microbiota. Biol Bull Rev 2014;4:457-66. [DOI: 10.1134/s2079086414060036] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
250 Swan ZD, Wonderlich ER, Barratt-Boyes SM. Macrophage accumulation in gut mucosa differentiates AIDS from chronic SIV infection in rhesus macaques. Eur J Immunol 2016;46:446-54. [PMID: 26549608 DOI: 10.1002/eji.201545738] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
251 Abegunde AT, Muhammad BH, Bhatti O, Ali T. Environmental risk factors for inflammatory bowel diseases: Evidence based literature review. World J Gastroenterol 2016; 22(27): 6296-6317 [PMID: 27468219 DOI: 10.3748/wjg.v22.i27.6296] [Cited by in CrossRef: 77] [Cited by in F6Publishing: 66] [Article Influence: 12.8] [Reference Citation Analysis]
252 Wagner J, Sim WH, Ellis JA, Ong EK, Catto-Smith AG, Cameron DJ, Bishop RF, Kirkwood CD. Interaction of Crohn's disease susceptibility genes in an Australian paediatric cohort. PLoS One 2010;5:e15376. [PMID: 21079743 DOI: 10.1371/journal.pone.0015376] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
253 Yin H, Li X, Zhang B, Liu T, Yuan B, Ni Q, Hu S, Gu H. Sirolimus ameliorates inflammatory responses by switching the regulatory T/T helper type 17 profile in murine colitis. Immunology 2013;139:494-502. [PMID: 23480027 DOI: 10.1111/imm.12096] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
254 O'Hara JR, Feener TD, Fischer CD, Buret AG. Campylobacter jejuni disrupts protective Toll-like receptor 9 signaling in colonic epithelial cells and increases the severity of dextran sulfate sodium-induced colitis in mice. Infect Immun. 2012;80:1563-1571. [PMID: 22311925 DOI: 10.1128/iai.06066-11] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
255 Leber A, Hontecillas R, Tubau-Juni N, Zoccoli-Rodriguez V, Hulver M, McMillan R, Eden K, Allen IC, Bassaganya-Riera J. NLRX1 Regulates Effector and Metabolic Functions of CD4+ T Cells. J Immunol 2017;198:2260-8. [PMID: 28159898 DOI: 10.4049/jimmunol.1601547] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
256 Kotze PG, Ma C, Almutairdi A, Panaccione R. Clinical utility of ustekinumab in Crohn's disease. J Inflamm Res. 2018;11:35-47. [PMID: 29445293 DOI: 10.2147/jir.s157358] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
257 Vitetta L, Briskey D, Hayes E, Shing C, Peake J. A review of the pharmacobiotic regulation of gastrointestinal inflammation by probiotics, commensal bacteria and prebiotics. Inflammopharmacology. 2012;20:251-266. [PMID: 22427210 DOI: 10.1007/s10787-012-0126-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
258 Mikami Y, Mizuno S, Nakamoto N, Hayashi A, Sujino T, Sato T, Kamada N, Matsuoka K, Hisamatsu T, Ebinuma H, Hibi T, Yoshimura A, Kanai T. Macrophages and dendritic cells emerge in the liver during intestinal inflammation and predispose the liver to inflammation. PLoS One 2014;9:e84619. [PMID: 24392145 DOI: 10.1371/journal.pone.0084619] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
259 Patra V, Laoubi L, Nicolas JF, Vocanson M, Wolf P. A Perspective on the Interplay of Ultraviolet-Radiation, Skin Microbiome and Skin Resident Memory TCRαβ+ Cells. Front Med (Lausanne) 2018;5:166. [PMID: 29900173 DOI: 10.3389/fmed.2018.00166] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
260 Noto Llana M, Sarnacki SH, Aya Castañeda Mdel R, Bernal MI, Giacomodonato MN, Cerquetti MC. Consumption of Lactobacillus casei fermented milk prevents Salmonella reactive arthritis by modulating IL-23/IL-17 expression. PLoS One 2013;8:e82588. [PMID: 24340048 DOI: 10.1371/journal.pone.0082588] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
261 Schieffer KM, Bruffy SM, Rauscher R, Koltun WA, Yochum GS, Gallagher CJ. Reduced total serum bilirubin levels are associated with ulcerative colitis. PLoS One. 2017;12:e0179267. [PMID: 28594959 DOI: 10.1371/journal.pone.0179267] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
262 Sánchez-Fayos Calabuig P, Martín Relloso MJ, Porres Cubero JC. [Multifactorial etiology and pathogenic factors in inflammatory bowel disease]. Gastroenterol Hepatol 2009;32:633-52. [PMID: 19647892 DOI: 10.1016/j.gastrohep.2009.02.011] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
263 Ahmed Z, Venkata K, Zhang N, Malik TA. Comparative Effectiveness of Ustekinumab Versus Adalimumab in Induction of Clinical Response and Remission in Crohn's Disease: Experience of a Real-World Cohort at a Tertiary Care Inflammatory Bowel Disease Referral Center. Gastroenterology Res 2019;12:245-51. [PMID: 31636774 DOI: 10.14740/gr1194] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
264 Pemmasani G, Elgendy I, Mamas MA, Leighton JA, Aronow WS, Tremaine WJ. Epidemiology and Clinical Outcomes of Patients With Inflammatory Bowel Disease Presenting With Acute Coronary Syndrome. Inflamm Bowel Dis 2021;27:1017-25. [PMID: 32978941 DOI: 10.1093/ibd/izaa237] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
265 Qian BF, Tonkonogy SL, Sartor RB. Reduced responsiveness of HLA-B27 transgenic rat cells to TGF-beta and IL-10-mediated regulation of IFN-gamma production. Inflamm Bowel Dis 2008;14:921-30. [PMID: 18340648 DOI: 10.1002/ibd.20415] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
266 Wang W, Chen L, Zhou R, Wang X, Song L, Huang S, Wang G, Xia B. Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease. J Clin Microbiol. 2014;52:398-406. [PMID: 24478468 DOI: 10.1128/jcm.01500-13] [Cited by in Crossref: 198] [Cited by in F6Publishing: 137] [Article Influence: 22.0] [Reference Citation Analysis]
267 Ben Aleya W, Sfar I, Habibi I, Mouelhi L, Aouadi H, Makhlouf M, Ayed-Jendoubi S, Najjar T, Ben Abdallah T, Ayed K. Interleukin-18 gene polymorphisms in tunisian patients with inflammatory bowel disease. Digestion. 2011;83:269-274. [PMID: 21273776 DOI: 10.1159/000319755] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
268 Park JS, Choi J, Kwon JY, Jung KA, Yang CW, Park SH, Cho ML. A probiotic complex, rosavin, zinc, and prebiotics ameliorate intestinal inflammation in an acute colitis mouse model. J Transl Med 2018;16:37. [PMID: 29466999 DOI: 10.1186/s12967-018-1410-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
269 Karrasch T, Kim JS, Muhlbauer M, Magness ST, Jobin C. Gnotobiotic IL-10-/-;NF-kappa B(EGFP) mice reveal the critical role of TLR/NF-kappa B signaling in commensal bacteria-induced colitis. J Immunol 2007;178:6522-32. [PMID: 17475882 DOI: 10.4049/jimmunol.178.10.6522] [Cited by in Crossref: 97] [Cited by in F6Publishing: 92] [Article Influence: 6.5] [Reference Citation Analysis]
270 Sartor RB, Mazmanian SK. Intestinal Microbes in Inflammatory Bowel Diseases. Am J Gastroenterol Suppl 2012;1:15-21. [DOI: 10.1038/ajgsup.2012.4] [Cited by in Crossref: 142] [Cited by in F6Publishing: 59] [Article Influence: 14.2] [Reference Citation Analysis]
271 Halfvarson J. Genetics in twins with Crohn’s disease: less pronounced than previously believed? Inflamm Bowel Dis. 2011;17:6-12. [PMID: 20848478 DOI: 10.1002/ibd.21295] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 5.7] [Reference Citation Analysis]
272 Wohlgemuth S, Haller D, Blaut M, Loh G. Reduced microbial diversity and high numbers of one single Escherichia coli strain in the intestine of colitic mice. Environ Microbiol 2009;11:1562-71. [PMID: 19245530 DOI: 10.1111/j.1462-2920.2009.01883.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
273 Tabibian-keissar H, Zuckerman NS, Barak M, Dunn-walters DK, Steiman-shimony A, Chowers Y, Ofek E, Rosenblatt K, Schiby G, Mehr R, Barshack I. B-cell clonal diversification and gut-lymph node trafficking in ulcerative colitis revealed using lineage tree analysis. Eur J Immunol 2008;38:2600-9. [DOI: 10.1002/eji.200838333] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
274 Zakerska-Banaszak O, Tomczak H, Gabryel M, Baturo A, Wolko L, Michalak M, Malinska N, Mankowska-Wierzbicka D, Eder P, Dobrowolska A, Slomski R, Skrzypczak-Zielinska M. Dysbiosis of gut microbiota in Polish patients with ulcerative colitis: a pilot study. Sci Rep 2021;11:2166. [PMID: 33495479 DOI: 10.1038/s41598-021-81628-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
275 Schmitz S, Garden OA, Werling D, Allenspach K. Gene expression of selected signature cytokines of T cell subsets in duodenal tissues of dogs with and without inflammatory bowel disease. Veterinary Immunology and Immunopathology 2012;146:87-91. [DOI: 10.1016/j.vetimm.2012.01.013] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
276 Yousef M, Pichyangkura R, Soodvilai S, Chatsudthipong V, Muanprasat C. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action. Pharmacol Res. 2012;66:66-79. [PMID: 22475725 DOI: 10.1016/j.phrs.2012.03.013] [Cited by in Crossref: 89] [Cited by in F6Publishing: 78] [Article Influence: 8.9] [Reference Citation Analysis]
277 Stronati L, Negroni A, Pierdomenico M, D’ottavio C, Tirindelli D, Di Nardo G, Oliva S, Viola F, Cucchiara S. Altered expression of innate immunity genes in different intestinal sites of children with ulcerative colitis. Digestive and Liver Disease 2010;42:848-53. [DOI: 10.1016/j.dld.2010.04.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
278 Blais M, Seidman EG, Asselin C. Dual effect of butyrate on IL-1beta--mediated intestinal epithelial cell inflammatory response. DNA Cell Biol 2007;26:133-47. [PMID: 17417942 DOI: 10.1089/dna.2006.0532] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
279 Ghattamaneni NKR, Panchal SK, Brown L. Nutraceuticals in rodent models as potential treatments for human Inflammatory Bowel Disease. Pharmacol Res 2018;132:99-107. [PMID: 29680446 DOI: 10.1016/j.phrs.2018.04.015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
280 Gulati AS, Dubinsky MC. Probiotics in pediatric inflammatory bowel diseases. Curr Gastroenterol Rep 2009;11:238-47. [DOI: 10.1007/s11894-009-0037-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
281 Kiasat A, Granström AL, Stenberg E, Gustafsson UO, Marsk R. The risk of inflammatory bowel disease after bariatric surgery. Surg Obes Relat Dis 2021:S1550-7289(21)00594-3. [PMID: 35012883 DOI: 10.1016/j.soard.2021.12.014] [Reference Citation Analysis]
282 Zhu Y, Jiang H, Chen Z, Lu B, Li J, Shen X. Genetic association between IL23R rs11209026 and rs10889677 polymorphisms and risk of Crohn’s disease and ulcerative colitis: evidence from 41 studies. Inflamm Res 2020;69:87-103. [DOI: 10.1007/s00011-019-01296-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
283 Wei X, Gong J, Zhu J, Niu L, Zhu W, Li N, Li J. Therapeutic effects of triptolide on interleukin-10 gene-deficient mice with colitis. International Immunopharmacology 2008;8:1808-12. [DOI: 10.1016/j.intimp.2008.08.019] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
284 Schoultz I, Verma D, Halfvarsson J, Törkvist L, Fredrikson M, Sjöqvist U, Lördal M, Tysk C, Lerm M, Söderkvist P. Combined polymorphisms in genes encoding the inflammasome components NALP3 and CARD8 confer susceptibility to Crohn’s disease in Swedish men. Am J Gastroenterol. 2009;104:1180-1188. [PMID: 19319132 DOI: 10.1038/ajg.2009.29] [Cited by in Crossref: 112] [Cited by in F6Publishing: 114] [Article Influence: 8.6] [Reference Citation Analysis]
285 Eichele DD, Kharbanda KK. Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis. World J Gastroenterol 2017; 23(33): 6016-6029 [PMID: 28970718 DOI: 10.3748/wjg.v23.i33.6016] [Cited by in CrossRef: 215] [Cited by in F6Publishing: 200] [Article Influence: 43.0] [Reference Citation Analysis]
286 Majumdar D, Tiernan JP, Lobo AJ, Evans CA, Corfe BM. Keratins in colorectal epithelial function and disease. Int J Exp Pathol 2012;93:305-18. [PMID: 22974212 DOI: 10.1111/j.1365-2613.2012.00830.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
287 Vargas-Robles H, Castro-Ochoa KF, Citalán-Madrid AF, Schnoor M. Beneficial effects of nutritional supplements on intestinal epithelial barrier functions in experimental colitis models in vivoWorld J Gastroenterol 2019; 25(30): 4181-4198 [PMID: 31435172 DOI: 10.3748/wjg.v25.i30.4181] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
288 Nell S, Suerbaum S, Josenhans C. The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nat Rev Microbiol. 2010;8:564-577. [PMID: 20622892 DOI: 10.1038/nrmicro2403] [Cited by in Crossref: 223] [Cited by in F6Publishing: 226] [Article Influence: 18.6] [Reference Citation Analysis]
289 Lennon EM, Borst LB, Edwards LL, Moeser AJ. Mast Cells Exert Anti-Inflammatory Effects in an IL10<sup>-/-</sup> Model of Spontaneous Colitis. Mediators Inflamm. 2018;2018:7817360. [PMID: 29849494 DOI: 10.1155/2018/7817360] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
290 Echarri A, Ollero V, Barreiro-de Acosta M, Fernández-villaverde A, Hernández V, Lorenzo A, Pereira S, Carpio D, Castro J. Clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn’s disease: predictors of efficacy in clinical practice. European Journal of Gastroenterology & Hepatology 2015;27:430-5. [DOI: 10.1097/meg.0000000000000296] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
291 Midtvedt T, Zabarovsky E, Norin E, Bark J, Gizatullin R, Kashuba V, Ljungqvist O, Zabarovska V, Möllby R, Ernberg I. Increase of faecal tryptic activity relates to changes in the intestinal microbiome: analysis of Crohn’s disease with a multidisciplinary platform. PLoS One. 2013;8:e66074. [PMID: 23840402 DOI: 10.1371/journal.pone.0066074] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
292 Mori K, Naganuma M, Mizuno S, Suzuki H, Kitazume MT, Shimamura K, Chiba S, Sugita A, Matsuoka K, Hisamatsu T, Kanai T. β-(1,3)-Glucan derived from Candida albicans induces inflammatory cytokines from macrophages and lamina propria mononuclear cells derived from patients with Crohn's disease. Intest Res 2018;16:384-92. [PMID: 30090037 DOI: 10.5217/ir.2018.16.3.384] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
293 Iwakawa H, Fukui T, Fukuwatari T, Bamba S, Sasaki M, Tsujikawa T, Doi Y, Shibata K. Blood concentrations and renal clearance of water-soluble vitamins in outpatients with ulcerative colitis. Biomed Rep 2019;10:202-10. [PMID: 30906550 DOI: 10.3892/br.2019.1191] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
294 Du Z, Hudcovic T, Mrazek J, Kozakova H, Srutkova D, Schwarzer M, Tlaskalova-Hogenova H, Kostovcik M, Kverka M. Development of gut inflammation in mice colonized with mucosa-associated bacteria from patients with ulcerative colitis. Gut Pathog 2015;7:32. [PMID: 26697117 DOI: 10.1186/s13099-015-0080-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
295 Jin Y, Kotakadi VS, Ying L, Hofseth AB, Cui X, Wood PA, Windust A, Matesic LE, Pena EA, Chiuzan C, Singh NP, Nagarkatti M, Nagarkatti PS, Wargovich MJ, Hofseth LJ. American ginseng suppresses inflammation and DNA damage associated with mouse colitis. Carcinogenesis 2008;29:2351-9. [PMID: 18802031 DOI: 10.1093/carcin/bgn211] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 3.7] [Reference Citation Analysis]
296 Jia Q, Lupton JR, Smith R, Weeks BR, Callaway E, Davidson LA, Kim W, Fan YY, Yang P, Newman RA, Kang JX, McMurray DN, Chapkin RS. Reduced colitis-associated colon cancer in Fat-1 (n-3 fatty acid desaturase) transgenic mice. Cancer Res 2008;68:3985-91. [PMID: 18483285 DOI: 10.1158/0008-5472.CAN-07-6251] [Cited by in Crossref: 106] [Cited by in F6Publishing: 73] [Article Influence: 7.6] [Reference Citation Analysis]
297 Edmunds SJ, Roy NC, Love DR, Laing WA. Kiwifruit extracts inhibit cytokine production by lipopolysaccharide-activated macrophages, and intestinal epithelial cells isolated from IL10 gene deficient mice. Cell Immunol 2011;270:70-9. [PMID: 21600571 DOI: 10.1016/j.cellimm.2011.04.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
298 Bloemendaal AL, Buchs NC, George BD, Guy RJ. Intestinal stem cells and intestinal homeostasis in health and in inflammation: A review. Surgery 2016;159:1237-48. [PMID: 26936524 DOI: 10.1016/j.surg.2016.01.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
299 Lee S, Lee J, Ha J, Choi Y, Kim S, Lee H, Yoon Y, Choi KH. Clinical relevance of infections with zoonotic and human oral species of Campylobacter. J Microbiol 2016;54:459-67. [PMID: 27350611 DOI: 10.1007/s12275-016-6254-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
300 Wang S, Bai M, Shu Q, Liu Z, Shao Y, Xu K, Xiong X, Liu H, Li Y. Modulating Effect of Paeonol on Piglets With Ulcerative Colitis. Front Nutr 2022;9:846684. [DOI: 10.3389/fnut.2022.846684] [Reference Citation Analysis]
301 Virumbrales-Muñoz M, Ayuso JM, Gong MM, Humayun M, Livingston MK, Lugo-Cintrón KM, McMinn P, Álvarez-García YR, Beebe DJ. Microfluidic lumen-based systems for advancing tubular organ modeling. Chem Soc Rev 2020;49:6402-42. [PMID: 32760967 DOI: 10.1039/d0cs00705f] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
302 Ismail Y, Mahendran V, Octavia S, Day AS, Riordan SM, Grimm MC, Lan R, Lemberg D, Tran TA, Zhang L. Investigation of the enteric pathogenic potential of oral Campylobacter concisus strains isolated from patients with inflammatory bowel disease. PLoS One 2012;7:e38217. [PMID: 22666490 DOI: 10.1371/journal.pone.0038217] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 4.8] [Reference Citation Analysis]
303 Renaud V, Faucher M, Perreault V, Serre E, Dubé P, Boutin Y, Bazinet L. Evolution of cranberry juice compounds during in vitro digestion and identification of the organic acid responsible for the disruption of in vitro intestinal cell barrier integrity. J Food Sci Technol 2020;57:2329-42. [PMID: 32431359 DOI: 10.1007/s13197-020-04271-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
304 Iida T, Ikeya K, Kato M, Abe J, Yamamoto M, Watanabe F, Sugimoto K, Hanai H. Adsorptive Depletion of Myeloid Lineage Leucocytes as Remission Induction Therapy in Patients with Ulcerative Colitis after Failure of First-Line Medications: Results from a Three-Year Real World, Clinical Practice. Digestion. 2017;96:119-126. [PMID: 28796990 DOI: 10.1159/000479502] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
305 Gomes-Neto JC, Kittana H, Mantz S, Segura Munoz RR, Schmaltz RJ, Bindels LB, Clarke J, Hostetter JM, Benson AK, Walter J, Ramer-Tait AE. A gut pathobiont synergizes with the microbiota to instigate inflammatory disease marked by immunoreactivity against other symbionts but not itself. Sci Rep 2017;7:17707. [PMID: 29255158 DOI: 10.1038/s41598-017-18014-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
306 Bernasconi E, Favre L, Maillard MH, Bachmann D, Pythoud C, Bouzourene H, Croze E, Velichko S, Parkinson J, Michetti P, Velin D. Granulocyte-macrophage colony-stimulating factor elicits bone marrow-derived cells that promote efficient colonic mucosal healing. Inflamm Bowel Dis 2010;16:428-41. [PMID: 19639560 DOI: 10.1002/ibd.21072] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 4.3] [Reference Citation Analysis]
307 Kothary V, Scherl EJ, Bosworth B, Jiang ZD, Dupont HL, Harel J, Simpson KW, Dogan B. Rifaximin resistance in Escherichia coli associated with inflammatory bowel disease correlates with prior rifaximin use, mutations in rpoB, and activity of Phe-Arg-β-naphthylamide-inhibitable efflux pumps. Antimicrob Agents Chemother. 2013;57:811-817. [PMID: 23183443 DOI: 10.1128/aac.02163-12] [Cited by in Crossref: 41] [Cited by in F6Publishing: 20] [Article Influence: 4.1] [Reference Citation Analysis]
308 Andoh A, Kobayashi T, Kuzuoka H, Tsujikawa T, Suzuki Y, Hirai F, Matsui T, Nakamura S, Matsumoto T, Fujiyama Y. Characterization of gut microbiota profiles by disease activity in patients with Crohn's disease using data mining analysis of terminal restriction fragment length polymorphisms. Biomed Rep 2014;2:370-3. [PMID: 24748976 DOI: 10.3892/br.2014.252] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
309 Albenberg LG, Lewis JD, Wu GD. Food and the gut microbiota in inflammatory bowel diseases: a critical connection. Curr Opin Gastroenterol. 2012;28:314-320. [PMID: 22573192 DOI: 10.1097/mog.0b013e328354586f] [Cited by in Crossref: 62] [Cited by in F6Publishing: 33] [Article Influence: 6.2] [Reference Citation Analysis]
310 Kim JW, Kim HJ, Lee CK, Shim JJ, Jang JY, Dong SH, Kim BH, Chang YW, Chi SG. Elevation of PRKCDBP, a novel transcriptional target of TNF-α, and its downregulation by infliximab in patients with ulcerative colitis. Dig Dis Sci 2014;59:2947-57. [PMID: 25052149 DOI: 10.1007/s10620-014-3282-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
311 Eriksson A, Jennische E, Flach C, Jorge A, Lange S. Real-time PCR quantification analysis of five mucosal transcripts in patients with Crohnʼs disease: . European Journal of Gastroenterology & Hepatology 2008;20:290-6. [DOI: 10.1097/meg.0b013e3282f3557c] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
312 Brandl K, Sun L, Neppl C, Siggs OM, Le Gall SM, Tomisato W, Li X, Du X, Maennel DN, Blobel CP. MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands. Proc Natl Acad Sci USA. 2010;107:19967-19972. [PMID: 21041656 DOI: 10.1073/pnas.1014669107] [Cited by in Crossref: 120] [Cited by in F6Publishing: 105] [Article Influence: 10.0] [Reference Citation Analysis]
313 Otter D, Cao M, Lin HM, Fraser K, Edmunds S, Lane G, Rowan D. Identification of urinary biomarkers of colon inflammation in IL10-/- mice using Short-Column LCMS metabolomics. J Biomed Biotechnol. 2011;2011:974701. [PMID: 21188174 DOI: 10.1155/2011/974701] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
314 Cheru L, Saylor CF, Lo J. Gastrointestinal Barrier Breakdown and Adipose Tissue Inflammation. Curr Obes Rep 2019;8:165-74. [PMID: 30847735 DOI: 10.1007/s13679-019-00332-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
315 Ding ZH, Xu XP, Wang TR, Liang X, Ran ZH, Lu H. The prevalence of Helicobacter pylori infection in inflammatory bowel disease in China: A case-control study. PLoS One 2021;16:e0248427. [PMID: 33711050 DOI: 10.1371/journal.pone.0248427] [Reference Citation Analysis]
316 Zhang L, Cheng J, Fan XM. MicroRNAs: New therapeutic targets for intestinal barrier dysfunction. World J Gastroenterol 2014; 20(19): 5818-5825 [PMID: 24914342 DOI: 10.3748/wjg.v20.i19.5818] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
317 Siniagina M, Markelova M, Laikov A, Boulygina E, Khusnutdinova D, Kharchenko A, Misbakhova A, Grigoryeva T. Cultivated Escherichia coli diversity in intestinal microbiota of Crohn's disease patients and healthy individuals: Whole genome data. Data Brief 2020;28:104948. [PMID: 31886370 DOI: 10.1016/j.dib.2019.104948] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
318 Schepens MA, Vink C, Schonewille AJ, Dijkstra G, van der Meer R, Bovee-oudenhoven IM. Dietary heme adversely affects experimental colitis in rats, despite heat-shock protein induction. Nutrition 2011;27:590-7. [DOI: 10.1016/j.nut.2010.05.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
319 Pitari GM. Pharmacology and clinical potential of guanylyl cyclase C agonists in the treatment of ulcerative colitis. Drug Des Devel Ther 2013;7:351-60. [PMID: 23637522 DOI: 10.2147/DDDT.S32252] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
320 Nyabanga C, Kochhar G, Costa G, Soliman B, Shen B, Abu-Elmagd K. Management of Crohn's Disease in the New Era of Gut Rehabilitation and Intestinal Transplantation. Inflamm Bowel Dis 2016;22:1763-76. [PMID: 27104827 DOI: 10.1097/MIB.0000000000000792] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 2.8] [Reference Citation Analysis]
321 Nones K, Dommels YE, Martell S, Butts C, McNabb WC, Park ZA, Zhu S, Hedderley D, Barnett MP, Roy NC. The effects of dietary curcumin and rutin on colonic inflammation and gene expression in multidrug resistance gene-deficient (mdr1a-/-) mice, a model of inflammatory bowel diseases. Br J Nutr. 2009;101:169-181. [PMID: 18761777 DOI: 10.1017/s0007114508009847] [Cited by in Crossref: 58] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
322 Amini Kadijani A, Asadzadeh Aghdaei H, Sorrentino D, Mirzaei A, Shahrokh S, Balaii H, Nguyen VQ, Mays JL, Reza Zali M. Transmembrane TNF-α Density, but not Soluble TNF-α Level, is Associated with Primary Response to Infliximab in Inflammatory Bowel Disease. Clin Transl Gastroenterol 2017;8:e117. [PMID: 28914262 DOI: 10.1038/ctg.2017.44] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
323 Wu Y, Shen J. Innate Lymphoid Cells in Crohn's Disease. Front Immunol 2020;11:554880. [PMID: 33329513 DOI: 10.3389/fimmu.2020.554880] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
324 Plevris N, Fulforth J, Lyons M, Siakavellas SI, Jenkinson PW, Chuah CS, Lucaciu L, Pattenden RJ, Arnott ID, Jones G, Lees CW. Normalization of Fecal Calprotectin Within 12 Months of Diagnosis Is Associated With Reduced Risk of Disease Progression in Patients With Crohn’s Disease. Clinical Gastroenterology and Hepatology 2021;19:1835-1844.e6. [DOI: 10.1016/j.cgh.2020.08.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
325 Buweiayixiemu•Yidisi, Kasimujiang•Aximujiang, Zhang JP, Xilinguli•Wushouer, Abulaiti•Ahemaiti, Huang JJ, Mairepaiti•Abodula, Adila•Abuduaini, Kurexi•Yunusi. Expression of IL-1 and IL-10 mRNAs in colonic tissue of ulcerative colitis rats with abnormal sapra syndrome. Shijie Huaren Xiaohua Zazhi 2017; 25(9): 775-782 [DOI: 10.11569/wcjd.v25.i9.775] [Reference Citation Analysis]
326 Chamberlin W, Borody TJ, Campbell J. Primary treatment of Crohn’s disease: combined antibiotics taking center stage. Expert Review of Clinical Immunology 2014;7:751-60. [DOI: 10.1586/eci.11.43] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
327 Giannogonas P, Apostolou A, Manousopoulou A, Theocharis S, Macari SA, Psarras S, Garbis SD, Pothoulakis C, Karalis KP. Identification of a novel interaction between corticotropin releasing hormone (Crh) and macroautophagy. Sci Rep. 2016;6:23342. [PMID: 26987580 DOI: 10.1038/srep23342] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
328 Petito V, Graziani C, Lopetuso LR, Fossati M, Battaglia A, Arena V, Scannone D, Quaranta G, Quagliariello A, Del Chierico F, Putignani L, Masucci L, Sanguinetti M, Sgambato A, Gasbarrini A, Scaldaferri F. Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis. World J Gastroenterol 2019; 25(12): 1465-1477 [PMID: 30948910 DOI: 10.3748/wjg.v25.i12.1465] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
329 Lee JH, Moon G, Kwon HJ, Jung WJ, Seo PJ, Baec TY, Lee JH, Kim HS. Effect of a Probiotic Preparation (VSL#3) in Patients with Mild to Moderate Ulcerative Colitis. Korean J Gastroenterol 2012;60:94. [DOI: 10.4166/kjg.2012.60.2.94] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
330 McAleer JP, Kolls JK. Contributions of the intestinal microbiome in lung immunity. Eur J Immunol. 2018;48:39-49. [PMID: 28776643 DOI: 10.1002/eji.201646721] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 15.6] [Reference Citation Analysis]
331 Jadhav P, Jiang Y, Jarr K, Layton C, Ashouri JF, Sinha SR. Efficacy of Dietary Supplements in Inflammatory Bowel Disease and Related Autoimmune Diseases. Nutrients 2020;12:E2156. [PMID: 32698454 DOI: 10.3390/nu12072156] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
332 Wei X, Gong J, Zhu J, Wang P, Li N, Zhu W, Li J. The suppressive effect of triptolide on chronic colitis and TNF-α/TNFR2 signal pathway in interleukin-10 deficient mice. Clinical Immunology 2008;129:211-8. [DOI: 10.1016/j.clim.2008.07.018] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
333 Mariano LNB, Arruda C, Somensi LB, Costa APM, Perondi EG, Boeing T, Mariott M, da Silva RDCMVDA, de Souza P, Bastos JK, de Andrade SF, da Silva LM. Brazilian green propolis hydroalcoholic extract reduces colon damages caused by dextran sulfate sodium-induced colitis in mice. Inflammopharmacol 2018;26:1283-92. [DOI: 10.1007/s10787-018-0467-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
334 Liu X, Zhou W, Zhang X, Lu P, Du Q, Tao L, Ding Y, Wang Y, Hu R. Dimethyl fumarate ameliorates dextran sulfate sodium-induced murine experimental colitis by activating Nrf2 and suppressing NLRP3 inflammasome activation. Biochemical Pharmacology 2016;112:37-49. [DOI: 10.1016/j.bcp.2016.05.002] [Cited by in Crossref: 68] [Cited by in F6Publishing: 71] [Article Influence: 11.3] [Reference Citation Analysis]
335 Hansen JJ, Holt L, Sartor RB. Gene expression patterns in experimental colitis in IL-10-deficient mice. Inflamm Bowel Dis 2009;15:890-9. [PMID: 19133689 DOI: 10.1002/ibd.20850] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 3.2] [Reference Citation Analysis]
336 Henrique G, Mello P, Hasse F, Vieira L, Brandao N, Osaku F. DOENÇA DE CROHN E ARTERITE DE TAKAYASU: UMA ASSOCIAÇÃO NÃO TÃO INCOMUM. POSSÍVEL MECANISMO FISIOPATOLÓGICO COMPARTILHADO? Revista Brasileira de Reumatologia 2017;57:S316. [DOI: 10.1016/j.rbr.2017.07.424] [Reference Citation Analysis]
337 Wei X, Zhang L, Zhang R, Koci M, Si D, Ahmad B, Cheng J, Wang J, Aihemaiti M, Zhang M. A Novel Cecropin-LL37 Hybrid Peptide Protects Mice Against EHEC Infection-Mediated Changes in Gut Microbiota, Intestinal Inflammation, and Impairment of Mucosal Barrier Functions. Front Immunol 2020;11:1361. [PMID: 32695115 DOI: 10.3389/fimmu.2020.01361] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
338 Ostanin DV, Bao J, Koboziev I, Gray L, Robinson-Jackson SA, Kosloski-Davidson M, Price VH, Grisham MB. T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am J Physiol Gastrointest Liver Physiol 2009;296:G135-46. [PMID: 19033538 DOI: 10.1152/ajpgi.90462.2008] [Cited by in Crossref: 259] [Cited by in F6Publishing: 261] [Article Influence: 18.5] [Reference Citation Analysis]
339 Bellizzi A, Barucca V, Di Nardo G, Fioriti F, Iebba V, Schippa S, Conte M, Checchi MP, Colosimo M, Cucchiara S, Oliva S, Chiarini F, Pietropaolo V. JC Viral Reactivation in a Pediatric Patient with Crohn's Disease. Int J Immunopathol Pharmacol 2010;23:955-9. [DOI: 10.1177/039463201002300333] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
340 Keely S, Talley NJ, Hansbro PM. Pulmonary-intestinal cross-talk in mucosal inflammatory disease. Mucosal Immunol. 2012;5:7-18. [PMID: 22089028 DOI: 10.1038/mi.2011.55] [Cited by in Crossref: 151] [Cited by in F6Publishing: 157] [Article Influence: 13.7] [Reference Citation Analysis]
341 Castaño-Rodríguez N, Kaakoush NO, Lee WS, Mitchell HM. Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and meta-analysis. Gut 2017;66:235-49. [PMID: 26508508 DOI: 10.1136/gutjnl-2015-310545] [Cited by in Crossref: 94] [Cited by in F6Publishing: 95] [Article Influence: 13.4] [Reference Citation Analysis]
342 Cordes F, Demmig C, Bokemeyer A, Brückner M, Lenze F, Lenz P, Nowacki T, Tepasse P, Schmidt HH, Schmidt MA, Cichon C, Bettenworth D. MicroRNA-320a Monitors Intestinal Disease Activity in Patients With Inflammatory Bowel Disease.Clin Transl Gastroenterol. 2020;11:e00134. [PMID: 32352717 DOI: 10.14309/ctg.0000000000000134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
343 Smarr L. Quantifying your body: a how-to guide from a systems biology perspective. Biotechnol J 2012;7:980-91. [PMID: 22887886 DOI: 10.1002/biot.201100495] [Cited by in Crossref: 61] [Cited by in F6Publishing: 41] [Article Influence: 6.8] [Reference Citation Analysis]
344 Muise A, Rotin D. Apical junction complex proteins and ulcerative colitis: a focus on the PTPRS gene. Expert Review of Molecular Diagnostics 2014;8:465-77. [DOI: 10.1586/14737159.8.4.465] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
345 Thomas CM, Versalovic J. Probiotics-host communication: Modulation of signaling pathways in the intestine. Gut Microbes. 2010;1:148-163. [PMID: 20672012 DOI: 10.4161/gmic.1.3.11712] [Cited by in Crossref: 217] [Cited by in F6Publishing: 205] [Article Influence: 19.7] [Reference Citation Analysis]
346 Chen Y, Li L, Zhang GQ, Xu R. Phenome-driven disease genetics prediction toward drug discovery. Bioinformatics 2015;31:i276-83. [PMID: 26072493 DOI: 10.1093/bioinformatics/btv245] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
347 Haller D, Antoine JM, Bengmark S, Enck P, Rijkers GT, Lenoir-Wijnkoop I. Guidance for substantiating the evidence for beneficial effects of probiotics: probiotics in chronic inflammatory bowel disease and the functional disorder irritable bowel syndrome. J Nutr. 2010;140:690S-697S. [PMID: 20107148 DOI: 10.3945/jn.109.113746] [Cited by in Crossref: 66] [Cited by in F6Publishing: 52] [Article Influence: 5.5] [Reference Citation Analysis]
348 Garza-Hernandez D, Sepulveda-Villegas M, Garcia-Pelaez J, Aguirre-Gamboa R, Lakatos PL, Estrada K, Martinez-Vazquez M, Trevino V. A systematic review and functional bioinformatics analysis of genes associated with Crohn's disease identify more than 120 related genes. BMC Genomics 2022;23:302. [PMID: 35418025 DOI: 10.1186/s12864-022-08491-y] [Reference Citation Analysis]
349 Chakilam S, Gandesiri M, Rau TT, Agaimy A, Vijayalakshmi M, Ivanovska J, Wirtz RM, Schulze-Luehrmann J, Benderska N, Wittkopf N, Chellappan A, Ruemmele P, Vieth M, Rave-Fränk M, Christiansen H, Hartmann A, Neufert C, Atreya R, Becker C, Steinberg P, Schneider-Stock R. Death-associated protein kinase controls STAT3 activity in intestinal epithelial cells. Am J Pathol 2013;182:1005-20. [PMID: 23438478 DOI: 10.1016/j.ajpath.2012.11.026] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
350 Alshehri D, Saadah O, Mosli M, Edris S, Alhindi R, Bahieldin A. Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches. Bosn J Basic Med Sci 2021;21:270-83. [PMID: 33052081 DOI: 10.17305/bjbms.2020.5016] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
351 Zhang M, Perrin L, Pardo P. A Randomized Phase 1 Study to Assess the Safety and Pharmacokinetics of the Subcutaneously Injected Anti-LIGHT Antibody, SAR252067. Clin Pharmacol Drug Dev 2017;6:292-301. [PMID: 27545119 DOI: 10.1002/cpdd.295] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
352 Chaudhary G, Mahajan UB, Goyal SN, Ojha S, Patil CR, Subramanya SB. Protective effect of Lagerstroemia speciose against dextran sulfate sodium induced ulcerative colitis in C57BL/6 mice. Am J Transl Res. 2017;9:1792-1800. [PMID: 28469784 DOI: 10.1055/s-0037-1608457] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
353 Nallathambi R, Mazuz M, Ion A, Selvaraj G, Weininger S, Fridlender M, Nasser A, Sagee O, Kumari P, Nemichenizer D, Mendelovitz M, Firstein N, Hanin O, Konikoff F, Kapulnik Y, Naftali T, Koltai H. Anti-Inflammatory Activity in Colon Models Is Derived from Δ9-Tetrahydrocannabinolic Acid That Interacts with Additional Compounds in Cannabis Extracts. Cannabis Cannabinoid Res 2017;2:167-82. [PMID: 29082314 DOI: 10.1089/can.2017.0027] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 6.2] [Reference Citation Analysis]
354 Blander JM. Death in the intestinal epithelium-basic biology and implications for inflammatory bowel disease. FEBS J. 2016;283:2720-2730. [PMID: 27250564 DOI: 10.1111/febs.13771] [Cited by in Crossref: 83] [Cited by in F6Publishing: 74] [Article Influence: 13.8] [Reference Citation Analysis]
355 Fonseca-Camarillo G, Furuzawa-Carballeda J, Yamamoto-Furusho JK. Interleukin 35 (IL-35) and IL-37: Intestinal and peripheral expression by T and B regulatory cells in patients with Inflammatory Bowel Disease. Cytokine 2015;75:389-402. [PMID: 26141420 DOI: 10.1016/j.cyto.2015.04.009] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 7.0] [Reference Citation Analysis]
356 Glas J, Stallhofer J, Ripke S, Wetzke M, Pfennig S, Klein W, Epplen JT, Griga T, Schiemann U, Lacher M, Koletzko S, Folwaczny M, Lohse P, Göke B, Ochsenkühn T, Müller-Myhsok B, Brand S. Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease. Am J Gastroenterol 2009;104:1737-44. [PMID: 19455118 DOI: 10.1038/ajg.2009.163] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 4.5] [Reference Citation Analysis]
357 Thomas C, Minty M, Vinel A, Canceill T, Loubières P, Burcelin R, Kaddech M, Blasco-Baque V, Laurencin-Dalicieux S. Oral Microbiota: A Major Player in the Diagnosis of Systemic Diseases. Diagnostics (Basel) 2021;11:1376. [PMID: 34441309 DOI: 10.3390/diagnostics11081376] [Reference Citation Analysis]
358 Kondo A, Ma S, Lee MYY, Ortiz V, Traum D, Schug J, Wilkins B, Terry NA, Lee H, Kaestner KH. Highly Multiplexed Image Analysis of Intestinal Tissue Sections in Patients With Inflammatory Bowel Disease. Gastroenterology 2021:S0016-5085(21)03480-6. [PMID: 34529988 DOI: 10.1053/j.gastro.2021.08.055] [Reference Citation Analysis]
359 Iraha A, Chinen H, Hokama A, Yonashiro T, Kinjo T, Kishimoto K, Nakamoto M, Hirata T, Kinjo N, Higa F, Tateyama M, Kinjo F, Fujita J. Fucoidan enhances intestinal barrier function by upregulating the expression of claudin-1. World J Gastroenterol 2013; 19(33): 5500-5507 [PMID: 24023493 DOI: 10.3748/wjg.v19.i33.5500] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
360 Nagar J, Ranade S, Kamath V, Singh S, Karunanithi P, Subramani S, Venkatesh K, Srivastava R, Dudhgaonkar S, Vikramadithyan RK. Therapeutic potential of chloroquine in a murine model of inflammatory bowel disease. Int Immunopharmacol 2014;21:328-35. [PMID: 24859061 DOI: 10.1016/j.intimp.2014.05.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
361 Semiz A, Ozgun Acar O, Cetin H, Semiz G, Sen A. Suppression of Inflammatory Cytokines Expression with Bitter Melon (Momordica Charantia) in TNBS-instigated Ulcerative Colitis. J Transl Int Med 2020;8:177-87. [PMID: 33062594 DOI: 10.2478/jtim-2020-0027] [Reference Citation Analysis]
362 Chojnacki C, Błasiak J, Fichna J, Chojnacki J, Popławski T. Evaluation of Melatonin Secretion and Metabolism Exponents in Patients with Ulcerative and Lymphocytic Colitis. Molecules 2018;23:E272. [PMID: 29382152 DOI: 10.3390/molecules23020272] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
363 Zhao Y, Yao Y, Xu M, Wang S, Wang X, Tu Y. Simulated gastrointestinal digest from preserved egg white exerts anti-inflammatory effects on Caco-2 cells and a mouse model of DSS-induced colitis. Journal of Functional Foods 2017;35:655-65. [DOI: 10.1016/j.jff.2017.06.028] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
364 Chen LL, Zou YY, Lu FG, Li FJ, Lian GH. Efficacy profiles for different concentrations of Lactobacillus acidophilus in experimental colitis. World J Gastroenterol 2013; 19(32): 5347-5356 [PMID: 23983440 DOI: 10.3748/wjg.v19.i32.5347] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
365 Hudson LE, Anderson SE, Corbett AH, Lamb TJ. Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies. Clin Microbiol Rev. 2017;30:191-231. [PMID: 27856521 DOI: 10.1128/cmr.00049-16] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 7.6] [Reference Citation Analysis]
366 Fan H, Zhang LJ, Zhong M, Liu XX, Duan XY, Zuo DM, Tang Q. Intervention effect of Compound Sophorae Flavescentis decoction on DOR-β-arrestin1-Bcl-2 signal transduction pathway in rats with ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2013; 21(8): 647-654 [DOI: 10.11569/wcjd.v21.i8.647] [Reference Citation Analysis]
367 Neurath M, Finotto S. The Many Roads to Inflammatory Bowel Diseases. Immunity 2006;25:189-91. [DOI: 10.1016/j.immuni.2006.08.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
368 Ohkusa T, Koido S. Intestinal microbiota and ulcerative colitis. Journal of Infection and Chemotherapy 2015;21:761-8. [DOI: 10.1016/j.jiac.2015.07.010] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 8.0] [Reference Citation Analysis]
369 Stadnicki A. Intestinal tissue kallikrein-kinin system in inflammatory bowel disease. Inflamm Bowel Dis 2011;17:645-54. [PMID: 20848521 DOI: 10.1002/ibd.21337] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
370 Marcon R, Claudino RF, Dutra RC, Bento AF, Schmidt EC, Bouzon ZL, Sordi R, Morais RL, Pesquero JB, Calixto JB. Exacerbation of DSS-induced colitis in mice lacking kinin B(1) receptors through compensatory up-regulation of kinin B(2) receptors: the role of tight junctions and intestinal homeostasis. Br J Pharmacol. 2013;168:389-402. [PMID: 22889120 DOI: 10.1111/j.1476-5381.2012.02136.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
371 Yang H, Kozicky L, Saferali A, Fung SY, Afacan N, Cai B, Falsafi R, Gill E, Liu M, Kollmann TR, Hancock RE, Sly LM, Turvey SE. Endosomal pH modulation by peptide-gold nanoparticle hybrids enables potent anti-inflammatory activity in phagocytic immune cells. Biomaterials 2016;111:90-102. [PMID: 27728817 DOI: 10.1016/j.biomaterials.2016.09.032] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
372 Berger E, Rath E, Yuan D, Waldschmitt N, Khaloian S, Allgäuer M, Staszewski O, Lobner EM, Schöttl T, Giesbertz P, Coleman OI, Prinz M, Weber A, Gerhard M, Klingenspor M, Janssen KP, Heikenwalder M, Haller D. Mitochondrial function controls intestinal epithelial stemness and proliferation. Nat Commun 2016;7:13171. [PMID: 27786175 DOI: 10.1038/ncomms13171] [Cited by in Crossref: 77] [Cited by in F6Publishing: 69] [Article Influence: 12.8] [Reference Citation Analysis]
373 Khajah MA, Orabi KY, Hawai S, Sary HG, El-Hashim AZ. Onion bulb extract reduces colitis severity in mice via modulation of colonic inflammatory pathways and the apoptotic machinery. J Ethnopharmacol 2019;241:112008. [PMID: 31158441 DOI: 10.1016/j.jep.2019.112008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
374 Chang TE, Luo JC, Yang UC, Huang YH, Hou MC, Lee FY. Fecal microbiota profile in patients with inflammatory bowel disease in Taiwan. J Chin Med Assoc 2021;84:580-7. [PMID: 33871395 DOI: 10.1097/JCMA.0000000000000532] [Reference Citation Analysis]
375 Gaujoux R, Starosvetsky E, Maimon N, Vallania F, Bar-Yoseph H, Pressman S, Weisshof R, Goren I, Rabinowitz K, Waterman M, Yanai H, Dotan I, Sabo E, Chowers Y, Khatri P, Shen-Orr SS; Israeli IBD research Network (IIRN). Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBD. Gut 2019;68:604-14. [PMID: 29618496 DOI: 10.1136/gutjnl-2017-315494] [Cited by in Crossref: 70] [Cited by in F6Publishing: 76] [Article Influence: 17.5] [Reference Citation Analysis]
376 El-Mahdy NA, El-Sayad ME, El-Kadem AH, Abu-Risha SE. Metformin alleviates inflammation in oxazolone induced ulcerative colitis in rats: plausible role of sphingosine kinase 1/sphingosine 1 phosphate signaling pathway. Immunopharmacol Immunotoxicol 2021;43:192-202. [PMID: 33504231 DOI: 10.1080/08923973.2021.1878214] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
377 Lee CS, Penberthy KK, Wheeler KM, Juncadella IJ, Vandenabeele P, Lysiak JJ, Ravichandran KS. Boosting Apoptotic Cell Clearance by Colonic Epithelial Cells Attenuates Inflammation In Vivo. Immunity 2016;44:807-20. [PMID: 27037190 DOI: 10.1016/j.immuni.2016.02.005] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 11.0] [Reference Citation Analysis]
378 Kramer K, Thye T, Treszl A, Peine S, Koch M, Sterneck M, Nashan B, Thude H. Polymorphism in NFKBIA gene is associated with recurrent acute rejections in liver transplant recipients. Tissue Antigens 2014;84:370-7. [DOI: 10.1111/tan.12411] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
379 Saez A, Gomez-Bris R, Herrero-Fernandez B, Mingorance C, Rius C, Gonzalez-Granado JM. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease. Int J Mol Sci 2021;22:7618. [PMID: 34299236 DOI: 10.3390/ijms22147618] [Reference Citation Analysis]
380 Ruffolo C, Scarpa M, Faggian D, Basso D, D’Incà R, Plebani M, Sturniolo GC, Bassi N, Angriman I. Subclinical intestinal inflammation in patients with Crohn’s disease following bowel resection: a smoldering fire. J Gastrointest Surg. 2010;14:24-31. [PMID: 19902313 DOI: 10.1007/s11605-009-1070-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
381 Billerey-Larmonier C, Uno JK, Larmonier N, Midura AJ, Timmermann B, Ghishan FK, Kiela PR. Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent. Inflamm Bowel Dis 2008;14:780-93. [PMID: 18200517 DOI: 10.1002/ibd.20348] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 3.4] [Reference Citation Analysis]
382 Kabakchiev B, Tyler A, Stempak JM, Milgrom R, Silverberg MS. Downregulation of expression of xenobiotic efflux genes is associated with pelvic pouch inflammation in ulcerative colitis. Inflamm Bowel Dis 2014;20:1157-64. [PMID: 24874456 DOI: 10.1097/MIB.0000000000000078] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
383 Nones K, Knoch B, Dommels YE, Paturi G, Butts C, McNabb WC, Roy NC. Multidrug resistance gene deficient (mdr1a-/-) mice have an altered caecal microbiota that precedes the onset of intestinal inflammation. J Appl Microbiol. 2009;107:557-566. [PMID: 19302324 DOI: 10.1111/j.1365-2672.2009.04225.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
384 Shen ZH, Zhu CX, Quan YS, Yang ZY, Wu S, Luo WW, Tan B, Wang XY. Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation. World J Gastroenterol 2018; 24(1): 5-14 [PMID: 29358877 DOI: 10.3748/wjg.v24.i1.5] [Cited by in CrossRef: 145] [Cited by in F6Publishing: 116] [Article Influence: 36.3] [Reference Citation Analysis]
385 Wine E, Ossa JC, Gray-Owen SD, Sherman PM. Adherent-invasive Escherichia coli, strain LF82 disrupts apical junctional complexes in polarized epithelia. BMC Microbiol. 2009;9:180. [PMID: 19709415 DOI: 10.1186/1471-2180-9-180] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 3.6] [Reference Citation Analysis]
386 Grassl GA, Valdez Y, Bergstrom KS, Vallance BA, Finlay BB. Chronic enteric salmonella infection in mice leads to severe and persistent intestinal fibrosis. Gastroenterology. 2008;134:768-780. [PMID: 18325390 DOI: 10.1053/j.gastro.2007.12.043] [Cited by in Crossref: 91] [Cited by in F6Publishing: 92] [Article Influence: 6.5] [Reference Citation Analysis]
387 Cui Y, Zhu C, Ming Z, Cao J, Yan Y, Zhao P, Pang G, Deng Z, Yao Y, Chen Q. Molecular mechanisms by which casein glycomacropeptide maintains internal homeostasis in mice with experimental ulcerative colitis. PLoS One 2017;12:e0181075. [PMID: 28700735 DOI: 10.1371/journal.pone.0181075] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
388 Washabau R, Day M, Willard M, Hall E, Jergens A, Mansell J, Minami T, Bilzer T; The WSAVA International Gastrointestinal Standardization Group. Endoscopic, Biopsy, and Histopathologic Guidelines for the Evaluation of Gastrointestinal Inflammation in Companion Animals. Journal of Veterinary Internal Medicine 2010;24:10-26. [DOI: 10.1111/j.1939-1676.2009.0443.x] [Cited by in Crossref: 203] [Cited by in F6Publishing: 185] [Article Influence: 16.9] [Reference Citation Analysis]
389 Lv Y, Yang X, Huo Y, Tian H, Li S, Yin Y, Hao Z. Adenovirus-mediated hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein suppresses dextran sulfate sodium-induced acute ulcerative colitis in rats. Inflamm Bowel Dis. 2012;18:1950-1960. [PMID: 22419609 DOI: 10.1002/ibd.22887] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
390 Nazarian A, Sichtig H, Riva A. A knowledge-based method for association studies on complex diseases. PLoS One 2012;7:e44162. [PMID: 22970175 DOI: 10.1371/journal.pone.0044162] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
391 Reiley WW, Jin W, Lee AJ, Wright A, Wu X, Tewalt EF, Leonard TO, Norbury CC, Fitzpatrick L, Zhang M, Sun SC. Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses. J Exp Med 2007;204:1475-85. [PMID: 17548520 DOI: 10.1084/jem.20062694] [Cited by in Crossref: 184] [Cited by in F6Publishing: 172] [Article Influence: 12.3] [Reference Citation Analysis]
392 Kim MS, Byun JS, Yoon YS, Yum DY, Chung MJ, Lee JC. A probiotic combination attenuates experimental colitis through inhibition of innate cytokine production. Benef Microbes 2017;8:231-41. [PMID: 28008786 DOI: 10.3920/BM2016.0031] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
393 Pile JE, Navalta JW, Davis CD, Sharma NC. Interventional effects of plumbagin on experimental ulcerative colitis in mice. J Nat Prod. 2013;76:1001-1006. [PMID: 23742275 DOI: 10.1021/np3008792] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
394 Steenholdt C, Andresen L, Pedersen G, Hansen A, Brynskov J. Expression and function of toll-like receptor 8 and Tollip in colonic epithelial cells from patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2009;44:195-204. [DOI: 10.1080/00365520802495529] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
395 Wang Z, Ding L, Wang Z, Wang J, Zhu N, Diao Y, Demmy TA, Haitsma JM, Lech-maranda EE, Bangia NN, Czuczman MA, Qian X, Kovacs KL. Circulating CD4 + CXCR5 + T Cells Exacerbate B Cell Antibody Production in Crohn's Disease Through IL-21 Secretion. Immunological Investigations 2015;44:665-77. [DOI: 10.3109/08820139.2015.1074246] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
396 Patel KK, Babyatsky MW. Medical education: a key partner in realizing personalized medicine in gastroenterology. Gastroenterology. 2008;134:656-661. [PMID: 18325381 DOI: 10.1053/j.gastro.2008.01.064] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
397 Tremelling M, Parkes M. Genome-wide association scans identify multiple confirmed susceptibility loci for Crohn's disease: lessons for study design. Inflamm Bowel Dis 2007;13:1554-60. [PMID: 17712840 DOI: 10.1002/ibd.20239] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
398 Jansson J, Willing B, Lucio M, Fekete A, Dicksved J, Halfvarson J, Tysk C, Schmitt-Kopplin P. Metabolomics reveals metabolic biomarkers of Crohn’s disease. PLoS One. 2009;4:e6386. [PMID: 19636438 DOI: 10.1371/journal.pone.0006386] [Cited by in Crossref: 331] [Cited by in F6Publishing: 322] [Article Influence: 25.5] [Reference Citation Analysis]
399 Wang S, Qin C. Interleukin 35 Rescues Regulatory B Cell Function, but the Effect Is Dysregulated in Ulcerative Colitis. DNA and Cell Biology 2017;36:413-21. [DOI: 10.1089/dna.2016.3570] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
400 Dumont L, Landman C, Sokol H, Beaugerie L, Cosnes J, Seksik P, Guégan S; CD-HS Study Group. Increased risk of permanent stoma in Crohn’s disease associated with hidradenitis suppurativa: a case-control study. Aliment Pharmacol Ther 2020;52:303-10. [DOI: 10.1111/apt.15863] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
401 Ma R, Liu F, Yap SF, Lee H, Leong RW, Riordan SM, Grimm MC, Zhang L. The Growth and Protein Expression of Inflammatory Bowel Disease-Associated Campylobacter concisus Is Affected by the Derivatives of the Food Additive Fumaric Acid. Front Microbiol. 2018;9:896. [PMID: 29867807 DOI: 10.3389/fmicb.2018.00896] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
402 Jin Y, Xia J, Pan Z, Yang J, Wang W, Fu Z. Polystyrene microplastics induce microbiota dysbiosis and inflammation in the gut of adult zebrafish. Environmental Pollution 2018;235:322-9. [DOI: 10.1016/j.envpol.2017.12.088] [Cited by in Crossref: 210] [Cited by in F6Publishing: 195] [Article Influence: 52.5] [Reference Citation Analysis]
403 Jauregui-Amezaga A, Cabezón R, Ramírez-Morros A, España C, Rimola J, Bru C, Pinó-Donnay S, Gallego M, Masamunt MC, Ordás I, Lozano M, Cid J, Panés J, Benítez-Ribas D, Ricart E. Intraperitoneal Administration of Autologous Tolerogenic Dendritic Cells for Refractory Crohn's Disease: A Phase I Study. J Crohns Colitis 2015;9:1071-8. [PMID: 26303633 DOI: 10.1093/ecco-jcc/jjv144] [Cited by in Crossref: 87] [Cited by in F6Publishing: 85] [Article Influence: 12.4] [Reference Citation Analysis]
404 Yang L, Wang L, Wang X, Xian CJ, Lu H. A Possible Role of Intestinal Microbiota in the Pathogenesis of Ankylosing Spondylitis. Int J Mol Sci 2016;17:E2126. [PMID: 27999312 DOI: 10.3390/ijms17122126] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
405 Kameyama K, Nemoto Y, Kanai T, Shinohara T, Okamoto R, Tsuchiya K, Nakamura T, Sakamoto N, Totsuka T, Hibi T, Watanabe M. IL-2 is positively involved in the development of colitogenic CD4+ IL-7R alpha high memory T cells in chronic colitis. Eur J Immunol 2010;40:2423-36. [PMID: 20623548 DOI: 10.1002/eji.200939764] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
406 Zhang XX, Diao LZ, Chen LZ, Ma D, Wang YM, Jiang H, Ruan BF, Liu XH. Discovery of 4-((E)-3,5-dimethoxy-2-((E)-2-nitrovinyl)styryl)aniline derivatives as potent and orally active NLRP3 inflammasome inhibitors for colitis. European Journal of Medicinal Chemistry 2022;236:114357. [DOI: 10.1016/j.ejmech.2022.114357] [Reference Citation Analysis]
407 Francoeur C, Bouatrouss Y, Seltana A, Pinchuk IV, Vachon PH, Powell DW, Sawan B, Seidman EG, Beaulieu JF. Degeneration of the pericryptal myofibroblast sheath by proinflammatory cytokines in inflammatory bowel diseases. Gastroenterology. 2009;136:268-277.e3. [PMID: 18976656 DOI: 10.1053/j.gastro.2008.10.014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
408 Basson A, Trotter A, Rodriguez-Palacios A, Cominelli F. Mucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel Disease. Front Immunol. 2016;7:290. [PMID: 27531998 DOI: 10.3389/fimmu.2016.00290] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 10.2] [Reference Citation Analysis]
409 Khan S, Imran A, Malik A, Chaudhary AA, Rub A, Jan AT, Syed JB, Rolfo C. Bacterial imbalance and gut pathologies: Association and contribution of E. coli in inflammatory bowel disease. Critical Reviews in Clinical Laboratory Sciences 2019;56:1-17. [DOI: 10.1080/10408363.2018.1517144] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
410 Jones EJ, Matthews ZJ, Gul L, Sudhakar P, Treveil A, Divekar D, Buck J, Wrzesinski T, Jefferson M, Armstrong SD, Hall LJ, Watson AJM, Carding SR, Haerty W, Di Palma F, Mayer U, Powell PP, Hautefort I, Wileman T, Korcsmaros T. Integrative analysis of Paneth cell proteomic and transcriptomic data from intestinal organoids reveals functional processes dependent on autophagy. Dis Model Mech 2019;12:dmm037069. [PMID: 30814064 DOI: 10.1242/dmm.037069] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
411 Akıncılar SC, Wu L, Ng QF, Chua JYH, Unal B, Noda T, Chor WHJ, Ikawa M, Tergaonkar V. NAIL: an evolutionarily conserved lncRNA essential for licensing coordinated activation of p38 and NFκB in colitis. Gut 2021;70:1857-71. [PMID: 33239342 DOI: 10.1136/gutjnl-2020-322980] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
412 Hammad A, Zheng ZH, Gao Y, Namani A, Shi HF, Tang X. Identification of novel Nrf2 target genes as prognostic biomarkers in colitis-associated colorectal cancer in Nrf2-deficient mice. Life Sci 2019;238:116968. [PMID: 31628914 DOI: 10.1016/j.lfs.2019.116968] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
413 Hyun CK. Molecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases. Int J Mol Sci 2021;22:9139. [PMID: 34502047 DOI: 10.3390/ijms22179139] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
414 Oliveira LG, Cunha AL, Duarte AC, Castañon MC, Chebli JM, Aguiar JA. Positive correlation between disease activity index and matrix metalloproteinases activity in a rat model of colitis. Arq Gastroenterol 2014;51:107-12. [PMID: 25003261 DOI: 10.1590/s0004-28032014000200007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
415 Peiravan A, Bertolini F, Rothschild MF, Simpson KW, Jergens AE, Allenspach K, Werling D. Genome-wide association studies of inflammatory bowel disease in German shepherd dogs. PLoS One 2018;13:e0200685. [PMID: 30028859 DOI: 10.1371/journal.pone.0200685] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
416 Günther C, Ruder B, Stolzer I, Dorner H, He G, Chiriac MT, Aden K, Strigli A, Bittel M, Zeissig S, Rosenstiel P, Atreya R, Neurath MF, Wirtz S, Becker C. Interferon Lambda Promotes Paneth Cell Death Via STAT1 Signaling in Mice and Is Increased in Inflamed Ileal Tissues of Patients With Crohn’s Disease. Gastroenterology 2019;157:1310-1322.e13. [DOI: 10.1053/j.gastro.2019.07.031] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
417 Manuc TE, Manuc MM, Diculescu MM. Recent insights into the molecular pathogenesis of Crohn's disease: a review of emerging therapeutic targets. Clin Exp Gastroenterol 2016;9:59-70. [PMID: 27042137 DOI: 10.2147/CEG.S53381] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
418 Rismo R, Olsen T, Cui G, Christiansen I, Florholmen J, Goll R. Mucosal cytokine gene expression profiles as biomarkers of response to infliximab in ulcerative colitis. Scand J Gastroenterol. 2012;47:538-547. [PMID: 22486187 DOI: 10.3109/00365521.2012.667146] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 5.2] [Reference Citation Analysis]
419 Holgersen K, Kvist PH, Markholst H, Hansen AK, Holm TL. Characterisation of enterocolitis in the piroxicam-accelerated interleukin-10 knock out mouse--a model mimicking inflammatory bowel disease. J Crohns Colitis 2014;8:147-60. [PMID: 23994255 DOI: 10.1016/j.crohns.2013.08.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
420 Tough DF, Rioja I, Prinjha RK. Anti-inflammatory Effects of BET Protein Inhibition Through Modulation of Gene Transcription. In: Zhou M, editor. Histone Recognition. Cham: Springer International Publishing; 2015. pp. 199-223. [DOI: 10.1007/978-3-319-18102-8_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
421 Mehta K, Jaiswal P, Briggs F, Faubion WA, Tabibian JH, Cominelli F, Dave M. In-patient outcomes of Hematopoietic Stem Cell Transplantation in Patients with Immune Mediated Inflammatory Diseases: A Nationwide Study. Sci Rep 2018;8:6825. [PMID: 29717163 DOI: 10.1038/s41598-018-24060-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
422 Zhang H, Kodera T, Eto Y, Mine Y. γ-Glutamyl valine supplementation-induced mitigation of gut inflammation in a porcine model of colitis. Journal of Functional Foods 2016;24:558-67. [DOI: 10.1016/j.jff.2016.04.038] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
423 Wang Z, Wang Z, Wang J, Diao Y, Qian X, Zhu N. T-bet-Expressing B Cells Are Positively Associated with Crohn's Disease Activity and Support Th1 Inflammation. DNA Cell Biol 2016;35:628-35. [PMID: 27348235 DOI: 10.1089/dna.2016.3304] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
424 Qin M, Long F, Wu W, Yang D, Huang M, Xiao C, Chen X, Liu X, Zhu YZ. Hydrogen sulfide protects against DSS-induced colitis by inhibiting NLRP3 inflammasome. Free Radic Biol Med 2019;137:99-109. [PMID: 31026586 DOI: 10.1016/j.freeradbiomed.2019.04.025] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
425 Russo E, Giudici F, Fiorindi C, Ficari F, Scaringi S, Amedei A. Immunomodulating Activity and Therapeutic Effects of Short Chain Fatty Acids and Tryptophan Post-biotics in Inflammatory Bowel Disease. Front Immunol. 2019;10:2754. [PMID: 31824517 DOI: 10.3389/fimmu.2019.02754] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
426 Van den Abbeele P, Van de Wiele T, Verstraete W, Possemiers S. The host selects mucosal and luminal associations of coevolved gut microorganisms: a novel concept. FEMS Microbiol Rev. 2011;35:681-704. [PMID: 21361997 DOI: 10.1111/j.1574-6976.2011.00270.x] [Cited by in Crossref: 153] [Cited by in F6Publishing: 143] [Article Influence: 13.9] [Reference Citation Analysis]
427 Macintyre G, Bailey J, Haviv I, Kowalczyk A. is-rSNP: a novel technique for in silico regulatory SNP detection. Bioinformatics 2010;26:i524-30. [PMID: 20823317 DOI: 10.1093/bioinformatics/btq378] [Cited by in Crossref: 92] [Cited by in F6Publishing: 82] [Article Influence: 7.7] [Reference Citation Analysis]
428 Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA. 2007;104:13780-13785. [PMID: 17699621 DOI: 10.1073/pnas.0706625104] [Cited by in Crossref: 2687] [Cited by in F6Publishing: 2509] [Article Influence: 179.1] [Reference Citation Analysis]
429 O'Hara JR, Feener TD, Fischer CD, Buret AG. Campylobacter jejuni disrupts protective Toll-like receptor 9 signaling in colonic epithelial cells and increases the severity of dextran sulfate sodium-induced colitis in mice. Infect Immun. 2012;80:1563-1571. [PMID: 22311925 DOI: 10.1128/IAI.06066-] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
430 Chi HG, Zheng XB, Wu ZG, Dai SX, Wan Z, Zou Y. Association of the interleukin-22 genetic polymorphisms with ulcerative colitis. Diagn Pathol 2014;9:183. [PMID: 25297677 DOI: 10.1186/s13000-014-0183-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
431 Kazama I. Roles of lymphocyte Kv1.3-channels in gut mucosal immune system: Novel therapeutic implications for inflammatory bowel disease. Medical Hypotheses 2015;85:61-3. [DOI: 10.1016/j.mehy.2015.03.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
432 Naganuma M, Watanabe K, Motoya S, Ogata H, Matsui T, Suzuki Y, Ursos L, Sakamoto S, Shikamura M, Hori T, Fernandez J, Watanabe M, Hibi T, Kanai T. Potential benefits of immunomodulator use with vedolizumab for maintenance of remission in ulcerative colitis. J Gastroenterol Hepatol 2021. [PMID: 34409654 DOI: 10.1111/jgh.15667] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
433 Young D, Ibuki M, Nakamori T, Fan M, Mine Y. Soy-derived di- and tripeptides alleviate colon and ileum inflammation in pigs with dextran sodium sulfate-induced colitis. J Nutr 2012;142:363-8. [PMID: 22190029 DOI: 10.3945/jn.111.149104] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 5.5] [Reference Citation Analysis]
434 Angeletti A, Arrigo S, Madeo A, Molteni M, Vietti E, Arcuri L, Coccia MC, Gandullia P, Ghiggeri GM. Different renal manifestations associated with very early onset pediatric inflammatory bowel disease: case report and review of literature. BMC Nephrol 2021;22:146. [PMID: 33888087 DOI: 10.1186/s12882-021-02358-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
435 Motilva V, García-Mauriño S, Talero E, Illanes M. New paradigms in chronic intestinal inflammation and colon cancer: role of melatonin. J Pineal Res. 2011;51:44-60. [PMID: 21752096 DOI: 10.1111/j.1600-079X.2011.00915.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 23] [Article Influence: 6.9] [Reference Citation Analysis]
436 Lin L, Zhang Y, Lin Y, Jin Y, Zheng C. Identifying candidate genes for discrimination of ulcerative colitis and Crohn’s disease. Mol Biol Rep 2014;41:6349-55. [DOI: 10.1007/s11033-014-3469-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
437 Laing BB, Lim AG, Ferguson LR. A Personalised Dietary Approach-A Way Forward to Manage Nutrient Deficiency, Effects of the Western Diet, and Food Intolerances in Inflammatory Bowel Disease. Nutrients 2019;11:E1532. [PMID: 31284450 DOI: 10.3390/nu11071532] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
438 Lin GJ, Huang SH, Chen SJ, Wang CH, Chang DM, Sytwu HK. Modulation by melatonin of the pathogenesis of inflammatory autoimmune diseases. Int J Mol Sci 2013;14:11742-66. [PMID: 23727938 DOI: 10.3390/ijms140611742] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 5.8] [Reference Citation Analysis]
439 Rol Á, Todorovski T, Martin-Malpartida P, Escolà A, Gonzalez-Rey E, Aragón E, Verdaguer X, Vallès-Miret M, Farrera-Sinfreu J, Puig E, Fernández-Carneado J, Ponsati B, Delgado M, Riera A, Macias MJ. Structure-based design of a Cortistatin analogue with immunomodulatory activity in models of inflammatory bowel disease. Nat Commun 2021;12:1869. [PMID: 33767180 DOI: 10.1038/s41467-021-22076-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
440 Mazzoccoli G, Palmieri O, Corritore G, Latiano T, Bossa F, Scimeca D, Biscaglia G, Valvano MR, D’Incà R, Cucchiara S. Association study of a polymorphism in clock gene PERIOD3 and risk of inflammatory bowel disease. Chronobiol Int. 2012;29:994-1003. [PMID: 22881285 DOI: 10.3109/07420528.2012.705935] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
441 Kemp R, Dunn E, Schultz M. Immunomodulators in inflammatory bowel disease: an emerging role for biologic agents. BioDrugs 2013;27:585-90. [PMID: 23749336 DOI: 10.1007/s40259-013-0045-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
442 Leite JSM, Cruzat VF, Krause M, Homem de Bittencourt PI. Physiological regulation of the heat shock response by glutamine: implications for chronic low-grade inflammatory diseases in age-related conditions. Nutrire 2016;41. [DOI: 10.1186/s41110-016-0021-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
443 Su L, Turner JR. Got Guts? Need Nerve! Gastroenterology 2007;132:1615-8. [DOI: 10.1053/j.gastro.2007.03.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
444 van Zyl WF, Deane SM, Dicks LMT. Molecular insights into probiotic mechanisms of action employed against intestinal pathogenic bacteria. Gut Microbes 2020;12:1831339. [PMID: 33112695 DOI: 10.1080/19490976.2020.1831339] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
445 Engelman RW, Kerr WG. Assessing inflammatory disease at mucosal surfaces in murine genetic models. Methods Mol Biol 2012;900:433-41. [PMID: 22933082 DOI: 10.1007/978-1-60761-720-4_21] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
446 Cui Y, Liu ZJ, Zhao ZG, Zheng PY, Huang DF. Significance of interleukin-27 expression in the intestinal mucosa of patients with inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2010; 18(1): 39-43 [DOI: 10.11569/wcjd.v18.i1.39] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
447 Kellermayer R. Challenges for epigenetic research in inflammatory bowel diseases. Epigenomics 2017;9:527-38. [PMID: 28343422 DOI: 10.2217/epi-2016-0155] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
448 Feng T, Wang L, Schoeb TR, Elson CO, Cong Y. Microbiota innate stimulation is a prerequisite for T cell spontaneous proliferation and induction of experimental colitis. J Exp Med 2010;207:1321-32. [PMID: 20498021 DOI: 10.1084/jem.20092253] [Cited by in Crossref: 155] [Cited by in F6Publishing: 156] [Article Influence: 12.9] [Reference Citation Analysis]
449 O'Sullivan S, Wang J, Pigott MT, Docherty N, Boyle N, Lis SK, Gilmer JF, Medina C. Inhibition of matrix metalloproteinase-9 by a barbiturate-nitrate hybrid ameliorates dextran sulphate sodium-induced colitis: effect on inflammation-related genes. Br J Pharmacol. 2017;174:512-524. [PMID: 28079248 DOI: 10.1111/bph.13712] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
450 Elshal MF, Aldahlawi AM, Saadah OI, McCoy JP. Reduced Dendritic Cells Expressing CD200R1 in Children with Inflammatory Bowel Disease: Correlation with Th17 and Regulatory T Cells. Int J Mol Sci 2015;16:28998-9010. [PMID: 26690123 DOI: 10.3390/ijms161226143] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
451 Onishi R, Ohnishi S, Higashi R, Watari M, Yamahara K, Okubo N, Nakagawa K, Katsurada T, Suda G, Natsuizaka M, Takeda H, Sakamoto N. Human Amnion-Derived Mesenchymal Stem Cell Transplantation Ameliorates Dextran Sulfate Sodium-Induced Severe Colitis in Rats. Cell Transplant 2015;24:2601-14. [DOI: 10.3727/096368915x687570] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 4.7] [Reference Citation Analysis]
452 Schieffer KM, Poritz LS, Yochum GS, Koltun WA. Development of a total colectomy and ileorectal anastomosis rat model to evaluate colonic metaplasia. J Surg Res 2017;218:217-25. [PMID: 28985852 DOI: 10.1016/j.jss.2017.05.120] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
453 Gonzalez-Lopez E, Kawasawa-Imamura Y, Zhang L, Huang X, Koltun WA, Coates MD, Vrana KE. A single nucleotide polymorphism in dopamine beta hydroxylase (rs6271(C>T)) is over-represented in inflammatory bowel disease patients and reduces circulating enzyme. PLoS One 2019;14:e0210175. [PMID: 30817802 DOI: 10.1371/journal.pone.0210175] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
454 Waddell LA, Rajić A, Sargeant J, Harris J, Amezcua R, Downey L, Read S, McEwen SA. The zoonotic potential of Mycobacterium avium spp. paratuberculosis: a systematic review. Can J Public Health 2008;99:145-55. [PMID: 18457292 [PMID: 18457292 DOI: 10.1007/bf03405464] [Cited by in Crossref: 61] [Article Influence: 4.4] [Reference Citation Analysis]
455 Peiravan A, Allenspach K, Boag AM, Soutter F, Holder A, Catchpole B, Kennedy LJ, Werling D, Procoli F. Single nucleotide polymorphisms in major histocompatibility class II haplotypes are associated with potential resistance to inflammatory bowel disease in German shepherd dogs. Vet Immunol Immunopathol 2016;182:101-5. [PMID: 27863539 DOI: 10.1016/j.vetimm.2016.10.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
456 Siegel RJ, Bridges SL Jr, Ahmed S. HLA-C: An Accomplice in Rheumatic Diseases. ACR Open Rheumatol 2019;1:571-9. [PMID: 31777841 DOI: 10.1002/acr2.11065] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
457 Pashirzad M, Shafiee M, Avan A, Ryzhikov M, Fiuji H, Bahreyni A, Khazaei M, Soleimanpour S, Hassanian SM. Therapeutic potency of crocin in the treatment of inflammatory diseases: Current status and perspective. J Cell Physiol 2019. [PMID: 30673132 DOI: 10.1002/jcp.28177] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
458 Miranda PM, De Palma G, Serkis V, Lu J, Louis-Auguste MP, McCarville JL, Verdu EF, Collins SM, Bercik P. High salt diet exacerbates colitis in mice by decreasing Lactobacillus levels and butyrate production. Microbiome 2018;6:57. [PMID: 29566748 DOI: 10.1186/s40168-018-0433-4] [Cited by in Crossref: 80] [Cited by in F6Publishing: 80] [Article Influence: 20.0] [Reference Citation Analysis]
459 Liu ZJ, Yadav PK, Su JL, Wang JS, Fei K. Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease. World J Gastroenterol 2009; 15(46): 5784-5788 [PMID: 19998498 DOI: 10.3748/wjg.15.5784] [Cited by in CrossRef: 97] [Cited by in F6Publishing: 101] [Article Influence: 7.5] [Reference Citation Analysis]
460 Gazouli M. Circulating microRNAs in Inflammatory Bowel Diseases. In: Igaz P, editor. Circulating microRNAs in Disease Diagnostics and their Potential Biological Relevance. Basel: Springer; 2015. pp. 197-214. [DOI: 10.1007/978-3-0348-0955-9_9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
461 Chen EZ, Bushman FD, Li H. A Model-Based Approach For Species Abundance Quantification Based On Shotgun Metagenomic Data. Stat Biosci 2017;9:13-27. [PMID: 28959368 DOI: 10.1007/s12561-016-9148-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
462 Conrad MA, Wu GD, Kelsen JR. The Gut Microbiota and Inflammatory Bowel Disease. In: Mamula P, Grossman AB, Baldassano RN, Kelsen JR, Markowitz JE, editors. Pediatric Inflammatory Bowel Disease. Cham: Springer International Publishing; 2017. pp. 45-54. [DOI: 10.1007/978-3-319-49215-5_4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
463 Carvalho L, Gomes JRM, Tavares LC, Xavier AR, Klika KD, Holmdahl R, Carvalho RA, Souto-Carneiro MM. Reactive Oxygen Species Deficiency Due to Ncf1-Mutation Leads to Development of Adenocarcinoma and Metabolomic and Lipidomic Remodeling in a New Mouse Model of Dextran Sulfate Sodium-Induced Colitis. Front Immunol 2018;9:701. [PMID: 29867918 DOI: 10.3389/fimmu.2018.00701] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
464 Morampudi V, Dalwadi U, Bhinder G, Sham HP, Gill SK, Chan J, Bergstrom KS, Huang T, Ma C, Jacobson K, Gibson DL, Vallance BA. The goblet cell-derived mediator RELM-β drives spontaneous colitis in Muc2-deficient mice by promoting commensal microbial dysbiosis. Mucosal Immunol 2016;9:1218-33. [PMID: 26813339 DOI: 10.1038/mi.2015.140] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 8.2] [Reference Citation Analysis]
465 Khodayari S, Salehi Z, Fakhrieh Asl S, Aminian K, Mirzaei Gisomi N, Torabi Dalivandan S. Catalase gene C-262T polymorphism: importance in ulcerative colitis. J Gastroenterol Hepatol 2013;28:819-22. [PMID: 23425094 DOI: 10.1111/jgh.12141] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
466 Xue H, Sawyer MB, Wischmeyer PE, Baracos VE. Nutrition modulation of gastrointestinal toxicity related to cancer chemotherapy: from preclinical findings to clinical strategy. JPEN J Parenter Enteral Nutr. 2011;35:74-90. [PMID: 21224434 DOI: 10.1177/0148607110377338] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
467 Hu S, Chen M, Wang Y, Wang Z, Pei Y, Fan R, Liu X, Wang L, Zhou J, Zheng S, Zhang T, Lin Y, Zhang M, Tao R, Zhong J. mTOR Inhibition Attenuates Dextran Sulfate Sodium-Induced Colitis by Suppressing T Cell Proliferation and Balancing TH1/TH17/Treg Profile. PLoS One 2016;11:e0154564. [PMID: 27128484 DOI: 10.1371/journal.pone.0154564] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
468 Rath E, Haller D. Unfolded Protein Responses in the Intestinal Epithelium: Sensors for the Microbial and Metabolic Environment. Journal of Clinical Gastroenterology 2012;46:S3-5. [DOI: 10.1097/mcg.0b013e318264e632] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
469 He P, Haque A, Lin S, Cominelli F, Yun CC. Inhibition of autotaxin alleviates inflammation and increases the expression of sodium-dependent glucose cotransporter 1 and Na+/H+ exchanger 3 in SAMP1/Fc mice. Am J Physiol Gastrointest Liver Physiol 2018;315:G762-71. [PMID: 30118349 DOI: 10.1152/ajpgi.00215.2018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
470 Ansaldo E, Slayden LC, Ching KL, Koch MA, Wolf NK, Plichta DR, Brown EM, Graham DB, Xavier RJ, Moon JJ, Barton GM. Akkermansia muciniphila induces intestinal adaptive immune responses during homeostasis. Science. 2019;364:1179-1184. [PMID: 31221858 DOI: 10.1126/science.aaw7479] [Cited by in Crossref: 112] [Cited by in F6Publishing: 107] [Article Influence: 56.0] [Reference Citation Analysis]
471 Bilski J, Brzozowski B, Mazur-Bialy A, Sliwowski Z, Brzozowski T. The role of physical exercise in inflammatory bowel disease. Biomed Res Int. 2014;2014:429031. [PMID: 24877092 DOI: 10.1155/2014/429031] [Cited by in Crossref: 23] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
472 de Vries JHM, Dijkhuizen M, Tap P, Witteman BJM. Patient's Dietary Beliefs and Behaviours in Inflammatory Bowel Disease. Dig Dis 2019;37:131-9. [PMID: 30391940 DOI: 10.1159/000494022] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 8.8] [Reference Citation Analysis]
473 Xiang C, Liu M, Lu Q, Fan C, Lu H, Feng C, Yang X, Li H, Tang W. Blockade of TLRs-triggered macrophage activation by caffeic acid exerted protective effects on experimental ulcerative colitis. Cell Immunol 2021;365:104364. [PMID: 33932876 DOI: 10.1016/j.cellimm.2021.104364] [Reference Citation Analysis]
474 Mao H, Pan F, Guo H, Bu F, Xin T, Chen S, Guo Y. Feedback mechanisms between M2 macrophages and Th17 cells in colorectal cancer patients. Tumor Biol 2016;37:12223-30. [DOI: 10.1007/s13277-016-5085-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
475 Seiderer J, Dambacher J, Leistner D, Tillack C, Glas J, Niess JH, Pfennig S, Jürgens M, Müller-Myhsok B, Göke B, Ochsenkühn T, Lohse P, Reinecker HC, Brand S. Genotype-phenotype analysis of the CXCL16 p.Ala181Val polymorphism in inflammatory bowel disease. Clin Immunol 2008;127:49-55. [PMID: 18248772 DOI: 10.1016/j.clim.2007.11.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
476 Shakhnovich V, Vyhlidal C, Friesen C, Hildreth A, Singh V, Daniel J, Kearns GL, Leeder JS. Decreased Pregnane X Receptor Expression in Children with Active Crohn's Disease. Drug Metab Dispos 2016;44:1066-9. [PMID: 27013401 DOI: 10.1124/dmd.115.068742] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
477 Iljazovic A, Amend L, Galvez EJC, de Oliveira R, Strowig T. Modulation of inflammatory responses by gastrointestinal Prevotella spp. - From associations to functional studies. Int J Med Microbiol 2021;311:151472. [PMID: 33461110 DOI: 10.1016/j.ijmm.2021.151472] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
478 Gaj P, Habior A, Mikula M, Ostrowski J. Lack of evidence for association of primary sclerosing cholangitis and primary biliary cirrhosis with risk alleles for Crohn's disease in Polish patients. BMC Med Genet 2008;9:81. [PMID: 18715515 DOI: 10.1186/1471-2350-9-81] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
479 Holleran G, Lopetuso L, Petito V, Graziani C, Ianiro G, McNamara D, Gasbarrini A, Scaldaferri F. The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease. Int J Mol Sci. 2017;18. [PMID: 28934123 DOI: 10.3390/ijms18102020] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
480 de Barros KSC, Flores C, Harlacher L, Francesconi CFM. Evolution of Clinical Behavior in Crohn's Disease: Factors Associated with Complicated Disease and Surgery. Dig Dis Sci 2017;62:2481-8. [PMID: 28748409 DOI: 10.1007/s10620-017-4685-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
481 Florholmen J, Øverland G, Olsen T, Rismo R, Cui G, Christiansen I, Paulssen EJ, Goll R. Short-and Long-Term Clinical Outcomes of Infliximab in Fulminant Ulcerative Colitis. Ulcers 2011;2011:1-7. [DOI: 10.1155/2011/156407] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
482 Stojanović M, Šćepanović L, Mitrović D, Šćepanović V, Šćepanović R, Djuric M, Ilić S, Šćepanović T, Djuric D. Different pathways involved in the stimulatory effects of homocysteine on rat duodenal smooth muscle. Acta Veterinaria 2017;67:254-70. [DOI: 10.1515/acve-2017-0021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
483 Schmitz S, Suchodolski J. Understanding the canine intestinal microbiota and its modification by pro-, pre- and synbiotics - what is the evidence? Vet Med Sci 2016;2:71-94. [PMID: 29067182 DOI: 10.1002/vms3.17] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 7.3] [Reference Citation Analysis]
484 Moon JM, Kang EA, Han K, Hong SW, Soh H, Park S, Lee J, Lee HJ, Im JP, Kim JS. Trends and risk factors of elderly-onset Crohn’s disease: A nationwide cohort study. World J Gastroenterol 2020; 26(4): 404-415 [PMID: 32063689 DOI: 10.3748/wjg.v26.i4.404] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
485 Sandborn WJ, Bhandari BR, Randall C, Younes ZH, Romanczyk T, Xin Y, Wendt E, Chai H, McKevitt M, Zhao S, Sundy JS, Keshav S, Danese S. Andecaliximab [Anti-matrix Metalloproteinase-9] Induction Therapy for Ulcerative Colitis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2/3 Study in Patients With Moderate to Severe Disease. J Crohns Colitis 2018;12:1021-9. [PMID: 29767728 DOI: 10.1093/ecco-jcc/jjy049] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
486 Ma H, Zhou M, Duan W, Chen L, Wang L, Liu P. Anemoside B4 prevents acute ulcerative colitis through inhibiting of TLR4/NF-κB/MAPK signaling pathway. Int Immunopharmacol 2020;87:106794. [PMID: 32688280 DOI: 10.1016/j.intimp.2020.106794] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
487 Camprubí-Font C, Lopez-Siles M, Ferrer-Guixeras M, Niubó-Carulla L, Abellà-Ametller C, Garcia-Gil LJ, Martinez-Medina M. Comparative genomics reveals new single-nucleotide polymorphisms that can assist in identification of adherent-invasive Escherichia coli. Sci Rep 2018;8:2695. [PMID: 29426864 DOI: 10.1038/s41598-018-20843-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
488 Galitovskiy V, Qian J, Chernyavsky AI, Marchenko S, Gindi V, Edwards RA, Grando SA. Cytokine-induced alterations of α7 nicotinic receptor in colonic CD4 T cells mediate dichotomous response to nicotine in murine models of Th1/Th17- versus Th2-mediated colitis. J Immunol 2011;187:2677-87. [PMID: 21784975 DOI: 10.4049/jimmunol.1002711] [Cited by in Crossref: 69] [Cited by in F6Publishing: 67] [Article Influence: 6.3] [Reference Citation Analysis]
489 Singh RS, Kaur HP, Rana V, Kennedy JF. Immunomodulatory and therapeutic potential of a mucin-specific mycelial lectin from Aspergillus panamensis. International Journal of Biological Macromolecules 2017;96:241-8. [DOI: 10.1016/j.ijbiomac.2016.12.036] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
490 Issazadeh-Navikas S, Teimer R, Bockermann R. Influence of dietary components on regulatory T cells. Mol Med 2012;18:95-110. [PMID: 22113499 DOI: 10.2119/molmed.2011.00311] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 5.4] [Reference Citation Analysis]
491 Endo Y, Marusawa H, Kou T, Nakase H, Fujii S, Fujimori T, Kinoshita K, Honjo T, Chiba T. Activation-induced cytidine deaminase links between inflammation and the development of colitis-associated colorectal cancers. Gastroenterology 2008;135:889-98, 898.e1-3. [PMID: 18691581 DOI: 10.1053/j.gastro.2008.06.091] [Cited by in Crossref: 95] [Cited by in F6Publishing: 89] [Article Influence: 6.8] [Reference Citation Analysis]
492 Anton PM, Craus A, Niquet-léridon C, Tessier FJ. Highly heated food rich in Maillard reaction products limit an experimental colitis in mice. Food Funct 2012;3:941. [DOI: 10.1039/c2fo30045a] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
493 Boltin D, Kamenetsky Z, Perets TT, Snir Y, Sapoznikov B, Schmilovitz-weiss H, Ablin JN, Dickman R, Niv Y. Circulating Bone Marrow-Derived CD45−/CD34+/CD133+/VEGF+ Endothelial Progenitor Cells in Adults with Crohn’s Disease. Dig Dis Sci 2017;62:633-8. [DOI: 10.1007/s10620-016-4234-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
494 Jena G, Trivedi PP, Sandala B. Oxidative stress in ulcerative colitis: an old concept but a new concern. Free Radic Res. 2012;46:1339-1345. [PMID: 22856328 DOI: 10.3109/10715762.2012.717692] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 6.3] [Reference Citation Analysis]
495 Seiderer J, Elben I, Diegelmann J, Glas J, Stallhofer J, Tillack C, Pfennig S, Jürgens M, Schmechel S, Konrad A. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn’s disease and analysis of the IL17F p.His161Arg polymorphism in IBD. Inflamm Bowel Dis. 2008;14:437-445. [PMID: 18088064 DOI: 10.1002/ibd.20339] [Cited by in Crossref: 236] [Cited by in F6Publishing: 241] [Article Influence: 16.9] [Reference Citation Analysis]
496 Gu Y, Forostyan T, Sabbadini R, Rosenblatt J. Epithelial cell extrusion requires the sphingosine-1-phosphate receptor 2 pathway. J Cell Biol 2011;193:667-76. [PMID: 21555463 DOI: 10.1083/jcb.201010075] [Cited by in Crossref: 110] [Cited by in F6Publishing: 92] [Article Influence: 10.0] [Reference Citation Analysis]
497 Lopetuso LR, Napoli M, Rizzatti G, Gasbarrini A. The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn’s disease. Expert Opinion on Investigational Drugs 2018;27:543-51. [DOI: 10.1080/13543784.2018.1483333] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
498 Titz B, Gadaleta RM, Lo Sasso G, Elamin A, Ekroos K, Ivanov NV, Peitsch MC, Hoeng J. Proteomics and Lipidomics in Inflammatory Bowel Disease Research: From Mechanistic Insights to Biomarker Identification.Int J Mol Sci. 2018;19. [PMID: 30223557 DOI: 10.3390/ijms19092775] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
499 Gandhi T, Sharma A, Vyas N, Gupta P, Parikh M, Shah H. Lansoprazole a Proton Pump Inhibitor Prevents IBD by Reduction of Oxidative Stress and NO Levels in the Rat. Drug Res (Stuttg) 2021;71:379-87. [DOI: 10.1055/a-1389-5499] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
500 Farombi EO, Adedara IA, Ajayi BO, Ayepola OR, Egbeme EE. Kolaviron, a natural antioxidant and anti-inflammatory phytochemical prevents dextran sulphate sodium-induced colitis in rats. Basic Clin Pharmacol Toxicol. 2013;113:49-55. [PMID: 23336970 DOI: 10.1111/bcpt.12050] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 5.9] [Reference Citation Analysis]
501 Daskalaki MG, Axarlis K, Aspevik T, Orfanakis M, Kolliniati O, Lapi I, Tzardi M, Dermitzaki E, Venihaki M, Kousoulaki K, Tsatsanis C. Fish Sidestream-Derived Protein Hydrolysates Suppress DSS-Induced Colitis by Modulating Intestinal Inflammation in Mice. Mar Drugs 2021;19:312. [PMID: 34071180 DOI: 10.3390/md19060312] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
502 Eshelman MA, Harris L, Deiling S, Koltun WA, Jeganathan NA, Yochum GS. Transcriptomic analysis of ileal tissue from Crohn's disease patients identifies extracellular matrix genes that distinguish individuals by age at diagnosis. Physiol Genomics 2020;52:478-84. [PMID: 32866088 DOI: 10.1152/physiolgenomics.00062.2020] [Reference Citation Analysis]
503 Wachsmann P, Moulari B, Béduneau A, Pellequer Y, Lamprecht A. Surfactant-dependence of nanoparticle treatment in murine experimental colitis. Journal of Controlled Release 2013;172:62-8. [DOI: 10.1016/j.jconrel.2013.07.031] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
504 Cummins EP, Seeballuck F, Keely SJ, Mangan NE, Callanan JJ, Fallon PG, Taylor CT. The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gastroenterology. 2008;134:156-165. [PMID: 18166353 DOI: 10.1053/j.gastro.2007.10.012] [Cited by in Crossref: 276] [Cited by in F6Publishing: 286] [Article Influence: 18.4] [Reference Citation Analysis]
505 Principi M, Cassano N, Contaldo A, Iannone A, Losurdo G, Barone M, Mastrolonardo M, Vena GA, Ierardi E, Di Leo A. Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing association. World J Gastroenterol 2016; 22(20): 4802-4811 [PMID: 27239107 DOI: 10.3748/wjg.v22.i20.4802] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
506 Nazareth N, Magro F, Silva J, Duro M, Gracio D, Coelho R, Appelberg R, Macedo G, Sarmento A. Infliximab therapy increases the frequency of circulating CD16(+) monocytes and modifies macrophage cytokine response to bacterial infection. Clin Exp Immunol 2014;177:703-11. [PMID: 24816497 DOI: 10.1111/cei.12375] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
507 Kolacz J, Kovacic KK, Porges SW. Traumatic stress and the autonomic brain-gut connection in development: Polyvagal Theory as an integrative framework for psychosocial and gastrointestinal pathology. Dev Psychobiol 2019;61:796-809. [PMID: 30953358 DOI: 10.1002/dev.21852] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
508 Owaga E, Hsieh RH, Mugendi B, Masuku S, Shih CK, Chang JS. Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases. Int J Mol Sci. 2015;16:20841-20858. [PMID: 26340622 DOI: 10.3390/ijms160920841] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 7.1] [Reference Citation Analysis]
509 Jergens A, Young J, Moore D, Wang C, Hostetter J, Augustine L, Allenspach K, Schmitz S, Mosher C. Bcl-2/caspase 3 mucosal imbalance favors T cell resistance to apoptosis in dogs with inflammatory bowel disease. Vet Immunol Immunopathol. 2014;158:167-174. [PMID: 24495616 DOI: 10.1016/j.vetimm.2014.01.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
510 Dicksved J, Halfvarson J, Rosenquist M, Järnerot G, Tysk C, Apajalahti J, Engstrand L, Jansson JK. Molecular analysis of the gut microbiota of identical twins with Crohn’s disease. ISME J. 2008;2:716-727. [PMID: 18401439 DOI: 10.1038/ismej.2008.37] [Cited by in Crossref: 311] [Cited by in F6Publishing: 297] [Article Influence: 22.2] [Reference Citation Analysis]
511 Hibi T, Sakuraba A, Watanabe M, Motoya S, Ito H, Sato N, Yoshinari T, Motegi K, Kinouchi Y, Takazoe M, Suzuki Y, Matsumoto T, Kawakami K, Matsumoto T, Hirata I, Tanaka S, Ashida T, Matsui T. C-reactive protein is an indicator of serum infliximab level in predicting loss of response in patients with Crohn’s disease. J Gastroenterol 2014;49:254-62. [DOI: 10.1007/s00535-013-0807-0] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 4.8] [Reference Citation Analysis]
512 Nunberg M, Werbner N, Neuman H, Bersudsky M, Braiman A, Ben-Shoshan M, Ben Izhak M, Louzoun Y, Apte RN, Voronov E, Koren O. Interleukin 1α-Deficient Mice Have an Altered Gut Microbiota Leading to Protection from Dextran Sodium Sulfate-Induced Colitis. mSystems 2018;3:e00213-17. [PMID: 29766049 DOI: 10.1128/mSystems.00213-17] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
513 Cordeiro N, Freitas RHCN, Fraga CAM, Fernandes PD. Therapeutic Effects of Anti-Inflammatory N-Acylhydrazones in the Resolution of Experimental Colitis. J Pharmacol Exp Ther 2020;374:420-7. [PMID: 32546529 DOI: 10.1124/jpet.120.000074] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
514 Gao S, Yi Y, Xia G, Yu C, Ye C, Tu F, Shen L, Wang W, Hua C. The characteristics and pivotal roles of triggering receptor expressed on myeloid cells-1 in autoimmune diseases. Autoimmun Rev 2019;18:25-35. [PMID: 30408584 DOI: 10.1016/j.autrev.2018.07.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
515 Brazilian Study Group of Inflammatory Bowel Diseases. Consensus guidelines for the management of inflammatory bowel disease. Arq Gastroenterol. 2010;47:313-325. [PMID: 21140096 DOI: 10.1590/s0004-28032010000300019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
516 Ke QM, Wu J, Fan H. Wumeiwan treatment alters the expression of delta-opioid receptor, β-arrestin 1 and Bcl-2 in the spleen tissue of rats with ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2013; 21(13): 1164-1170 [DOI: 10.11569/wcjd.v21.i13.1164] [Reference Citation Analysis]
517 Keller JJ, Wang J, Hwang YL, Chou CC, Wang LH, Hsu JL, Bai CH, Chiou HY. Increased risk of stroke among patients with Crohn's disease: a population-based matched cohort study. Int J Colorectal Dis 2015;30:645-53. [PMID: 25608496 DOI: 10.1007/s00384-015-2132-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
518 Belkaid Y, Bouladoux N, Hand TW. Effector and memory T cell responses to commensal bacteria. Trends Immunol 2013;34:299-306. [PMID: 23643444 DOI: 10.1016/j.it.2013.03.003] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
519 Mavroudis G, Magnusson MK, Isaksson S, Sundin J, Simrén M, Öhman L, Strid H. Mucosal and Systemic Immune Profiles Differ During Early and Late Phases of the Disease in Patients With Active Ulcerative Colitis. Journal of Crohn's and Colitis 2019;13:1450-8. [DOI: 10.1093/ecco-jcc/jjz072] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
520 Wagner SJ, Schmidt A, Effenberger MJP, Gruber L, Danier J, Haller D. Semisynthetic Diet Ameliorates Crohn’s Disease–Like Ileitis in TNFΔARE/WT Mice Through Antigen-Independent Mechanisms of Gluten: . Inflammatory Bowel Diseases 2013;19:1285-94. [DOI: 10.1097/mib.0b013e318281f573] [Cited by in Crossref: 29] [Cited by in F6Publishing: 7] [Article Influence: 3.2] [Reference Citation Analysis]
521 Smith EJ, Thompson AP, O'Driscoll A, Clarke DJ. Pathogenesis of adherent-invasive Escherichia coli. Future Microbiol 2013;8:1289-300. [PMID: 24059919 DOI: 10.2217/fmb.13.94] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
522 Nguyen HT, Merlin D. Homeostatic and innate immune responses: role of the transmembrane glycoprotein CD98. Cell Mol Life Sci. 2012;69:3015-3026. [PMID: 22460579 DOI: 10.1007/s00018-012-0963-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
523 Sun J. Pathogenic Bacterial Proteins and their Anti-Inflammatory Effects in the Eukaryotic Host. Antiinflamm Antiallergy Agents Med Chem 2009;8:214-27. [PMID: 20090866 DOI: 10.2174/187152309789151986] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
524 Vineis JH, Ringus DL, Morrison HG, Delmont TO, Dalal S, Raffals LH, Antonopoulos DA, Rubin DT, Eren AM, Chang EB, Sogin ML. Patient-Specific Bacteroides Genome Variants in Pouchitis. mBio 2016;7:e01713-16. [PMID: 27935837 DOI: 10.1128/mBio.01713-16] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
525 Balfour Sartor R. Bacteria in Crohn's disease: mechanisms of inflammation and therapeutic implications. J Clin Gastroenterol 2007;41 Suppl 1:S37-43. [PMID: 17438417 DOI: 10.1097/MCG.0b013e31802db364] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
526 Han Z, Wang H, Guo D, Zhang J. Integrative transcriptomic and metabonomic profiling analyses reveal the molecular mechanism of Chinese traditional medicine huankuile suspension on TNBS-induced ulcerative colitis. Aging (Albany NY) 2021;13:5087-103. [PMID: 33535180 DOI: 10.18632/aging.202427] [Reference Citation Analysis]
527 Kim JM. [Inflammatory bowel diseases and enteric microbiota]. Korean J Gastroenterol 2010;55:4-18. [PMID: 20098062 DOI: 10.4166/kjg.2010.55.1.4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
528 Ward MS, Zhao DY, Bernstein PS. Macular and serum carotenoid concentrations in patients with malabsorption syndromes. J Ocul Biol Dis Infor 2008;1:12-8. [PMID: 19081745 DOI: 10.1007/s12177-008-9008-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
529 Spencer EA, Dubinsky MC. Precision Medicine in Pediatric Inflammatory Bowel Disease. Pediatr Clin North Am 2021;68:1171-90. [PMID: 34736583 DOI: 10.1016/j.pcl.2021.07.011] [Reference Citation Analysis]
530 Heazlewood CK, Cook MC, Eri R, Price GR, Tauro SB, Taupin D, Thornton DJ, Png CW, Crockford TL, Cornall RJ, Adams R, Kato M, Nelms KA, Hong NA, Florin TH, Goodnow CC, McGuckin MA. Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med. 2008;5:e54. [PMID: 18318598 DOI: 10.1371/journal.pmed.0050054] [Cited by in Crossref: 442] [Cited by in F6Publishing: 436] [Article Influence: 31.6] [Reference Citation Analysis]
531 Kumar M, Hemalatha R, Nagpal R, Singh B, Parasannanavar D, Verma V, Kumar A, Marotta F, Catanzaro R, Cuffari B, Jain S, Bissi L, Yadav H. PROBIOTIC APPROACHES FOR TARGETING INFLAMMATORY BOWEL DISEASE: AN UPDATE ON ADVANCES AND OPPORTUNITIES IN MANAGING THE DISEASE. Int J Probiotics Prebiotics 2016;11:99-116. [PMID: 31452650] [Reference Citation Analysis]
532 Ono K, Nimura S, Nishinakagawa T, Hideshima Y, Enjyoji M, Nabeshima K, Nakashima M. Sodium 4-phenylbutyrate suppresses the development of dextran sulfate sodium-induced colitis in mice. Exp Ther Med 2014;7:573-8. [PMID: 24520247 DOI: 10.3892/etm.2013.1456] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
533 Kim SC, Tonkonogy SL, Karrasch T, Jobin C, Sartor RB. Dual-association of gnotobiotic IL-10-/- mice with 2 nonpathogenic commensal bacteria induces aggressive pancolitis. Inflamm Bowel Dis. 2007;13:1457-1466. [PMID: 17763473 DOI: 10.1002/ibd.20246] [Cited by in Crossref: 101] [Cited by in F6Publishing: 91] [Article Influence: 7.2] [Reference Citation Analysis]
534 Kim KU, Kim J, Kim WH, Min H, Choi CH. Treatments of inflammatory bowel disease toward personalized medicine. Arch Pharm Res 2021;44:293-309. [PMID: 33763844 DOI: 10.1007/s12272-021-01318-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
535 Nguyen HT, Dalmasso G, Torkvist L, Halfvarson J, Yan Y, Laroui H, Shmerling D, Tallone T, D'Amato M, Sitaraman SV. CD98 expression modulates intestinal homeostasis, inflammation, and colitis-associated cancer in mice. J Clin Invest. 2011;121:1733-1747. [PMID: 21490400 DOI: 10.1172/jci44631] [Cited by in Crossref: 76] [Cited by in F6Publishing: 50] [Article Influence: 6.9] [Reference Citation Analysis]
536 Soleymani S, Moradkhani A, Eftekhari M, Rahmanian F, Moosavy SH. Correlation between Clinical Symptoms and Lab Tests with Endoscopic Severity Indexes in Patients with Inflammatory Bowel Diseases. Middle East J Dig Dis 2020;12:162-70. [PMID: 33062221 DOI: 10.34172/mejdd.2020.178] [Reference Citation Analysis]
537 Long Y, Zhao X, Xia C, Liu X, Fan C, Liu C. Infection of Epstein-Barr Virus is Associated with the Decrease of Helios+FoxP3+Regulatory T Cells in Active Ulcerative Colitis Patients. Immunol Invest 2021;50:23-36. [PMID: 32046542 DOI: 10.1080/08820139.2020.1723021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
538 Ambruzs JM, Larsen CP. Renal Manifestations of Inflammatory Bowel Disease. Rheum Dis Clin North Am 2018;44:699-714. [PMID: 30274631 DOI: 10.1016/j.rdc.2018.06.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
539 Kotakadi VS, Jin Y, Hofseth AB, Ying L, Cui X, Volate S, Chumanevich A, Wood PA, Price RL, McNeal A. Ginkgo biloba extract EGb 761 has anti-inflammatory properties and ameliorates colitis in mice by driving effector T cell apoptosis. Carcinogenesis. 2008;29:1799-1806. [PMID: 18567620 DOI: 10.1093/carcin/bgn143] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 3.4] [Reference Citation Analysis]
540 Zhong XS, Winston JH, Luo X, Kline KT, Nayeem SZ, Cong Y, Savidge TC, Dashwood RH, Powell DW, Li Q. Neonatal Colonic Inflammation Epigenetically Aggravates Epithelial Inflammatory Responses to Injury in Adult Life. Cell Mol Gastroenterol Hepatol 2018;6:65-78. [PMID: 29928672 DOI: 10.1016/j.jcmgh.2018.02.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
541 Dige A, Magnusson MK, Öhman L, Hvas CL, Kelsen J, Wick MJ, Agnholt J. Reduced numbers of mucosal DR int macrophages and increased numbers of CD103 + dendritic cells during anti-TNF-α treatment in patients with Crohn’s disease. Scandinavian Journal of Gastroenterology 2016;51:692-9. [DOI: 10.3109/00365521.2015.1134649] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
542 Li Y, Ligr M, McCarron JP, Daniels G, Zhang D, Zhao X, Ye F, Wang J, Liu X, Osman I, Mencher SK, Lepor H, Wang LG, Ferrari A, Lee P. Natura-alpha targets forkhead box m1 and inhibits androgen-dependent and -independent prostate cancer growth and invasion. Clin Cancer Res 2011;17:4414-24. [PMID: 21606178 DOI: 10.1158/1078-0432.CCR-11-0431] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
543 Singh K, Coburn LA, Barry DP, Boucher JL, Chaturvedi R, Wilson KT. L-arginine uptake by cationic amino acid transporter 2 is essential for colonic epithelial cell restitution. Am J Physiol Gastrointest Liver Physiol 2012;302:G1061-73. [PMID: 22361732 DOI: 10.1152/ajpgi.00544.2011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
544 Wu XX, Huang XL, Chen RR, Li T, Ye HJ, Xie W, Huang ZM, Cao GZ. Paeoniflorin Prevents Intestinal Barrier Disruption and Inhibits Lipopolysaccharide (LPS)-Induced Inflammation in Caco-2 Cell Monolayers. Inflammation 2019;42:2215-25. [PMID: 31473900 DOI: 10.1007/s10753-019-01085-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 15.5] [Reference Citation Analysis]
545 Kellermayer R, Balasa A, Zhang W, Lee S, Mirza S, Chakravarty A, Szigeti R, Laritsky E, Tatevian N, Smith CW. Epigenetic maturation in colonic mucosa continues beyond infancy in mice. Hum Mol Genet. 2010;19:2168-2176. [PMID: 20197410 DOI: 10.1093/hmg/ddq095] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
546 Chumanevich AA, Causey CP, Knuckley BA, Jones JE, Poudyal D, Chumanevich AP, Davis T, Matesic LE, Thompson PR, Hofseth LJ. Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor. Am J Physiol Gastrointest Liver Physiol 2011;300:G929-38. [PMID: 21415415 DOI: 10.1152/ajpgi.00435.2010] [Cited by in Crossref: 116] [Cited by in F6Publishing: 120] [Article Influence: 10.5] [Reference Citation Analysis]
547 Overstreet AC, Ramer-Tait AE, Suchodolski JS, Hostetter JM, Wang C, Jergens AE, Phillips GJ, Wannemuehler MJ. Temporal Dynamics of Chronic Inflammation on the Cecal Microbiota in IL-10-/- Mice. Front Immunol 2020;11:585431. [PMID: 33664728 DOI: 10.3389/fimmu.2020.585431] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
548 Shirzad-Aski H, Besharat S, Kienesberger S, Sohrabi A, Roshandel G, Amiriani T, Norouzi A, Keshtkar A. Association Between Helicobacter pylori Colonization and Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. J Clin Gastroenterol 2021;55:380-92. [PMID: 32833699 DOI: 10.1097/MCG.0000000000001415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
549 Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell. 2012;148:1258-1270. [PMID: 22424233 DOI: 10.1016/j.cell. 2012.01.035] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
550 Fan HN, Zhu P, Lu YM, Guo JH, Zhang J, Qu GQ, Zhu JS. Mild changes in the mucosal microbiome during terminal ileum inflammation. Microb Pathog 2020;142:104104. [PMID: 32120004 DOI: 10.1016/j.micpath.2020.104104] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
551 Lo Sasso G, Menzies KJ, Mottis A, Piersigilli A, Perino A, Yamamoto H, Schoonjans K, Auwerx J. SIRT2 deficiency modulates macrophage polarization and susceptibility to experimental colitis. PLoS One 2014;9:e103573. [PMID: 25072851 DOI: 10.1371/journal.pone.0103573] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 7.9] [Reference Citation Analysis]
552 Wang S, Zhang Y, Saas P, Wang H, Xu Y, Chen K, Zhong J, Yuan Y, Wang Y, Sun Y. Oridonin's therapeutic effect: suppressing Th1/Th17 simultaneously in a mouse model of Crohn's disease. J Gastroenterol Hepatol 2015;30:504-12. [PMID: 25211373 DOI: 10.1111/jgh.12710] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
553 Yin R, Neyens DM. Online Health Resource Use by Individuals With Inflammatory Bowel Disease: Analysis Using the National Health Interview Survey. J Med Internet Res 2020;22:e15352. [PMID: 32969831 DOI: 10.2196/15352] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
554 Thapa SD, Hadid H, Imam W, Hassan A, Usman M, Jafri S, Schairer J. Persistent Reactive Thrombocytosis May Increase the Risk of Coronary Artery Disease Among Inflammatory Bowel Disease Patients. Dig Dis Sci 2015;60:3062-8. [DOI: 10.1007/s10620-015-3701-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
555 Dai Z, Chen XY, An LY, Li CC, Zhao N, Yang F, You ST, Hou CZ, Li K, Jiang C, You QD, Di B, Xu LL. Development of Novel Tetrahydroquinoline Inhibitors of NLRP3 Inflammasome for Potential Treatment of DSS-Induced Mouse Colitis. J Med Chem 2021;64:871-89. [PMID: 33332136 DOI: 10.1021/acs.jmedchem.0c01924] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
556 Mitchel EB, Rosh JR. Pediatric Management of Crohn’s Disease. Gastroenterology Clinics of North America 2022. [DOI: 10.1016/j.gtc.2021.12.013] [Reference Citation Analysis]
557 Claudino RF, Leite DF, Bento AF, Chichorro JG, Calixto JB, Rae GA. Potential role for ET-2 acting through ETA receptors in experimental colitis in mice. Inflamm Res 2017;66:141-55. [PMID: 27778057 DOI: 10.1007/s00011-016-1001-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
558 Gadaleta RM, Garcia-Irigoyen O, Moschetta A. Exploration of Inflammatory Bowel Disease in Mice: Chemically Induced Murine Models of Inflammatory Bowel Disease (IBD). Curr Protoc Mouse Biol 2017;7:13-28. [PMID: 28252200 DOI: 10.1002/cpmo.20] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
559 Goodman WA, Basavarajappa SC, Liu AR, Rodriguez FDS, Mathes T, Ramakrishnan P. Sam68 contributes to intestinal inflammation in experimental and human colitis. Cell Mol Life Sci 2021. [PMID: 34693458 DOI: 10.1007/s00018-021-03976-7] [Reference Citation Analysis]
560 Zezos P, Kabakchiev B, Weizman AV, Nguyen GC, Narula N, Croitoru K, Steinhart AH, Silverberg MS. Ulcerative Colitis Patients Continue to Improve Over the First Six Months of Vedolizumab Treatment: 12-Month Clinical and Mucosal Healing Effectiveness. J Can Assoc Gastroenterol 2020;3:74-82. [PMID: 32328546 DOI: 10.1093/jcag/gwy065] [Reference Citation Analysis]
561 Brooks MN, Rajaram MV, Azad AK, Amer AO, Valdivia-Arenas MA, Park JH, Núñez G, Schlesinger LS. NOD2 controls the nature of the inflammatory response and subsequent fate of Mycobacterium tuberculosis and M. bovis BCG in human macrophages. Cell Microbiol 2011;13:402-18. [PMID: 21040358 DOI: 10.1111/j.1462-5822.2010.01544.x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 85] [Article Influence: 7.3] [Reference Citation Analysis]
562 Karrasch T, Spaeth T, Allard B, Jobin C. PI3K-dependent GSK3ß(Ser9)-phosphorylation is implicated in the intestinal epithelial cell wound-healing response. PLoS One 2011;6:e26340. [PMID: 22039465 DOI: 10.1371/journal.pone.0026340] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
563 Nakka P, Raphael BJ, Ramachandran S. Gene and Network Analysis of Common Variants Reveals Novel Associations in Multiple Complex Diseases. Genetics 2016;204:783-98. [PMID: 27489002 DOI: 10.1534/genetics.116.188391] [Cited by in Crossref: 41] [Cited by in F6Publishing: 22] [Article Influence: 6.8] [Reference Citation Analysis]
564 Vezza T, Rodríguez-nogales A, Algieri F, Utrilla M, Rodriguez-cabezas M, Galvez J. Flavonoids in Inflammatory Bowel Disease: A Review. Nutrients 2016;8:211. [DOI: 10.3390/nu8040211] [Cited by in Crossref: 113] [Cited by in F6Publishing: 99] [Article Influence: 18.8] [Reference Citation Analysis]
565 Luo Y, Gao C, Chen W, Zhou K, Xu M. Molecular Magnetic Resonance Imaging with Contrast Agents for Assessment of Inflammatory Bowel Disease: A Systematic Review. Contrast Media Mol Imaging 2020;2020:4764985. [PMID: 32454803 DOI: 10.1155/2020/4764985] [Reference Citation Analysis]
566 Lin CY, Lee AH, Chiu KK, Vieson MD, Steelman AJ, Swanson KS. Saccharomyces cerevisiae Fermentation Product Did Not Attenuate Clinical Signs, but Psyllium Husk Has Protective Effects in a Murine Dextran Sulfate Sodium-Induced Colitis Model. Curr Dev Nutr 2020;4:nzaa159. [PMID: 33215055 DOI: 10.1093/cdn/nzaa159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
567 Zaghloul MS, Elshal M, Abdelmageed ME. Preventive empagliflozin activity on acute acetic acid-induced ulcerative colitis in rats via modulation of SIRT-1/PI3K/AKT pathway and improving colon barrier. Environ Toxicol Pharmacol 2022;:103833. [PMID: 35218923 DOI: 10.1016/j.etap.2022.103833] [Reference Citation Analysis]
568 Feng JR, Qiu X, Wang F, Chen PF, Gao Q, Peng YN, Lin X, Liu Q, Liu J, Zhao Q, Li J. Diagnostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Crohn's Disease. Gastroenterol Res Pract 2017;2017:3526460. [PMID: 28798770 DOI: 10.1155/2017/3526460] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
569 Benson JR, Xu J, Moynes DM, Lapointe TK, Altier C, Vanner SJ, Lomax AE. Sustained neurochemical plasticity in central terminals of mouse DRG neurons following colitis. Cell Tissue Res 2014;356:309-17. [DOI: 10.1007/s00441-014-1832-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
570 Ming Z, Jia Y, Yan Y, Pang G, Chen Q. Amelioration effect of bovine casein glycomacropeptide on ulcerative colitis in mice. Food and Agricultural Immunology 2015;26:717-28. [DOI: 10.1080/09540105.2015.1018874] [Cited by in Crossref: 5] [Article Influence: 0.7] [Reference Citation Analysis]
571 Ye J, Lee JW, Presley LL, Bent E, Wei B, Braun J, Schiller NL, Straus DS, Borneman J. Bacteria and bacterial rRNA genes associated with the development of colitis in IL-10(-/-) mice. Inflamm Bowel Dis. 2008;14:1041-1050. [PMID: 18381614 DOI: 10.1002/ibd.20442] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
572 Elten M, Benchimol EI, Fell DB, Kuenzig ME, Smith G, Chen H, Kaplan GG, Lavigne E. Ambient air pollution and the risk of pediatric-onset inflammatory bowel disease: A population-based cohort study. Environment International 2020;138:105676. [DOI: 10.1016/j.envint.2020.105676] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
573 Schreiner P, Neurath MF, Ng SC, El-Omar EM, Sharara AI, Kobayashi T, Hisamatsu T, Hibi T, Rogler G. Mechanism-Based Treatment Strategies for IBD: Cytokines, Cell Adhesion Molecules, JAK Inhibitors, Gut Flora, and More. Inflamm Intest Dis 2019;4:79-96. [PMID: 31559260 DOI: 10.1159/000500721] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
574 Ballini A, Santacroce L, Cantore S, Bottalico L, Dipalma G, Topi S, Saini R, De Vito D, Inchingolo F. Probiotics Efficacy on Oxidative Stress Values in Inflammatory Bowel Disease: A Randomized Double-Blinded Placebo-Controlled Pilot Study. Endocr Metab Immune Disord Drug Targets 2019;19:373-81. [PMID: 30574857 DOI: 10.2174/1871530319666181221150352] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 11.3] [Reference Citation Analysis]
575 Mura C, Nácher A, Merino V, Merino-sanjuan M, Carda C, Ruiz A, Manconi M, Loy G, Fadda A, Diez-sales O. N-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: In vivo study with TNBS-induced colitis model in rats. International Journal of Pharmaceutics 2011. [DOI: 10.1016/j.ijpharm.2011.06.025] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
576 Yadav PK, Chen C, Liu Z. Potential role of NK cells in the pathogenesis of inflammatory bowel disease. J Biomed Biotechnol. 2011;2011:348530. [PMID: 21687547 DOI: 10.1155/2011/348530] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
577 Chen M, Cho J, Zhao H. Incorporating biological pathways via a Markov random field model in genome-wide association studies. PLoS Genet 2011;7:e1001353. [PMID: 21490723 DOI: 10.1371/journal.pgen.1001353] [Cited by in Crossref: 47] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
578 Mashtoub S, Hoang BV, Vu M, Lymn KA, Feinle-Bisset C, Howarth GS. Clinical and structural effects of traditional Chinese medicine and the herbal preparation, Iberogast, in a rat model of ulcerative colitis. J Evid Based Complementary Altern Med 2014;19:10-9. [PMID: 24647374 DOI: 10.1177/2156587213503660] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
579 Elshazly SM, Elhassanny AEM, Mahmoud NM. Cilostazol protects against acetic acid-induced colitis in rats: Possible role for cAMP/SIRT1 pathway. Eur J Pharmacol 2020;881:173234. [PMID: 32497625 DOI: 10.1016/j.ejphar.2020.173234] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
580 Schepens MA, Schonewille AJ, Vink C, van Schothorst EM, Kramer E, Hendriks T, Brummer RJ, Keijer J, van der Meer R, Bovee-Oudenhoven IM. Supplemental calcium attenuates the colitis-related increase in diarrhea, intestinal permeability, and extracellular matrix breakdown in HLA-B27 transgenic rats. J Nutr. 2009;139:1525-1533. [PMID: 19535420 DOI: 10.3945/jn.109.105205] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
581 Negroni A, Costanzo M, Vitali R, Superti F, Bertuccini L, Tinari A, Minelli F, Di Nardo G, Nuti F, Pierdomenico M, Cucchiara S, Stronati L. Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:913-924. [PMID: 21994005 DOI: 10.1002/ibd.21899] [Cited by in Crossref: 68] [Cited by in F6Publishing: 71] [Article Influence: 6.2] [Reference Citation Analysis]
582 Ahirwar DK, Kesarwani P, Singh R, Ghoshal UC, Mittal RD. Role of tumor necrosis factor-alpha (C-863A) polymorphism in pathogenesis of inflammatory bowel disease in Northern India. J Gastrointest Cancer. 2012;43:196-204. [PMID: 21249467 DOI: 10.1007/s12029-010-9238-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
583 Fan HN, Zhu P, Zhang J, Zhu JS. Mucosal microbiome dysbiosis associated with duodenum bulb inflammation. Microb Pathog 2021;150:104711. [PMID: 33385493 DOI: 10.1016/j.micpath.2020.104711] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
584 Brandhorst G, Weigand S, Eberle C, Raddatz D, Karaus M, Oellerich M, Walson PD. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity. Clin Chim Acta. 2013;421:31-33. [PMID: 23485644 DOI: 10.1016/j.cca.2013.02.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
585 Sepehri S, Kotlowski R, Bernstein CN, Krause DO. Phylogenetic analysis of inflammatory bowel disease associated Escherichia coli and the fimH virulence determinant. Inflamm Bowel Dis. 2009;15:1737-1745. [PMID: 19462430 DOI: 10.1002/ibd.20966] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
586 Kellermayer R, Dowd SE, Harris RA, Balasa A, Schaible TD, Wolcott RD, Tatevian N, Szigeti R, Li Z, Versalovic J. Colonic mucosal DNA methylation, immune response, and microbiome patterns in Toll-like receptor 2-knockout mice. FASEB J. 2011;25:1449-1460. [PMID: 21228220 DOI: 10.1096/fj.10-172205] [Cited by in Crossref: 92] [Cited by in F6Publishing: 87] [Article Influence: 8.4] [Reference Citation Analysis]
587 Yao Y, Han W, Liang J, Ji J, Wang J, Cantor H, Lu L. Glatiramer acetate ameliorates inflammatory bowel disease in mice through the induction of Qa-1-restricted CD8⁺ regulatory cells. Eur J Immunol 2013;43:125-36. [PMID: 23002042 DOI: 10.1002/eji.201242758] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
588 Liu W, Guo W, Wu J, Luo Q, Tao F, Gu Y, Shen Y, Li J, Tan R, Xu Q, Sun Y. A novel benzo[d]imidazole derivate prevents the development of dextran sulfate sodium-induced murine experimental colitis via inhibition of NLRP3 inflammasome. Biochem Pharmacol 2013;85:1504-12. [PMID: 23506741 DOI: 10.1016/j.bcp.2013.03.008] [Cited by in Crossref: 79] [Cited by in F6Publishing: 76] [Article Influence: 8.8] [Reference Citation Analysis]
589 Vitetta L, Coulson S, Linnane AW, Butt H. The gastrointestinal microbiome and musculoskeletal diseases: a beneficial role for probiotics and prebiotics. Pathogens 2013;2:606-26. [PMID: 25437335 DOI: 10.3390/pathogens2040606] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
590 Suzuki Y, Matsui T, Ito H, Ashida T, Nakamura S, Motoya S, Matsumoto T, Sato N, Ozaki K, Watanabe M, Hibi T. Circulating Interleukin 6 and Albumin, and Infliximab Levels Are Good Predictors of Recovering Efficacy After Dose Escalation Infliximab Therapy in Patients with Loss of Response to Treatment for Crohnʼs Disease: A Prospective Clinical Trial. Inflammatory Bowel Diseases 2015;21:2114-22. [DOI: 10.1097/mib.0000000000000475] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
591 Ganesh BP, Klopfleisch R, Loh G, Blaut M. Commensal Akkermansia muciniphila exacerbates gut inflammation in Salmonella Typhimurium-infected gnotobiotic mice. PLoS One 2013;8:e74963. [PMID: 24040367 DOI: 10.1371/journal.pone.0074963] [Cited by in Crossref: 210] [Cited by in F6Publishing: 202] [Article Influence: 23.3] [Reference Citation Analysis]
592 Olsson P, Turesson C, Mandl T, Jacobsson L, Theander E. Cigarette smoking and the risk of primary Sjögren's syndrome: a nested case control study. Arthritis Res Ther 2017;19:50. [PMID: 28270185 DOI: 10.1186/s13075-017-1255-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
593 Jacques P, Van Praet L, Carron P, Van den Bosch F, Elewaut D. Pathophysiology and role of the gastrointestinal system in spondyloarthritides. Rheum Dis Clin North Am 2012;38:569-82. [PMID: 23083756 DOI: 10.1016/j.rdc.2012.08.012] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
594 Yoshino T, Sono M, Yazumi S. Usefulness of sulfasalazine for patients with refractory-ulcerative colits. BMJ Open Gastroenterol 2016;3:e000103. [PMID: 27648296 DOI: 10.1136/bmjgast-2016-000103] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
595 Pandey A, Verma S, Kumar VL. Metformin maintains mucosal integrity in experimental model of colitis by inhibiting oxidative stress and pro-inflammatory signaling. Biomed Pharmacother 2017;94:1121-8. [PMID: 28821163 DOI: 10.1016/j.biopha.2017.08.020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
596 Sim WH, Wagner J, Cameron DJ, Catto-Smith AG, Bishop RF, Kirkwood CD. Expression profile of genes involved in pathogenesis of pediatric Crohn’s disease. J Gastroenterol Hepatol. 2012;27:1083-1093. [PMID: 22098497 DOI: 10.1111/j.1440-1746.2011.06973.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
597 Kim DH, Cheon JH. Intestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis? Yonsei Med J 2016;57:22-32. [PMID: 26632379 DOI: 10.3349/ymj.2016.57.1.22] [Cited by in Crossref: 43] [Cited by in F6Publishing: 29] [Article Influence: 7.2] [Reference Citation Analysis]
598 Nielsen TS, Fredborg M, Theil PK, Yue Y, Bruhn LV, Andersen V, Purup S. Dietary Red Meat Adversely Affects Disease Severity in a Pig Model of DSS-Induced Colitis Despite Reduction in Colonic Pro-Inflammatory Gene Expression. Nutrients 2020;12:E1728. [PMID: 32526985 DOI: 10.3390/nu12061728] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
599 Canny G, Levy O. Bactericidal/permeability-increasing protein (BPI) and BPI homologs at mucosal sites. Trends Immunol 2008;29:541-7. [PMID: 18838299 DOI: 10.1016/j.it.2008.07.012] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 4.5] [Reference Citation Analysis]
600 Pineton de Chambrun G, Colombel J, Poulain D, Darfeuille-michaud A. Pathogenic agents in inflammatory bowel diseases: . Current Opinion in Gastroenterology 2008;24:440-7. [DOI: 10.1097/mog.0b013e3283023be5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
601 Bafford AC, Coakley B, Powers S, Greenwald D, Ha CY, Weintraub J, Chessin DB, Gorfine SR, Bauer JJ. The clinical impact of preoperative percutaneous drainage of abdominopelvic abscesses in patients with Crohn's disease. Int J Colorectal Dis 2012;27:953-8. [PMID: 22249438 DOI: 10.1007/s00384-011-1401-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
602 Rabizadeh S, Sears C. New horizons for the infectious diseases specialist: how gut microflora promote health and disease. Curr Infect Dis Rep. 2008;10:92-98. [PMID: 18462581 DOI: 10.1007/s11908-008-0017-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
603 Arya VS, Kanthlal SK, Linda G. The role of dietary polyphenols in inflammatory bowel disease: A possible clue on the molecular mechanisms involved in the prevention of immune and inflammatory reactions. J Food Biochem 2020;44:e13369. [PMID: 32885438 DOI: 10.1111/jfbc.13369] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
604 Defendenti C, Sarzi-Puttini P, Saibeni S, Bollani S, Bruno S, Almasio PL, Declich P, Atzeni F. Significance of serum Il-9 levels in inflammatory bowel disease. Int J Immunopathol Pharmacol. 2015;28:569-575. [PMID: 26377844 DOI: 10.1177/0394632015600535] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
605 Huang XL, Xu DH, Wang GP, Zhang S, Yu CG. Associations between CD24 gene polymorphisms and inflammatory bowel disease: A meta-analysis. World J Gastroenterol 2015; 21(19): 6052-6059 [PMID: 26019472 DOI: 10.3748/wjg.v21.i19.6052] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
606 Lu Y, Zamora-Ros R, Chan S, Cross AJ, Ward H, Jakszyn P, Luben R, Opstelten JL, Oldenburg B, Hallmans G, Karling P, Grip O, Key T, Bergmann MM, Boeing H, Overvad K, Palli D, Masala G, Khaw KT, Racine A, Carbonnel F, Boutron-Ruault MC, Andersen V, Olsen A, Tjonneland A, Kaaks R, Tumino R, Trichopoulou A, Scalbert A, Riboli E, Hart AR. Dietary Polyphenols in the Aetiology of Crohn's Disease and Ulcerative Colitis-A Multicenter European Prospective Cohort Study (EPIC). Inflamm Bowel Dis 2017;23:2072-82. [PMID: 28837515 DOI: 10.1097/MIB.0000000000001108] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
607 Tran V, Shammas RM, Sauk JS, Padua D. Evaluating tofacitinib citrate in the treatment of moderate-to-severe active ulcerative colitis: design, development and positioning of therapy. Clin Exp Gastroenterol 2019;12:179-91. [PMID: 31118734 DOI: 10.2147/CEG.S150908] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
608 Sabe VT, Basson AR, Jordaan E, Mazinu M. The association between environmental exposures during childhood and the subsequent development of Crohn's disease: A score analysis approach. PLoS One 2017;12:e0171742. [PMID: 28170439 DOI: 10.1371/journal.pone.0171742] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
609 van der Waal MB, Flach J, Browne PD, Besseling-van der Vaart I, Claassen E, van de Burgwal LH. Probiotics for improving quality of life in ulcerative colitis: Exploring the patient perspective. PharmaNutrition 2019;7:100139. [DOI: 10.1016/j.phanu.2018.100139] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
610 Tamboli CP. Current Medical Therapy for Chronic Inflammatory Bowel Diseases. Surgical Clinics of North America 2007;87:697-725. [DOI: 10.1016/j.suc.2007.03.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
611 Roberts-Thomson IC, Bryant RV, Costello SP. Uncovering the cause of ulcerative colitis. JGH Open 2019;3:274-6. [PMID: 31406918 DOI: 10.1002/jgh3.12216] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
612 Janeczko S, Atwater D, Bogel E, Greiter-Wilke A, Gerold A, Baumgart M, Bender H, McDonough PL, McDonough SP, Goldstein RE. The relationship of mucosal bacteria to duodenal histopathology, cytokine mRNA, and clinical disease activity in cats with inflammatory bowel disease. Vet Microbiol. 2008;128:178-193. [PMID: 18054447 DOI: 10.1016/j.vetmic.2007.10.014] [Cited by in Crossref: 120] [Cited by in F6Publishing: 101] [Article Influence: 8.0] [Reference Citation Analysis]
613 Libera J, Wittner M, Kantowski M, Woost R, Eberhard JM, de Heer J, Reher D, Huber S, Haag F, Schulze Zur Wiesch J. Decreased Frequency of Intestinal CD39+ γδ+ T Cells With Tissue-Resident Memory Phenotype in Inflammatory Bowel Disease. Front Immunol 2020;11:567472. [PMID: 33072107 DOI: 10.3389/fimmu.2020.567472] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
614 Sun X, Zhu MJ. AMP-activated protein kinase: a therapeutic target in intestinal diseases. Open Biol 2017;7:170104. [PMID: 28835570 DOI: 10.1098/rsob.170104] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
615 Stronati L, Negroni A, Merola P, Pannone V, Borrelli O, Cirulli M, Annese V, Cucchiara S. Mucosal NOD2 expression and NF-κB activation in pediatric Crohnʼs disease: . Inflammatory Bowel Diseases 2008;14:295-302. [DOI: 10.1002/ibd.20332] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
616 Li J, Doty A, Glover SC. Aryl hydrocarbon receptor signaling involves in the human intestinal ILC3/ILC1 conversion in the inflamed terminal ileum of Crohn's disease patients. Inflamm Cell Signal 2016;3:e1404. [PMID: 28286805 DOI: 10.14800/ics.1404] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
617 Marjoram L, Alvers A, Deerhake ME, Bagwell J, Mankiewicz J, Cocchiaro JL, Beerman RW, Willer J, Sumigray KD, Katsanis N, Tobin DM, Rawls JF, Goll MG, Bagnat M. Epigenetic control of intestinal barrier function and inflammation in zebrafish. Proc Natl Acad Sci U S A 2015;112:2770-5. [PMID: 25730872 DOI: 10.1073/pnas.1424089112] [Cited by in Crossref: 112] [Cited by in F6Publishing: 91] [Article Influence: 16.0] [Reference Citation Analysis]
618 Bilski J, Mazur-Bialy A, Brzozowski B, Magierowski M, Zahradnik-Bilska J, Wójcik D, Magierowska K, Kwiecien S, Mach T, Brzozowski T. Can exercise affect the course of inflammatory bowel disease? Experimental and clinical evidence. Pharmacol Rep 2016;68:827-36. [PMID: 27255494 DOI: 10.1016/j.pharep.2016.04.009] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
619 Small CL, Reid-Yu SA, McPhee JB, Coombes BK. Persistent infection with Crohn’s disease-associated adherent-invasive Escherichia coli leads to chronic inflammation and intestinal fibrosis. Nat Commun. 2013;4:1957. [PMID: 23748852 DOI: 10.1038/ncomms2957] [Cited by in Crossref: 77] [Cited by in F6Publishing: 77] [Article Influence: 8.6] [Reference Citation Analysis]
620 Hiyama S, Iijima H, Shinzaki S, Mukai A, Inoue T, Shiraishi E, Kawai S, Yamada T, Nishida T, Tsujii M, Takehara T. Narrow Band Imaging with Magnifying Endoscopy for Peyer's Patches in Patients with Inflammatory Bowel Disease. Digestion 2013;87:269-80. [DOI: 10.1159/000349953] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
621 Sullivan S, Alex P, Dassopoulos T, Zachos NC, Iacobuzio-Donahue C, Donowitz M, Brant SR, Cuffari C, Harris ML, Datta LW, Conklin L, Chen Y, Li X. Downregulation of sodium transporters and NHERF proteins in IBD patients and mouse colitis models: potential contributors to IBD-associated diarrhea. Inflamm Bowel Dis 2009;15:261-74. [PMID: 18942765 DOI: 10.1002/ibd.20743] [Cited by in Crossref: 86] [Cited by in F6Publishing: 83] [Article Influence: 6.6] [Reference Citation Analysis]
622 Shioya M, Nishida A, Yagi Y, Ogawa A, Tsujikawa T, Kim-Mitsuyama S, Takayanagi A, Shimizu N, Fujiyama Y, Andoh A. Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease. Clin Exp Immunol 2007;149:480-6. [PMID: 17590175 DOI: 10.1111/j.1365-2249.2007.03439.x] [Cited by in Crossref: 156] [Cited by in F6Publishing: 149] [Article Influence: 10.4] [Reference Citation Analysis]
623 Tada Y, Ishihara S, Kawashima K, Fukuba N, Sonoyama H, Kusunoki R, Oka A, Mishima Y, Oshima N, Moriyama I, Yuki T, Ishikawa N, Araki A, Harada Y, Maruyama R, Kinoshita Y. Downregulation of serotonin reuptake transporter gene expression in healing colonic mucosa in presence of remaining low-grade inflammation in ulcerative colitis. J Gastroenterol Hepatol 2016;31:1443-52. [PMID: 26676714 DOI: 10.1111/jgh.13268] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
624 Suwandi JS, Nikolic T, Roep BO. Translating Mechanism of Regulatory Action of Tolerogenic Dendritic Cells to Monitoring Endpoints in Clinical Trials. Front Immunol 2017;8:1598. [PMID: 29250062 DOI: 10.3389/fimmu.2017.01598] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
625 Boeing H, Bechthold A, Bub A, Ellinger S, Haller D, Kroke A, Leschik-Bonnet E, Müller MJ, Oberritter H, Schulze M, Stehle P, Watzl B. Critical review: vegetables and fruit in the prevention of chronic diseases. Eur J Nutr 2012;51:637-63. [PMID: 22684631 DOI: 10.1007/s00394-012-0380-y] [Cited by in Crossref: 935] [Cited by in F6Publishing: 743] [Article Influence: 93.5] [Reference Citation Analysis]
626 Jian Y, Zhang D, Liu M, Wang Y, Xu ZX. The Impact of Gut Microbiota on Radiation-Induced Enteritis. Front Cell Infect Microbiol 2021;11:586392. [PMID: 34395308 DOI: 10.3389/fcimb.2021.586392] [Reference Citation Analysis]
627 Amon P, Sanderson I. What is the microbiome? Arch Dis Child Educ Pract Ed 2017;102:257-60. [DOI: 10.1136/archdischild-2016-311643] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
628 Moehle MS, Daher JP, Hull TD, Boddu R, Abdelmotilib HA, Mobley J, Kannarkat GT, Tansey MG, West AB. The G2019S LRRK2 mutation increases myeloid cell chemotactic responses and enhances LRRK2 binding to actin-regulatory proteins. Hum Mol Genet 2015;24:4250-67. [PMID: 25926623 DOI: 10.1093/hmg/ddv157] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
629 Westbrook AM, Schiestl RH. Atm-deficient mice exhibit increased sensitivity to dextran sulfate sodium-induced colitis characterized by elevated DNA damage and persistent immune activation. Cancer Res 2010;70:1875-84. [PMID: 20179206 DOI: 10.1158/0008-5472.CAN-09-2584] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 3.7] [Reference Citation Analysis]
630 Sorrentino D, Nguyen VQ, Chitnavis MV. Capturing the Biologic Onset of Inflammatory Bowel Diseases: Impact on Translational and Clinical Science. Cells 2019;8:E548. [PMID: 31174359 DOI: 10.3390/cells8060548] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
631 Jin Y, Hofseth AB, Cui X, Windust AJ, Poudyal D, Chumanevich AA, Matesic LE, Singh NP, Nagarkatti M, Nagarkatti PS. American ginseng suppresses colitis through p53-mediated apoptosis of inflammatory cells. Cancer Prev Res (Phila). 2010;3:339-347. [PMID: 20179294 DOI: 10.1158/1940-6207.CAPR-09-0116] [Cited by in Crossref: 43] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
632 An K, Fang L, Luo R, Wang D, Xie L, Yang J, Chen H, Xiao S. Quantitative proteomic analysis reveals that transmissible gastroenteritis virus activates the JAK-STAT1 signaling pathway. J Proteome Res 2014;13:5376-90. [PMID: 25357264 DOI: 10.1021/pr500173p] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 4.3] [Reference Citation Analysis]
633 McQueen P, Busman-Sahay K, Rieder F, Noël-Romas L, McCorrister S, Westmacott G, Estes JD, Burgener A. Intestinal proteomic analysis of a novel non-human primate model of experimental colitis reveals signatures of mitochondrial and metabolic dysfunction. Mucosal Immunol 2019;12:1327-35. [PMID: 31481749 DOI: 10.1038/s41385-019-0200-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
634 Stolzer I, Kaden-Volynets V, Ruder B, Letizia M, Bittel M, Rausch P, Basic M, Bleich A, Baines JF, Neurath MF, Wirtz S, Weidinger C, Bischoff SC, Becker C, Günther C. Environmental Microbial Factors Determine the Pattern of Inflammatory Lesions in a Murine Model of Crohn's Disease-Like Inflammation. Inflamm Bowel Dis 2020;26:66-79. [PMID: 31276162 DOI: 10.1093/ibd/izz142] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
635 Gruber L, Lichti P, Rath E, Haller D. Nutrigenomics and nutrigenetics in inflammatory bowel diseases. J Clin Gastroenterol. 2012;46:735-747. [PMID: 22941427 DOI: 10.1097/MCG.0b013e31825ca21a] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
636 Zhou F, Wang N, Yang L, Zhang L, Meng L, Xia Y. Saikosaponin A protects against dextran sulfate sodium-induced colitis in mice. International Immunopharmacology 2019;72:454-8. [DOI: 10.1016/j.intimp.2019.04.024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
637 Williams HR, Cox IJ, Walker DG, Cobbold JF, Taylor-Robinson SD, Marshall SE, Orchard TR. Differences in gut microbial metabolism are responsible for reduced hippurate synthesis in Crohn’s disease. BMC Gastroenterol. 2010;10:108. [PMID: 20849615 DOI: 10.1186/1471-230x-10-108] [Cited by in Crossref: 64] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
638 Waldner MJ, Neurath MF. Potential avenues for immunotherapy of colitis-associated neoplasia. Immunotherapy 2012;4:397-405. [PMID: 22512634 DOI: 10.2217/imt.12.15] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
639 Trivedi PP, Jena GB. Dextran sulfate sodium-induced ulcerative colitis leads to increased hematopoiesis and induces both local as well as systemic genotoxicity in mice. Mutat Res. 2012;744:172-183. [PMID: 22414559 DOI: 10.1016/j.mrgentox.2012.03.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
640 Mittal R, Debs LH, Patel AP, Nguyen D, Patel K, O'Connor G, Grati M, Mittal J, Yan D, Eshraghi AA, Deo SK, Daunert S, Liu XZ. Neurotransmitters: The Critical Modulators Regulating Gut-Brain Axis. J Cell Physiol 2017;232:2359-72. [PMID: 27512962 DOI: 10.1002/jcp.25518] [Cited by in Crossref: 152] [Cited by in F6Publishing: 144] [Article Influence: 30.4] [Reference Citation Analysis]
641 Dogan B, Simpson KW. Microflora in Crohn's disease: the emergence of adherent and invasive Escherichia coli. Expert Rev Clin Immunol 2008;4:133-7. [PMID: 20477044 DOI: 10.1586/1744666X.4.2.133] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
642 Kaakoush NO, Deshpande NP, Wilkins MR, Tan CG, Burgos-Portugal JA, Raftery MJ, Day AS, Lemberg DA, Mitchell H. The pathogenic potential of Campylobacter concisus strains associated with chronic intestinal diseases. PLoS One. 2011;6:e29045. [PMID: 22194985 DOI: 10.1371/journal.pone.0029045] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 4.8] [Reference Citation Analysis]
643 Sadr M, Moazzami B, Soleimanifar N, Elhamian N, Rezaei A, Ebrahimi Daryani N, Rezaei N. Single Nucleotide Polymorphisms of PTPN22 Gene in Iranian Patients with Ulcerative Colitis. Fetal Pediatr Pathol 2019;38:8-13. [PMID: 30636557 DOI: 10.1080/15513815.2018.1543371] [Reference Citation Analysis]
644 Natividad JM, Verdu EF. Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications. Pharmacol Res. 2013;69:42-51. [PMID: 23089410 DOI: 10.1016/j.phrs.2012.10.007] [Cited by in Crossref: 176] [Cited by in F6Publishing: 157] [Article Influence: 17.6] [Reference Citation Analysis]
645 Vigsnæs LK, Brynskov J, Steenholdt C, Wilcks A, Licht TR. Gram-negative bacteria account for main differences between faecal microbiota from patients with ulcerative colitis and healthy controls. Benef Microbes 2012;3:287-97. [PMID: 22968374 DOI: 10.3920/BM2012.0018] [Cited by in Crossref: 61] [Cited by in F6Publishing: 34] [Article Influence: 6.8] [Reference Citation Analysis]
646 Ramachandran R, Hyun E, Zhao L, Lapointe TK, Chapman K, Hirota CL, Ghosh S, McKemy DD, Vergnolle N, Beck PL, Altier C, Hollenberg MD. TRPM8 activation attenuates inflammatory responses in mouse models of colitis. Proc Natl Acad Sci U S A 2013;110:7476-81. [PMID: 23596210 DOI: 10.1073/pnas.1217431110] [Cited by in Crossref: 94] [Cited by in F6Publishing: 93] [Article Influence: 10.4] [Reference Citation Analysis]
647 Thapa SD, Hadid H, Usman M, Imam W, Hassan A, Schairer J, Jafri SM, Kaur N. Predictors of Thiopurine Treatment Failure in Biologic-Naïve Ulcerative Colitis Patients. Dig Dis Sci 2016;61:230-7. [PMID: 26511478 DOI: 10.1007/s10620-015-3864-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
648 Ding L, Yang L, Wang Z, Huang W. Bile acid nuclear receptor FXR and digestive system diseases. Acta Pharm Sin B. 2015;5:135-144. [PMID: 26579439 DOI: 10.1016/j.apsb.2015.01.004] [Cited by in Crossref: 133] [Cited by in F6Publishing: 125] [Article Influence: 19.0] [Reference Citation Analysis]
649 Date AA, Rais R, Babu T, Ortiz J, Kanvinde P, Thomas AG, Zimmermann SC, Gadiano AJ, Halpert G, Slusher BS, Ensign LM. Local enema treatment to inhibit FOLH1/GCPII as a novel therapy for inflammatory bowel disease. J Control Release 2017;263:132-8. [PMID: 28159515 DOI: 10.1016/j.jconrel.2017.01.036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
650 Loh G, Brodziak F, Blaut M. The Toll-like receptors TLR2 and TLR4 do not affect the intestinal microbiota composition in mice. Environ Microbiol 2008;10:709-15. [PMID: 18036181 DOI: 10.1111/j.1462-2920.2007.01493.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
651 Halpert G, Eitan T, Voronov E, Apte RN, Rath-Wolfson L, Albeck M, Kalechman Y, Sredni B. Multifunctional activity of a small tellurium redox immunomodulator compound, AS101, on dextran sodium sulfate-induced murine colitis. J Biol Chem 2014;289:17215-27. [PMID: 24764299 DOI: 10.1074/jbc.M113.536664] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
652 Rath E, Haller D. Inflammation and cellular stress: a mechanistic link between immune-mediated and metabolically driven pathologies. Eur J Nutr. 2011;50:219-233. [PMID: 21547407 DOI: 10.1007/s00394-011-0197-0] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 4.8] [Reference Citation Analysis]
653 Abreu MT, Plevy S, Sands BE, Weinstein R. Selective leukocyte apheresis for the treatment of inflammatory bowel disease. J Clin Gastroenterol. 2007;41:874-888. [PMID: 18090155 DOI: 10.1097/mcg.0b013e3180479435] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
654 Ahmad H, Verma S, Kumar VL. Effect of roxithromycin on mucosal damage, oxidative stress and pro-inflammatory markers in experimental model of colitis. Inflamm Res 2018;67:147-55. [PMID: 28988395 DOI: 10.1007/s00011-017-1103-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
655 Karwad MA, Macpherson T, Wang B, Theophilidou E, Sarmad S, Barrett DA, Larvin M, Wright KL, Lund JN, O'Sullivan SE. Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARα. FASEB J 2017;31:469-81. [PMID: 27623929 DOI: 10.1096/fj.201500132] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 7.3] [Reference Citation Analysis]
656 Pu T, Liu W, Wu Y, Zhao Y. ABIN1 alleviates inflammatory responses and colitis via facilitating A20 activity. Ther Adv Chronic Dis 2020;11:2040622320944782. [PMID: 32843955 DOI: 10.1177/2040622320944782] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
657 Wu CC, Tung YT, Chen SY, Lee WT, Lin HT, Yen GC. Anti-Inflammatory, Antioxidant, and Microbiota-Modulating Effects of Camellia Oil from Camellia brevistyla on Acetic Acid-Induced Colitis in Rats. Antioxidants (Basel) 2020;9:E58. [PMID: 31936300 DOI: 10.3390/antiox9010058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
658 Dikopoulos N, Schmid RM, Bachem M, Buttenschoen K, Adler G, Chiang JY, Weidenbach H. Bile synthesis in rat models of inflammatory bowel diseases. Eur J Clin Invest 2007;37:222-30. [PMID: 17359490 DOI: 10.1111/j.1365-2362.2007.01779.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
659 Waldner MJ, Neurath MF. Chemically induced mouse models of colitis. Curr Protoc Pharmacol. 2009;Chapter 5:Unit 5.55. [PMID: 22294401 DOI: 10.1002/0471141755.ph0555s46] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
660 Kolodziej LE, Lodolce JP, Chang JE, Schneider JR, Grimm WA, Bartulis SJ, Zhu X, Messer JS, Murphy SF, Reddy N. TNFAIP3 maintains intestinal barrier function and supports epithelial cell tight junctions. PLoS One. 2011;6:e26352. [PMID: 22031828 DOI: 10.1371/journal.pone.0026352] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 4.1] [Reference Citation Analysis]
661 Bushell KN, Leeman SE, Gillespie E, Gower AC, Reed KL, Stucchi AF, Becker JM, Amar S. LITAF mediation of increased TNF-α secretion from inflamed colonic lamina propria macrophages. PLoS One 2011;6:e25849. [PMID: 21984950 DOI: 10.1371/journal.pone.0025849] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
662 Silva FA, Rodrigues BL, Ayrizono ML, Leal RF. The Immunological Basis of Inflammatory Bowel Disease. Gastroenterol Res Pract. 2016;2016:2097274. [PMID: 28070181 DOI: 10.1155/2016/2097274] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 8.5] [Reference Citation Analysis]
663 Rasmussen HE, Hamaker BR. Prebiotics and Inflammatory Bowel Disease. Gastroenterol Clin North Am 2017;46:783-95. [PMID: 29173521 DOI: 10.1016/j.gtc.2017.08.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
664 Glas J, Seiderer J, Pasciuto G, Tillack C, Diegelmann J, Pfennig S, Konrad A, Schmechel S, Wetzke M, Török HP, Stallhofer J, Jürgens M, Griga T, Klein W, Epplen JT, Schiemann U, Mussack T, Lohse P, Göke B, Ochsenkühn T, Folwaczny M, Müller-Myhsok B, Brand S. rs224136 on chromosome 10q21.1 and variants in PHOX2B, NCF4, and FAM92B are not major genetic risk factors for susceptibility to Crohn's disease in the German population. Am J Gastroenterol 2009;104:665-72. [PMID: 19262523 DOI: 10.1038/ajg.2008.65] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
665 Mantarro A, Scalise P, Guidi E, Neri E. Magnetic resonance enterography in Crohn’s disease: How we do it and common imaging findings. World J Radiol 2017; 9(2): 46-54 [PMID: 28298964 DOI: 10.4329/wjr.v9.i2.46] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
666 Saygın D, Syed AU, Lowder CY, Srivastava S, Maya JJ, Hajj-Ali RA. Characteristics of inflammatory eye disease associated with hidradenitis suppurativa. Eur J Rheumatol 2018;5:165-8. [PMID: 30071934 DOI: 10.5152/eurjrheum.2018.17163] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
667 Lahat A, Kopylov U, Neuman S, Levhar N, Yablecovitch D, Avidan B, Weiss B, Ben-Horin S, Eliakim R; on behalf of the Israeli IBD research Network (IIRN). Helicobacter pylori prevalence and clinical significance in patients with quiescent Crohn's disease. BMC Gastroenterol 2017;17:27. [PMID: 28193167 DOI: 10.1186/s12876-017-0588-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
668 Shi Y, Kellingray L, Zhai Q, Gall GL, Narbad A, Zhao J, Zhang H, Chen W. Structural and Functional Alterations in the Microbial Community and Immunological Consequences in a Mouse Model of Antibiotic-Induced Dysbiosis. Front Microbiol 2018;9:1948. [PMID: 30186263 DOI: 10.3389/fmicb.2018.01948] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
669 Bilski J, Mazur-Bialy AI, Brzozowski B, Magierowski M, Jasnos K, Krzysiek-Maczka G, Urbanczyk K, Ptak-Belowska A, Zwolinska-Wcislo M, Mach T, Brzozowski T. Moderate exercise training attenuates the severity of experimental rodent colitis: the importance of crosstalk between adipose tissue and skeletal muscles. Mediators Inflamm 2015;2015:605071. [PMID: 25684862 DOI: 10.1155/2015/605071] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
670 Van den Berghe N, Verstockt B, Gils A, Sabino J, Ferrante M, Vermeire S, Declerck P, Thomas D. Tissue Exposure does not Explain Non-Response in Ulcerative Colitis Patients with Adequate Serum Vedolizumab Concentrations. Journal of Crohn's and Colitis 2021;15:988-93. [DOI: 10.1093/ecco-jcc/jjaa239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
671 Terry PD, Villinger F, Bubenik GA, Sitaraman SV. Melatonin and ulcerative colitis: evidence, biological mechanisms, and future research. Inflamm Bowel Dis. 2009;15:134-140. [PMID: 18626968 DOI: 10.1002/ibd.20527] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
672 Lemoine R, Pachlopnik-Schmid J, Farin HF, Bigorgne A, Debré M, Sepulveda F, Héritier S, Lemale J, Talbotec C, Rieux-Laucat F. Immune deficiency-related enteropathy-lymphocytopenia-alopecia syndrome results from tetratricopeptide repeat domain 7A deficiency. J Allergy Clin Immunol. 2014;134:1354-1364.e6. [PMID: 25174867 DOI: 10.1016/j.jaci.2014.07.019] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
673 Picardo S, Panaccione R. Anti-MADCAM therapy for ulcerative colitis. Expert Opin Biol Ther 2020;20:437-42. [PMID: 31709847 DOI: 10.1080/14712598.2020.1691520] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
674 Kim DH, Sung B, Chung HY, Kim ND. Modulation of Colitis-associated Colon Tumorigenesis by Baicalein and Betaine. J Cancer Prev 2014;19:153-60. [PMID: 25337584 DOI: 10.15430/JCP.2014.19.3.153] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
675 Nagahama K, Ogawa A, Shirane K, Shimomura Y, Sugimoto K, Mizoguchi A. Protein Kinase C θ Plays a Fundamental Role in Different Types of Chronic Colitis. Gastroenterology 2008;134:459-69. [DOI: 10.1053/j.gastro.2007.11.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
676 Sarvestani SK, Signs SA, Lefebvre V, Mack S, Ni Y, Morton A, Chan ER, Li X, Fox P, Ting A, Kalady MF, Cruise M, Ashburn J, Stiene J, Lai W, Liska D, Xiang S, Huang EH. Cancer-predicting transcriptomic and epigenetic signatures revealed for ulcerative colitis in patient-derived epithelial organoids. Oncotarget. 2018;9:28717-28730. [PMID: 29983891 DOI: 10.18632/oncotarget.25617] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
677 Lee SH, Kwon JY, Moon J, Choi J, Jhun J, Jung K